The Biosynthesis the T Th The The BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
Oxidized Lipids oxidized O Ox Oxi Oxid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 4 0 0 0 0 1
Ali A. ali A Al Ali Ali BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .*,.,,. 7 10 0 0 0 0 1
and Valerie and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .' 2 10 0 0 0 0 1
1 Systems 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 ,,,, 4 10 0 0 0 0 1
2 Institute 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 ,,,,, 5 9 0 0 0 0 1
Barts Cancer barts B Ba Bar Bart BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,, 3 6 0 0 0 0 1
Enzymatically oxidized enzymatically E En Enz Enzy BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 9 0 0 0 0 1
signaling mediators signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 , 1 10 0 0 0 0 1
from metabolism from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
broadly categorized broadly b br bro broa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ()( 3 9 0 0 0 0 1
oxygenated PUFA oxygenated o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 "",,) 5 9 0 0 0 0 1
derivatives (oxysterols, derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (,,). 5 9 0 0 0 0 1
accomplished by accomplished a ac acc acco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 (), 3 7 0 0 0 0 1
cyclooxygenases (COX), cyclooxygenases c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 (),(),-(). 10 9 0 0 0 0 1
contrast, non-enzymatically contrast, c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,- 2 9 0 0 0 0 1
are broadly are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ., 2 9 0 0 0 0 1
and enzymology and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,,., 5 8 0 0 0 0 1
biosynthetic pathways biosynthetic b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,, 3 9 0 0 0 0 1
steroid hormones. steroid s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 1 ., 2 8 0 0 0 0 1
future work. future f fu fut futu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 1 0 0 0 0 1
Keywords: biosynthesis keywords: K Ke Key Keyw BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :,(),(),,- 10 10 0 0 0 0 1
reductase (AKR), reductase r re red redu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 (),,, 5 7 0 0 0 0 1
INTRODUCTION INTRODUCTION introduction I IN INT INTR BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 no 0 10 0 0 0 0 1
Lipids are lipids L Li Lip Lipi BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 ., 2 9 0 0 0 0 1
and energy and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ., 2 9 0 0 0 0 1
their functional their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 0 0 0 0 1
oxygenation, with oxygenation, o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 ,: 2 10 0 0 0 0 1
detection of detection d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,- 2 9 0 0 0 0 1
biological processes biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ."" 3 10 0 0 0 0 1
oxygenated lipid oxygenated o ox oxy oxyg BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 5 , 1 9 0 0 0 0 1
Abbreviations: 4-HNE, abbreviations: A Ab Abb Abbr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 :-,---;,;,-;,-;, 16 9 0 1 0 0 1
cyclooxygenase; CE, cyclooxygenase; c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ;,;,;,--;,; 11 9 0 1 0 0 1
DPEP2, dipeptidase dpep2, D DP DPE DPEP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 ,;,-;,;,-;, 11 9 0 1 0 0 1
g-linolenic acid; g-linolenic g g- g-l g-li BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 -;,-;,-;,- 10 8 0 1 0 0 1
eicosatetraenoic acid; eicosatetraenoic e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ;,;,;,;,; 9 10 0 1 0 0 1
lysoPL, lysophospholipid; lysopl, l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ,;,;,;,;, 9 9 0 1 0 0 1
acid; SDR, acid; a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ;,-/;,-. 8 7 0 1 0 0 1
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 .. 2 10 0 1 0 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 9 no 0 8 0 1 0 0 0
1 1 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 9 no 0 0 0 1 0 0 0
Edited by: edited E Ed Edi Edit BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 3 0 0 0 0 1
Maria Fedorova, maria M Ma Mar Mari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 9 , 1 5 0 0 0 0 1
Leipzig University, leipzig L Le Lei Leip BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 , 1 10 0 0 0 0 1
Reviewed by: reviewed R Re Rev Revi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 : 1 3 0 0 0 0 1
Consolato Sergi, consolato C Co Con Cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 , 1 4 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 10 0 0 0 0 1
Katja Hummitzsch, katja K Ka Kat Katj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 , 1 4 0 0 0 0 1
University of university U Un Uni Univ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 8 0 0 0 0 1
*Correspondence: *Correspondence: *correspondence: * *C *Co *Cor BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 *: 2 7 0 0 0 0 1
Ali A. ali A Al Ali Ali BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 10 . 1 6 0 0 0 0 1
hajeyahaa@cardiff.ac.uk hajeyahaa@cardiff.ac.uk hajeyahaa@cardiff.ac.uk h ha haj haje BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 1 0 0 10 @.. 3 10 0 0 0 0 1
Specialty section: specialty S Sp Spe Spec BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 : 1 6 0 0 0 0 1
This article this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 10 0 0 0 0 1
Systems Endocrinology, systems S Sy Sys Syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 10 , 1 7 0 0 0 0 1
a section a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 10 no 0 8 0 0 0 0 1
Frontiers in frontiers F Fr Fro Fron BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 9 0 0 0 0 1
Received: 05 received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 : 1 8 0 0 0 0 1
Accepted: 26 accepted: A Ac Acc Acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 : 1 9 0 0 0 0 1
Published: 19 published: P Pu Pub Publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 : 1 10 0 0 0 0 1
Citation: Citation: citation: C Ci Cit Cita BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 2 0 1 0 0 1
Hajeyah AA, hajeyah H Ha Haj Haje BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ,,, 3 10 0 1 0 0 1
Finch AJ finch F Fi Fin Finc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 11 '() 3 9 0 1 0 0 1
The Biosynthesis the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 0 1 0 0 1
Oxidized Lipids. oxidized O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 . 1 5 0 1 0 0 1
Front. Endocrinol. front. F Fr Fro Fron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ..:. 4 8 0 1 0 0 1
doi: 10.3389/fendo.2020.591819 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 :./.. 5 9 0 1 0 0 1
REVIEW REVIEW review R RE REV REVI BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 2 0 1 0 0 0
published: 19 published: p pu pub publ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 : 1 9 0 1 0 0 0
doi: 10.3389/fendo.2020.591819 doi: d do doi doi: BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 :./.. 5 10 0 1 0 0 0
biosynthetic pathways biosynthetic b bi bio bios BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
derived from derived d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 () 2 8 0 0 0 0 1
such as such s su suc such BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()(), 5 8 0 0 0 0 1
thromboxanes and thromboxanes t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
inflammation, the inflammation, i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,,, 3 8 0 0 0 0 1
broadly termed broadly b br bro broa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ""(,). 6 8 0 0 0 0 1
multiply oxygenated multiply m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 () 2 8 0 0 0 0 1
and docosahexaenoic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (), 3 8 0 0 0 0 1
have been have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 "-"() 5 8 0 0 0 0 1
for their for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 9 0 0 0 0 1
SPMs derived spms S SP SPM SPMs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 -, 2 7 0 0 0 0 1
protectin. On protectin. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .,- 3 8 0 0 0 0 1
generated from generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
require further require r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 9 0 0 0 0 1
functional group functional f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
phospholipids (oxPL), phospholipids p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (), 3 8 0 0 0 0 1
(CE). Oxidized (ce). ( (C (CE (CE) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 (). 3 7 0 0 0 0 1
atherosclerosis progression atherosclerosis a at ath athe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (), 3 9 0 0 0 0 1
phospholipids (eoxPL) phospholipids p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()- 3 8 0 0 0 0 1
of innate of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 8 0 0 0 0 1
Enzymatically oxidized enzymatically E En Enz Enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
containing oxygenated containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 7 0 0 0 0 1
derivatives of derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
and their and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
multiple physiological multiple m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (.., 4 8 0 0 0 0 1
glucose homeostasis glucose g gl glu gluc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ),, 3 8 0 0 0 0 1
immune function, immune i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,(- 3 8 0 0 0 0 1
8). Bile 8). 8 8) 8). 8). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 )., 3 9 0 0 0 0 1
and bilirubin and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
signaling molecules signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (,)., 5 9 0 0 0 0 1
accumulating evidence accumulating a ac acc accu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
bile acid bile b bi bil bile BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (). 3 8 0 0 0 0 1
Enzymatic lipid enzymatic E En Enz Enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
that use that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 0 0 0 0 1
(LOX), cyclooxygenase (lox), ( (L (LO (LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 (),(),(), 9 8 0 0 0 0 1
which exist which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
(12-16). In (12-16). ( (1 (12 (12- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 (-).,,, 7 9 0 0 0 0 1
and to and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 9 0 0 0 0 1
initiated by initiated i in ini init BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,,, 4 8 0 0 0 0 1
is proposed is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 7 0 0 0 0 1
cholesterol oxidation cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
sidechain shortening sidechain s si sid side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
catalyzed by catalyzed c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 (). 3 9 0 0 0 0 1
cholesterol predominantly cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 : 1 8 0 0 0 0 1
starting with starting s st sta star BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 8 0 0 0 0 1
(17). CYPs (17). ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ()., 4 9 0 0 0 0 1
the formation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 9 0 0 0 0 1
keto reductases keto k ke ket keto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ()() 4 8 0 0 0 0 1
catalyze key catalyze c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
hormone biosynthesis. hormone h ho hor horm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 3 0 0 0 0 1
By contrast, by B By By By BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 0 0 0 0 1
through uncontrolled through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
This involves this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 9 0 0 0 0 1
chain propagation chain c ch cha chai BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ., 2 8 0 0 0 0 1
oxygenation of oxygenation o ox oxy oxyg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 , 1 9 0 0 0 0 1
react in react r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 10 0 0 0 0 1
forming due forming f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 - 1 8 0 0 0 0 1
pathway intermediates. pathway p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 3 0 0 0 0 1
Here, we here, H He Her Here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 , 1 8 0 0 0 0 1
lipid metabolism, lipid l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ,,,. 4 9 0 0 0 0 1
we outline we w we we we BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 ,, 2 8 0 0 0 0 1
oxysterols, bile oxysterols, o ox oxy oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 6 ,., 3 10 0 0 0 0 1
outstanding questions outstanding o ou out outs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 6 . 1 9 0 0 0 0 1
ENZYME FAMILIES enzyme E EN ENZ ENZY BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
BIOSYNTHESIS OF biosynthesis B BI BIO BIOS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 6 no 0 10 0 0 0 0 1
Lipoxygenase (LOX) lipoxygenase L Li Lip Lipo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 () 2 10 0 0 0 0 1
Human LOX: human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 : 1 10 0 0 0 0 1
Lipoxygenases (LOX) lipoxygenases L Li Lip Lipo BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 ()-- 4 9 0 0 0 0 1
dioxygenases. They dioxygenases. d di dio diox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 8 0 0 0 0 1
dioxygen to dioxygen d di dio diox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (,)- 4 8 0 0 0 0 1
producing lipid producing p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 8 0 0 0 0 1
six functional six s si six six BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,(). 4 9 0 0 0 0 1
LOXs were loxs L LO LOX LOXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 no 0 8 0 0 0 0 1
specificity for specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ()., 4 8 0 0 0 0 1
characterized member characterized c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 0 0 0 0 1
(38), while (38), ( (3 (38 (38) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 (),. 4 8 0 0 0 0 1
Sequence analysis sequence S Se Seq Sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 (()) 4 9 0 0 0 0 1
shows that shows s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 -()- 4 8 0 0 0 0 1
LOX-2 (ALOX15B; lox-2 L LO LOX LOX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 -(;.)-(; 8 8 0 0 0 0 1
35.7% identity). 35.7% 3 35 35. 35.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 .).,--() 8 8 0 0 0 0 1
exhibits dual exhibits e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
name (18). name n na nam name BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 (). 3 8 0 0 0 0 1
cause of cause c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ., 2 8 0 0 0 0 1
enzyme names enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 (). 3 5 0 0 0 0 1
LOXs are loxs L LO LOX LOXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 7 ,- 2 8 0 0 0 0 1
LOX-1 (ALOX15) lox-1 L LO LOX LOX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 -()-- 5 8 0 0 0 0 1
monocyte-derived macrophages monocyte-derived m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 -().-- 6 7 0 0 0 0 1
(ALOX15B) is (alox15b) ( (A (AL (ALO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 (), 3 9 0 0 0 0 1
expression can expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,, 2 8 0 0 0 0 1
lipopolysaccharide. It lipopolysaccharide. l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 . 1 9 0 0 0 0 1
expressed LOXs expressed e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 5 0 0 0 0 1
Structure and structure S St Str Stru BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 10 0 0 0 0 1
of Mammalian of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 5 0 0 0 0 1
There are there T Th The Ther BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 9 0 0 0 0 1
mammalian LOXs. mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 .-- 3 8 0 0 0 0 1
a single a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 10 : 1 9 0 0 0 0 1
b-barrel N-terminal b-barrel b b- b-b b-ba BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 ----- 5 9 0 0 0 0 1
domain containing domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 -(-). 5 8 0 0 0 0 1
coordination positions coordination c co coo coor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 9 0 0 0 0 1
conserved His conserved c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 ,- 2 9 0 0 0 0 1
residue, a residue, r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 ,(,, 4 10 0 0 0 0 1
Asn, or asn, A As Asn Asn, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ,).- 4 8 0 0 0 0 1
terminal domain terminal t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 , 1 10 0 0 0 0 1
functions in functions f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 (,).- 5 8 0 0 0 0 1
terminal domain terminal t te ter term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 -() 3 8 0 0 0 0 1
be important be b be be be BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 - 1 9 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 .. 2 10 0 1 1 1 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 11 no 0 8 0 1 0 0 0
2 2 2 2 2 2 2 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 0 0 1 0 0 0
cytosol or cytosol c cy cyt cyto BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 () 2 8 0 0 0 0 1
envelope and envelope e en env enve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (,). 4 8 0 0 0 0 1
reported for reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 8 0 0 0 0 1
the cytosol the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (,). 4 8 0 0 0 0 1
LOXs, the loxs, L LO LOX LOXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ,- 2 8 0 0 0 0 1
proteins 5-lipoxygenase proteins p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -(),- 5 8 0 0 0 0 1
like protein like l li lik like BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()()(, 6 9 0 0 0 0 1
50). Additionally, 50). 5 50 50) 50). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ).,- 4 8 0 0 0 0 1
sites, regulating sites, s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 10 0 0 0 0 1
activated by activated a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (-). 4 3 0 0 0 0 1
On the on O On On On BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,- 2 8 0 0 0 0 1
for free for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .,- 3 8 0 0 0 0 1
small scaffolding small s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 ,- 2 8 0 0 0 0 1
protein 1 protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()().- 6 9 0 0 0 0 1
on PL-esterified on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
ferroptosis along ferroptosis f fe fer ferr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 .- 2 9 0 0 0 0 1
LOX activity lox L LO LOX LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 (). 3 9 0 0 0 0 1
The crystal the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 --() 4 8 0 0 0 0 1
hydrophobic loop hydrophobic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
calcium binding calcium c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-(). 5 8 0 0 0 0 1
Hydrogen-deuterium exchange hydrogen-deuterium H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 7 0 0 0 0 1
decrease in decrease d de dec decr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 /, 2 8 0 0 0 0 1
role in role r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (,).-- 6 8 0 0 0 0 1
associate with associate a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 9 0 0 0 0 1
exhibit differences exhibit e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,. 2 9 0 0 0 0 1
Calcium-dependent membrane calcium-dependent C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 7 0 0 0 0 1
shown for shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -(),, 5 7 0 0 0 0 1
12R-LOX (ALOX12B), 12r-lox 1 12 12R 12R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -(),(,). 8 7 0 0 0 0 1
12S-LOX (ALOX12) 12s-lox 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -() 3 7 0 0 0 0 1
availability of availability a av ava avai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 , 1 8 0 0 0 0 1
action of action a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 8 0 0 0 0 1
12S-LOX is 12s-lox 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -. 2 8 0 0 0 0 1
regulation of regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 8 0 0 0 0 1
calcium has calcium c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 - 1 8 0 0 0 0 1
LOX but lox L LO LOX LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 (). 3 3 0 0 0 0 1
Aside from aside A As Asi Asid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -(), 4 7 0 0 0 0 1
crystal structures crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 -., 3 8 0 0 0 0 1
human platelet human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 -() 3 7 0 0 0 0 1
small-angle x-ray small-angle s sm sma smal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --, 3 8 0 0 0 0 1
in solution in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 (). 3 9 0 0 0 0 1
exist and exist e ex exi exis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 .- 2 8 0 0 0 0 1
activity as activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 8 0 0 0 0 1
thought to thought t th tho thou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ().,-- 6 9 0 0 0 0 1
1 (ALOX15) 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 4 ()- 3 9 0 0 0 0 1
solutions, and solutions, s so sol solu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
presence of presence p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (). 3 10 0 0 0 0 1
monomer-dimer equilibria monomer-dimer m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 -.--(. 6 8 0 0 0 0 1
sequence identity sequence s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ). 2 9 0 0 0 0 1
In summary, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 4 , 1 8 0 0 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 -.- 3 8 0 0 0 0 1
protein partners protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 8 0 0 0 0 1
whereas 15-LOXs whereas w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 - 1 9 0 0 0 0 1
catalyze the catalyze c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 -. 2 9 0 0 0 0 1
about the about a ab abo abou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -. 2 9 0 0 0 0 1
monomer-dimer equilibria monomer-dimer m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 - 1 8 0 0 0 0 1
isoforms and isoforms i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 8 0 0 0 0 1
Finally, complete finally, F Fi Fin Fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 , 1 9 0 0 0 0 1
12S-LOX, 12R-LOX, 12s-lox, 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 -,-,.-, 7 8 0 0 0 0 1
crystal structure crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 4 no 0 9 0 0 0 0 1
inhibitors, as inhibitors, i in inh inhi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ,. 2 9 0 0 0 0 1
Reaction Mechanism reaction R Re Rea Reac BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 10 0 0 0 0 1
The dioxygenase the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 9 0 0 0 0 1
form of form f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ()., 4 8 0 0 0 0 1
hydrogen atom hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 - 1 8 0 0 0 0 1
iron [Fe(III)]. iron i ir iro iron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 [()].() 7 9 0 0 0 0 1
hydrogen directly. hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 .,- 3 8 0 0 0 0 1
electron transfer electron e el ele elec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ()()(). 7 9 0 0 0 0 1
this, the this, t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ,() 3 10 0 0 0 0 1
is picked is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 8 0 0 0 0 1
(simultaneously), producing (simultaneously), ( (s (si (sim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (), 3 9 0 0 0 0 1
[Fe(II)]. This [fe(ii)]. [ [F [Fe [Fe( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 [()]. 5 9 0 0 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ., 2 9 0 0 0 0 1
introduced onto introduced i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 8 0 0 0 0 1
(antarafacially), generating (antarafacially), ( (a (an (ant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 (),., 5 9 0 0 0 0 1
lipid peroxyl lipid l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 () 2 9 0 0 0 0 1
a lipid a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 0 7 ,.() 4 8 0 0 0 0 1
another round another a an ano anot BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 4 0 0 0 0 1
TABLE 1 table T TA TAB TABL BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 :,,. 4 10 0 1 0 0 1
Gene Gene gene G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 9 no 0 2 0 1 0 0 1
Protein Protein protein P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 3 0 1 0 0 1
Preferred substrate(s) preferred P Pr Pre Pref BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 () 2 10 0 1 0 0 1
Expression sites expression E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 7 0 1 0 0 1
Refs. Refs. refs. R Re Ref Refs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 2 0 1 0 0 1
ALOX12 ALOX12 alox12 A AL ALO ALOX BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 no 0 0 0 1 0 0 1
12S-LOX 12S-LOX 12s-lox 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 - 1 1 0 1 0 0 1
DHA & dha D DH DHA DHA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 no 0 2 0 1 0 0 1
Platelets, umbilical platelets, P Pl Pla Plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,,, 3 10 0 1 0 0 1
skin epidermis skin s sk ski skin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 2 0 1 0 0 1
(18-22), (18-22), (18-22), ( (1 (18 (18- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 (-), 4 10 0 1 0 0 1
ALOX12B 12R-LOX alox12b A AL ALO ALOX BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 - 1 4 0 1 0 0 1
O-Linoleoyl-w-hydroxyceramide O-Linoleoyl-w-hydroxyceramide o-linoleoyl-w-hydroxyceramide O O- O-L O-Li BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 --- 3 8 0 1 0 0 1
AA & aa A AA AA AA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 ,,- 3 10 0 1 0 0 1
GLA GLA gla G GL GLA GLA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 9 no 0 1 0 1 0 0 1
Hair roots, hair H Ha Hai Hair BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 10 ,,-,, 5 10 0 1 0 0 1
cells cells cells c ce cel cell BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 10 no 0 0 0 1 0 0 1
(23-27) (23-27) (23-27) ( (2 (23 (23- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (-) 3 10 0 1 0 0 1
ALOX15 ALOX15 alox15 A AL ALO ALOX BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 no 0 3 0 0 0 0 1
15-LOX-1 15-LOX-1 15-lox-1 1 15 15- 15-L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 -- 2 5 0 0 0 0 1
(12/15 LOX (12/15 ( (1 (12 (12/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (/ 2 10 0 0 0 0 1
ortholog) ortholog) ortholog) o or ort orth BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 ) 1 5 0 0 0 0 1
DHA > dha D DH DHA DHA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 2 0 0 0 0 1
Monocytes, macrophages, monocytes, M Mo Mon Mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ,,,,, 5 10 0 0 0 0 1
tracheal epithelium tracheal t tr tra trac BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 2 0 0 0 0 1
(18, 28-32) (18, ( (1 (18 (18, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (,-) 4 10 0 0 0 0 1
ALOX15B 15-LOX-2 alox15b A AL ALO ALOX BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 -- 2 10 0 0 0 0 1
(8-LOX (8-LOX (8-lox ( (8 (8- (8-L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (- 2 4 0 0 0 0 1
murine ortholog) murine m mu mur muri BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 10 ) 1 10 0 0 0 0 1
DHA > dha D DH DHA DHA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 no 0 2 0 0 0 0 1
Macrophages, hair macrophages, M Ma Mac Macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 10 ,,,,, 5 10 0 0 0 0 1
(18, 28, (18, ( (1 (18 (18, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 10 (,,), 5 2 0 0 0 0 1
ALOX5 ALOX5 alox5 A AL ALO ALOX BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 no 0 1 0 0 0 0 1
5-LOX 5-LOX 5-lox 5 5- 5-L 5-LO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 - 1 1 0 0 0 0 1
AA & aa A AA AA AA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 - 1 2 0 0 0 0 1
Leukocytes, dendritic leukocytes, L Le Leu Leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ,,,, 4 10 0 0 0 0 1
(34-36) (34-36) (34-36) ( (3 (34 (34- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 (-) 3 1 0 0 0 0 1
ALOXE3 ALOXE3 aloxe3 A AL ALO ALOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 no 0 1 0 0 0 0 1
eLOX3 eLOX3 elox3 e eL eLO eLOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 no 0 1 0 0 0 0 1
9R-Hydroperoxy-linoleoyl-w- 9R-Hydroperoxy-linoleoyl-w- 9r-hydroperoxy-linoleoyl-w- 9 9R 9R- 9R-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 ---- 4 4 0 0 0 0 1
hydroxyceramide hydroxyceramide hydroxyceramide h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 2 0 0 0 0 1
12R-HpETE 12R-HpETE 12r-hpete 1 12 12R 12R- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 - 1 1 0 0 0 0 1
Skin epidermis skin S Sk Ski Skin BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 no 0 10 0 0 0 0 1
(25, 37) (25, ( (2 (25 (25, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 (,) 3 6 0 0 0 0 1
AA arachidonic aa A AA AA AA BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ,;,;,-;,-. 10 10 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 0 11 no 0 8 0 1 0 0 0
3 3 3 3 3 3 3 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 11 no 0 0 0 1 0 0 0
A A a A A A A BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
D D d D D D D BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 0 0 0 1
C C c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
FIGURE 1 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ().().-(), 10 10 1 0 0 0 1
electron and electron e el ele elec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 (),.().().(). 13 10 1 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 . 1 10 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 .. 2 10 0 0 0 0 0
November 2020 november N No Nov Nove BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 10 no 0 10 1 0 0 0 0
4 4 4 4 4 4 4 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 10 1 0 0 0 0
The stereo the T Th The The BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
determined by determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 :() 3 9 0 0 0 0 1
position the position p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,() 3 10 0 0 0 0 1
radical rearrangement radical r ra rad radi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 8 0 0 0 0 1
include a include i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
(63), a (63), ( (6 (63 (63) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (),(),/ 7 9 0 0 0 0 1
"switch" that "switch" " "s "sw "swi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 "" 2 9 0 0 0 0 1
(65), and (65), ( (6 (65 (65) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (), 3 9 0 0 0 0 1
specificity (66, specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,).- 5 9 0 0 0 0 1
Newcomer and newcomer N Ne New Newc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 3 0 0 0 0 1
In addition in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
other reactions other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 10 0 0 0 0 1
abstraction, homolytic abstraction, a ab abs abst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,, 2 9 0 0 0 0 1
(69). eLOX3 (69). ( (6 (69 (69) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (). 3 8 0 0 0 0 1
(lipohydroperoxidase activity) (lipohydroperoxidase ( (l (li (lip BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 9 0 0 0 0 1
to epoxy-alcohols to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -()(). 6 8 0 0 0 0 1
restricted dioxygenase restricted r re res rest BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (), 3 9 0 0 0 0 1
isomerase activity isomerase i is iso isom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
Also, mammalian also, A Al Als Also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ,---() 6 7 0 0 0 0 1
possess leukotriene possess p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
epoxides from epoxides e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (-). 4 7 0 0 0 0 1
involves the involves i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
alkoxy radical alkoxy a al alk alko BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 8 0 0 0 0 1
bis-allylic methylene bis-allylic b bi bis bis- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 -. 2 9 0 0 0 0 1
resulting biradical resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
(Figure 1C). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 1 0 0 0 0 1
LOXs are loxs L LO LOX LOXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 9 0 0 0 0 1
activation via activation a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ()(). 5 10 0 0 0 0 1
is facilitated is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
reaction products. reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 0 0 0 0 1
regenerates the regenerates r re reg rege BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 0 0 0 0 1
amounts of amounts a am amo amou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
resulting in resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 0 0 0 0 1
repeated activation repeated r re rep repe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (() 3 8 0 0 0 0 1
hydroperoxide) for hydroperoxide) h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 )(,,). 6 8 0 0 0 0 1
Some LOXs some S So Som Some BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
the reaction the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .- 2 9 0 0 0 0 1
LOX is lox L LO LOX LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
and leukotriene and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ().,- 5 9 0 0 0 0 1
(human 15-LOX-1 (human ( (h (hu (hum BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (--)- 5 8 0 0 0 0 1
HpETE, and hpete, H Hp HpE HpET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 , 1 7 0 0 0 0 1
formation of formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
enzyme (78). enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 8 0 0 0 0 1
activities (lipohydroperoxidase activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 9 0 0 0 0 1
been proposed been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 9 0 0 0 0 1
but the but b bu but but BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (). 3 7 0 0 0 0 1
LOXs Act loxs L LO LOX LOXs BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 10 0 0 0 0 1
LOX isoforms lox L LO LOX LOX BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 . 1 9 0 0 0 0 1
mammalian 5-LOXs mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -,- 3 8 0 0 0 0 1
HpETE, as hpete, H Hp HpE HpET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 ,- 2 8 0 0 0 0 1
(71, 79). (71, ( (7 (71 (71, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 (,). 4 9 0 0 0 0 1
leukotrienes, while leukotrienes, l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 , 1 10 0 0 0 0 1
E-and D-series e-and E E- E-a E-an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 --,(,).- 8 8 0 0 0 0 1
(ALOX15 and (alox15 ( (A (AL (ALO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 (),,, 5 8 0 0 0 0 1
(LA), and (la), ( (L (LA (LA) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 (),-(). 7 9 0 0 0 0 1
human 15-LOX human h hu hum huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -: 2 7 0 0 0 0 1
(18). One (18). ( (1 (18 (18) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 ().--() 7 8 0 0 0 0 1
dual positional dual d du dua dual BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (.., 4 9 0 0 0 0 1
15-lipoxygenase activities 15-lipoxygenase 1 15 15- 15-l BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -),-- 5 7 0 0 0 0 1
(ALOX15B) exhibits (alox15b) ( (A (AL (ALO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 ()(- 4 7 0 0 0 0 1
activity) (55). activity) a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 )(). 4 8 0 0 0 0 1
activities of activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --() 4 8 0 0 0 0 1
the synthesis the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,-, 3 8 0 0 0 0 1
their respective their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,-- 4 8 0 0 0 0 1
oxygenates PUFA-containing oxygenates o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 --- 3 8 0 0 0 0 1
glycerol ester glycerol g gl gly glyc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (,).,- 6 9 0 0 0 0 1
the oxygenation the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (),, 4 8 0 0 0 0 1
CEs, and ces, C CE CEs CEs, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ,(-). 5 4 0 0 0 0 1
PUFA substrates pufa P PU PUF PUFA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 -(), 4 7 0 0 0 0 1
EPA, DHA, epa, E EP EPA EPA, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 ,,--()(,). 10 8 0 0 0 0 1
no single no n no no no BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
determined the determined d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
to be: to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 :(). 4 8 0 0 0 0 1
parameters for parameters p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,,(). 5 8 0 0 0 0 1
observed a observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -.,, 4 9 0 0 0 0 1
and a-linolenic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -() 3 8 0 0 0 0 1
for 12S-LOX for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -(,,).,- 8 7 0 0 0 0 1
possesses lipoxin possesses p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
A 4 a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 5 ().- 4 8 0 0 0 0 1
LOX are lox L LO LOX LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 0 0 0 1
hepoxilins and hepoxilins h he hep hepo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (,).,- 6 7 0 0 0 0 1
shown to shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --, 3 7 0 0 0 0 1
pathways for pathways p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 6 0 0 0 0 1
Mammalian 12R-LOX mammalian M Ma Mam Mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 -()() 5 7 0 0 0 0 1
co-expressed in co-expressed c co co- co-e BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -.- 3 8 0 0 0 0 1
efficiently catalyzes efficiently e ef eff effi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,, 2 8 0 0 0 0 1
less efficiently less l le les less BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,(,).,- 7 8 0 0 0 0 1
shown to shown s sh sho show BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -- 2 8 0 0 0 0 1
more efficiently more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 9 0 0 0 0 1
this reaction this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
isomerase activity isomerase i is iso isom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
the proper the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 7 0 0 0 0 1
corneocytes (25). corneocytes c co cor corn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (). 3 8 0 0 0 0 1
observed on observed o ob obs obse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --, 3 8 0 0 0 0 1
reaction occurring reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --(). 5 9 0 0 0 0 1
These reactions these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
inflammation. Curiously, inflammation. i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,- 3 8 0 0 0 0 1
the methyl the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 7 0 0 0 0 1
unmodified FAs unmodified u un unm unmo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ()., 4 8 0 0 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 8 0 0 0 0 1
specificity (95). specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 ()., 4 10 0 0 0 0 1
human 12R-LOX human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
reaction is reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 4 0 0 0 0 1
Several aspects several S Se Sev Seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 8 0 0 0 0 1
the functional the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
that is, that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 8 0 0 0 0 1
suicide inactivation. suicide s su sui suic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
property, perhaps property, p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,., 3 8 0 0 0 0 1
details of details d de det deta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
due to due d du due due BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 -, 2 8 0 0 0 0 1
difficult to difficult d di dif diff BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 11 no 0 8 0 1 0 0 0
5 5 5 5 5 5 5 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 0 0 1 0 0 0
clear functions clear c cl cle clea BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 10 0 1 0 0 1
15-LOX-2 (ALOX15B) 15-lox-2 1 15 15- 15-L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 --(), 5 7 0 1 0 0 1
although it although a al alt alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 1 0 0 1
levels (96). levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ().(..,- 8 9 0 1 0 0 1
LOXs, lysoPLs loxs, L LO LOX LOXs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ,-). 4 8 0 1 0 0 1
Cyclooxygenase (COX) cyclooxygenase C Cy Cyc Cycl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 () 2 10 0 0 0 0 1
Human COX: human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 : 1 10 0 0 0 0 1
Cyclooxygenases (COXs), cyclooxygenases C Cy Cyc Cycl BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (),- 4 7 0 0 0 0 1
endoperoxide synthases endoperoxide e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 /, 2 9 0 0 0 0 1
heme-containing enzymes heme-containing h he hem heme BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 - 1 8 0 0 0 0 1
peroxidase activities. peroxidase p pe per pero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 .: 2 8 0 0 0 0 1
PTGS1 and ptgs1 P PT PTG PTGS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ,--, 4 7 0 0 0 0 1
respectively. Traditionally, respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .,- 3 8 0 0 0 0 1
constitutively expressed, constitutively c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,- 2 8 0 0 0 0 1
response to response r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ., 2 9 0 0 0 0 1
suggest constitutive suggest s su sug sugg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -,,, 4 9 0 0 0 0 1
thymus, kidneys, thymus, t th thy thym BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,,(-)., 7 9 0 0 0 0 1
COX-2 has cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
prostacyclin (100, prostacyclin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (,).- 5 9 0 0 0 0 1
body, and body, b bo bod body BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,,, 3 9 0 0 0 0 1
immune cells immune i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (,-),,, 7 9 0 0 0 0 1
inflammatory cells, inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ,, 2 9 0 0 0 0 1
organs (102-105). organs o or org orga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (-).,- 6 9 0 0 0 0 1
many tissues many m ma man many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 0 ,(-,-, 6 10 0 0 0 0 1
monocytes), and monocytes), m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ),(-,), 7 9 0 0 0 0 1
expressed in expressed e ex exp expr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 7 0 0 0 0 1
Structure of structure S St Str Stru BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 10 0 0 0 0 1
The role the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 8 0 0 0 0 1
potential as potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 9 0 0 0 0 1
their structures. their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 .- 2 9 0 0 0 0 1
solved in solved s so sol solv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 9 0 0 0 0 1
(107-109). Similarly, (107-109). ( (1 (10 (107 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 (-)., 5 9 0 0 0 0 1
COX-2 in cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 - 1 8 0 0 0 0 1
ligands (13, ligands l li lig liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 (,-),- 6 8 0 0 0 0 1
inhibitors (114, inhibitors i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 (,). 4 3 0 0 0 0 1
Both COX both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 , 1 8 0 0 0 0 1
structure is structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 (). 3 8 0 0 0 0 1
monomer consists monomer m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 :- 2 8 0 0 0 0 1
growth factor growth g gr gro grow BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ()-,, 5 9 0 0 0 0 1
and a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 -.- 3 9 0 0 0 0 1
located at located l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 8 0 0 0 0 1
dimerization. It dimerization. d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 . 1 9 0 0 0 0 1
(117). The (117). ( (1 (11 (117 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 2 (). 3 7 0 0 0 0 1
amphipathic a-helices amphipathic a am amp amph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 - 1 9 0 0 0 0 1
bilayer. Both bilayer. b bi bil bila BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 . 1 8 0 0 0 0 1
endoplasmic reticulum endoplasmic e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 () 2 8 0 0 0 0 1
membranes (118). membranes m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ().,- 5 8 0 0 0 0 1
apparatus (119). apparatus a ap app appa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ().() 5 8 0 0 0 0 1
contains separate contains c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 8 0 0 0 0 1
opposite sides opposite o op opp oppo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 9 0 0 0 0 1
is located is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 9 0 0 0 0 1
hydrophobic tunnel hydrophobic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 , 1 9 0 0 0 0 1
peroxidase active peroxidase p pe per pero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 2 no 0 10 0 0 0 0 1
enzyme (120). enzyme e en enz enzy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 (). 3 2 0 0 0 0 1
COXs undergo coxs C CO COX COXs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 - 1 7 0 0 0 0 1
residues. This residues. r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
turnover of turnover t tu tur turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 - 1 9 0 0 0 0 1
and the and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (,,).-- 7 8 0 0 0 0 1
nitrosylated by nitrosylated n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 9 0 0 0 0 1
recombinant human recombinant r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 -- 2 8 0 0 0 0 1
isoforms can isoforms i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 -, 2 9 0 0 0 0 1
COX-2 showed cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 -(). 4 9 0 0 0 0 1
dichroism data dichroism d di dic dich BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
both isoforms both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --,, 4 10 0 0 0 0 1
random coils, random r ra ran rand BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,-. 3 8 0 0 0 0 1
more pronounced more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 --. 3 7 0 0 0 0 1
findings provide findings f fi fin find BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 8 0 0 0 0 1
COXs. The coxs. C CO COX COXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 . 1 9 0 0 0 0 1
COX conformation cox C CO COX COX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 5 no 0 9 0 0 0 0 1
further investigation. further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 . 1 3 0 0 0 0 1
Although COXs although A Al Alt Alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 7 0 0 0 0 1
considered conformational considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 7 0 0 0 0 1
monomer functions monomer m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 () 2 8 0 0 0 0 1
other as other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ()(-). 6 9 0 0 0 0 1
isoforms, the isoforms, i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 , 1 10 0 0 0 0 1
full activity. full f fu ful full BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .- 2 9 0 0 0 0 1
E allo e E E E E BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 5 , 1 10 0 0 0 0 1
exhibit differences exhibit e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .- 2 9 0 0 0 0 1
acid, stearic acid, a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ,,(), 5 9 0 0 0 0 1
which are which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 .,- 3 7 0 0 0 0 1
stimulated by stimulated s st sti stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 (). 3 9 0 0 0 0 1
FAs (like fas F FA FAs FAs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 5 () 2 8 0 0 0 0 1
activity, with activity, a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 , 1 9 0 0 0 0 1
isoforms (reviewed isoforms i is iso isof BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 (()). 5 4 0 0 0 0 1
Catalytic Mechanism catalytic C Ca Cat Cata BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 10 0 0 0 0 1
COXs possess coxs C CO COX COXs BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 : 1 9 0 0 0 0 1
and a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 . 1 10 0 0 0 0 1
peroxidation process peroxidation p pe per pero BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 (), 3 8 0 0 0 0 1
direct hydrogen direct d di dir dire BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 8 0 0 0 0 1
formation of formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 (). 3 7 0 0 0 0 1
hydrogen abstraction hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 - 1 8 0 0 0 0 1
Fe(III), hydrogen fe(iii), F Fe Fe( Fe(I BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 (), 3 9 0 0 0 0 1
tyrosyl radical tyrosyl t ty tyr tyro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 (). 3 9 0 0 0 0 1
residue in residue r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 9 0 0 0 0 1
hydrogen (stereo-and hydrogen h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 (--)(,)- 8 8 0 0 0 0 1
pentadiene group pentadiene p pe pen pent BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 . 1 7 0 0 0 0 1
substrate, the substrate, s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 ,--. 4 9 0 0 0 0 1
alkyl radical alkyl a al alk alky BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 no 0 8 0 0 0 0 1
addition of addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ,(- 3 9 0 0 0 0 1
stereochemistry). Rotation stereochemistry). s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 9 ). 2 9 0 0 0 0 1
outer oxygen outer o ou out oute BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
carbon resulting carbon c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 (). 3 9 0 0 0 0 1
involving C8 involving i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 9 0 0 0 0 1
C15. Note c15. C C1 C15 C15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 . 1 8 0 0 0 0 1
configuration (131). configuration c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ().- 4 8 0 0 0 0 1
generated isoprostanes generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 no 0 8 0 0 0 0 1
configuration (132). configuration c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 ()., 4 9 0 0 0 0 1
is added is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 9 0 0 0 0 1
(15S-stereochemistry). Hydrogen (15s-stereochemistry). ( (1 (15 (15S BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 9 (-). 4 9 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 11 no 0 8 0 1 0 0 0
6 6 6 6 6 6 6 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 0 0 1 0 0 0
site tyrosine site s si sit site BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 8 1 0 0 0 1
regenerates the regenerates r re reg rege BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 9 1 0 0 0 1
The peroxidase the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 8 1 0 0 0 1
(Figure 2A). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ().- 4 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 8 1 0 0 0 1
oxidation of oxidation o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 () 2 8 1 0 0 0 1
(Figure 2B). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 8 1 0 0 0 1
by two by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -. 2 8 1 0 0 0 1
activity is activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 1 0 0 0 1
cation radical cation c ca cat cati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 no 0 9 1 0 0 0 1
(133) (Figure (133) ( (1 (13 (133 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 ()(). 5 9 1 0 0 0 1
both the both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 7 1 0 0 0 1
(133, 134). (133, ( (1 (13 (133 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 4 (,). 4 1 1 0 0 0 1
The dioxygenase the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 7 1 0 0 0 1
lipoxygenase-type reaction, lipoxygenase-type l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 -, 2 9 1 0 0 0 1
introduced and introduced i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 (,) 3 8 1 0 0 0 1
(Figure 2A). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 ()., 4 9 1 0 0 0 1
addition of addition a ad add addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 no 0 9 1 0 0 0 1
participating in participating p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 10 1 0 0 0 1
an incomplete an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 4 . 1 9 1 0 0 0 1
AA as aa A AA AA AA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 ,-( 3 8 1 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 1 8 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 8 no 0 10 1 0 0 0 1
FIGURE 2 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ().() 5 9 1 0 0 0 1
activities of activities a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 .... 4 9 1 0 0 0 1
reactions that reactions r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -.()( 5 10 1 0 0 0 1
ring of ring r ri rin ring BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 8 ). 2 1 1 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 . 1 4 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 1 11 no 0 8 0 1 0 0 0
7 7 7 7 7 7 7 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 11 no 0 0 0 1 0 0 0
reduction by reduction r re red redu BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 )- 2 9 0 0 0 0 1
(HETE: hydroxy-eicosatetraenoic (hete: ( (H (HE (HET BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (:-),-- 7 8 0 0 0 0 1
HETE (minor hete H HE HET HETE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (- 2 7 0 0 0 0 1
isoforms) (137). isoforms) i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 )(). 4 9 0 0 0 0 1
sites in sites s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (),- 4 10 0 0 0 0 1
products are products p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
substrate in substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 5 0 0 0 0 1
Aspirin (acetylsalicylic aspirin A As Asp Aspi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 (), 3 9 0 0 0 0 1
mechanism of mechanism m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
(Ser530 in (ser530 ( (S (Se (Ser BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-).- 5 10 0 0 0 0 1
to complete to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (),- 4 9 0 0 0 0 1
promotes the promotes p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
15R-HETE (140). 15r-hete 1 15 15R 15R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -(). 4 9 0 0 0 0 1
completely inhibits completely c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -( 2 9 0 0 0 0 1
reaction). However, reaction). r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 )., 3 9 0 0 0 0 1
enzyme retains enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (-) 3 9 0 0 0 0 1
favorably forms favorably f fa fav favo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(), 4 9 0 0 0 0 1
products compared products p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ---. 4 8 0 0 0 0 1
findings are findings f fi fin find BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 no 0 9 0 0 0 0 1
formation of formation f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 --()., 6 9 0 0 0 0 1
both acetylation both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 9 0 0 0 0 1
15R-PG formation. 15r-pg 1 15 15R 15R- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -. 2 2 0 0 0 0 1
COX Isoforms cox C CO COX COX BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 2 no 0 10 0 0 0 0 1
COXs catalyze coxs C CO COX COXs BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 , 1 9 0 0 0 0 1
precursor of precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (,,,) 5 8 0 0 0 0 1
thromboxane. These thromboxane. t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 . 1 8 0 0 0 0 1
through the through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 8 0 0 0 0 1
COX (discussed cox C CO COX COX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 2 (.), 4 9 0 0 0 0 1
blood flow blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 8 0 0 0 0 1
with specific with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (). 3 3 0 0 0 0 1
COXs also coxs C CO COX COXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 7 0 0 0 0 1
DGLA, LA, dgla, D DG DGL DGLA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 ,,,,(),. 8 8 0 0 0 0 1
early study early e ea ear earl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
human COXs human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (/), 4 8 0 0 0 0 1
ALA being ala A AL ALA ALA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 -. 2 8 0 0 0 0 1
substrates for substrates s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 9 0 0 0 0 1
COX-2 than cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 --(). 5 8 0 0 0 0 1
PUFAs like pufas P PU PUF PUFA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 ,, 2 8 0 0 0 0 1
acid and acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (,).,- 6 8 0 0 0 0 1
was found was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 9 0 0 0 0 1
PUFAs. That pufas. P PU PUF PUFA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 ., 2 8 0 0 0 0 1
isoforms, but isoforms, i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ,- 2 8 0 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 - 1 8 0 0 0 0 1
regulation by regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (). 3 3 0 0 0 0 1
COX-2 can cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 --,-,- 6 8 0 0 0 0 1
bis-oxygenation of bis-oxygenation b bi bis bis- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 --, 3 9 0 0 0 0 1
reactions and reactions r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -. 2 9 0 0 0 0 1
However, acetylation however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 ,- 2 9 0 0 0 0 1
15R-dioxygenation producing 15r-dioxygenation 1 15 15R 15R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 -,-()., 7 9 0 0 0 0 1
COX-2 can cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 2 -; 2 7 0 0 0 0 1
arachidonoylethanolamide, 2-arachidonoylglycerol arachidonoylethanolamide, a ar ara arac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ,-(-), 6 8 0 0 0 0 1
N-arachidonoyl-glycine (147-149). n-arachidonoyl-glycine N N- N-a N-ar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 2 --(-).,--, 10 8 0 0 0 0 1
ethanolamide derivatives ethanolamide e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 no 0 8 0 0 0 0 1
be COX-2 be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 -(,).-- 7 9 0 0 0 0 1
2 generates 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 2 -, 2 9 0 0 0 0 1
eicosanoids through eicosanoids e ei eic eico BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 ().- 4 10 0 0 0 0 1
to bind to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
COX-1 has cox-1 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 -, 2 10 0 0 0 0 1
an Arg an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 6 no 0 8 0 0 0 0 1
residues lining residues r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 9 0 0 0 0 1
site (13). site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (). 3 1 0 0 0 0 1
COX isoforms cox C CO COX COX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 6 , 1 7 0 0 0 0 1
distribution, allosteric distribution, d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,,. 3 9 0 0 0 0 1
However, some however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 ,. 2 8 0 0 0 0 1
example, the example, e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ,-- 3 7 0 0 0 0 1
oxygenated endocannabinoids oxygenated o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 .,- 3 8 0 0 0 0 1
2 oxygenates 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 6 --, 3 8 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 8 0 0 0 0 1
mediators (88). mediators m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ().,- 5 8 0 0 0 0 1
requires further requires r re req requ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 4 0 0 0 0 1
Cytochrome P450 cytochrome C Cy Cyt Cyto BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 () 2 10 0 0 0 0 1
Human CYPs: human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 : 1 10 0 0 0 0 1
Cytochrome P450s cytochrome C Cy Cyt Cyto BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 ()- 3 8 0 0 0 0 1
monooxygenases that monooxygenases m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 . 1 9 0 0 0 0 1
There are there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 , 1 9 0 0 0 0 1
are further are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 - 1 9 0 0 0 0 1
amino acid amino a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (,)., 5 9 0 0 0 0 1
system has system s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 , 1 9 0 0 0 0 1
across living across a ac acr acro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (,). 4 9 0 0 0 0 1
"CYP", followed "cyp", " "C "CY "CYP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 "",,, 5 10 0 0 0 0 1
a gene-identifying a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 7 -., 3 9 0 0 0 0 1
and a and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (). 3 10 0 0 0 0 1
and subfamilies and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 8 0 0 0 0 1
identity, respectively. identity, i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,. 2 3 0 0 0 0 1
CYPs are cyps C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 (-), 4 8 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,, 2 10 0 0 0 0 1
lung. Intracellularly, lung. l lu lun lung BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ., 2 8 0 0 0 0 1
mitochondrial membranes mitochondrial m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (; 2 8 0 0 0 0 1
microsomes when microsomes m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 )(,). 5 9 0 0 0 0 1
mammalian CYPs mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 no 0 8 0 0 0 0 1
membrane and membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 , 1 9 0 0 0 0 1
cells (161-164). cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (-). 4 8 0 0 0 0 1
the mitochondria the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ()., 4 9 0 0 0 0 1
functional CYP functional f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 , 1 8 0 0 0 0 1
remaining seven remaining r re rem rema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 8 0 0 0 0 1
inducible by inducible i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 , 1 8 0 0 0 0 1
constitutively expressed constitutively c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 (). 3 9 0 0 0 0 1
environmental compounds environmental e en env envi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 8 0 0 0 0 1
nuclear receptors, nuclear n nu nuc nucl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,,- 3 9 0 0 0 0 1
coding RNAs coding c co cod codi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (). 3 2 0 0 0 0 1
Two major two T Tw Two Two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 8 0 0 0 0 1
lipid metabolism. lipid l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 ., 2 8 0 0 0 0 1
involves members involves i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 9 0 0 0 0 1
review, the review, r re rev revi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ,(). 4 8 0 0 0 0 1
Structure of structure S St Str Stru BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 0 0 0 0 1
Structural characterization structural S St Str Stru BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 0 1 0 0 1
CYPs, which cyps, C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 ,., 3 9 0 1 0 0 1
mammalian CYPs mammalian m ma mam mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 -, 2 9 0 1 0 0 1
crystallize them crystallize c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 - 1 9 0 1 0 0 1
hydrophobic helical hydrophobic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 9 0 1 0 0 1
sequence from sequence s se seq sequ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 9 0 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 2 11 no 0 8 0 1 0 0 0
8 8 8 8 8 8 8 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 no 0 0 0 1 0 0 0
published was published p pu pub publ BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 7 0 0 0 0 1
that hydroxylates that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 8 0 0 0 0 1
structure with structure s st str stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
folding geometry, folding f fo fol fold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
were observed were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
to play to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 5 0 0 0 0 1
CYPs consist cyps C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 :--- 4 7 0 0 0 0 1
domain and domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 --. 3 8 0 0 0 0 1
The N-terminal the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 7 0 0 0 0 1
transmembrane helix transmembrane t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
but that but b bu but but BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ( 1 8 0 0 0 0 1
the catalytic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ). 2 6 0 0 0 0 1
transmembrane helix transmembrane t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 7 0 0 0 0 1
and their and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
amphipathic regions amphipathic a am amp amph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (,).- 5 8 0 0 0 0 1
also contains also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
appropriate compartment, appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
CYPs, is cyps, C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ,. 2 7 0 0 0 0 1
contains a contains c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
A thiolate a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
coordination position coordination c co coo coor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
the sixth the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
been correlated been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,). 4 8 0 0 0 0 1
helices surrounding helices h he hel heli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
for catalysis. for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .,, 3 9 0 0 0 0 1
has been has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
glutamic acid glutamic g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (), 3 9 0 0 0 0 1
substrate positioning substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -( 2 8 0 0 0 0 1
methyl end methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 )(). 4 3 0 0 0 0 1
Other structural other O Ot Oth Othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
allow entry allow a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
compartments and compartments c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 7 0 0 0 0 1
Furthermore, oligomerization furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 7 0 0 0 0 1
microsomal and microsomal m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 , 1 7 0 0 0 0 1
subunits of subunits s su sub subu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 (;..,) 6 7 0 0 0 0 1
different CYPs different d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (;..,/ 6 7 0 0 0 0 1
CYP1A2/CYP2B4) (173-180). cyp1a2/cyp2b4) C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 /)(-). 6 7 0 0 0 0 1
additional layer additional a ad add addi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 0 0 0 0 1
Enzymology of enzymology E En Enz Enzy BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 no 0 10 0 0 0 0 1
CYPs catalyze cyps C CY CYP CYPs BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 4 (,), 4 9 0 0 0 0 1
common include common c co com comm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 -,, 3 7 0 0 0 0 1
heteroatom dealkylation, heteroatom h he het hete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ,, 2 8 0 0 0 0 1
(182). Many (182). ( (1 (18 (182 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 (). 3 8 0 0 0 0 1
(owing to (owing ( (o (ow (owi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 (-) 3 9 0 0 0 0 1
dioxygen and dioxygen d di dio diox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 no 0 8 0 0 0 0 1
substrate, with substrate, s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ,. 2 9 0 0 0 0 1
require electron require r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,,. 3 9 0 0 0 0 1
However, transfer however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 8 0 0 0 0 1
protein partners: protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 : 1 8 0 0 0 0 1
of microsomal of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 8 0 0 0 0 1
reductase and reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ., 2 8 0 0 0 0 1
form complexes form f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 ,. 2 10 0 0 0 0 1
That said, that T Th Tha That BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 8 0 0 0 0 1
electron donors. electron e el ele elec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 . 1 9 0 0 0 0 1
by CYP5A1 by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()( 3 8 0 0 0 0 1
synthase) (183), synthase) s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 )(),. 5 9 0 0 0 0 1
A generalized a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 2 5 () 2 8 0 0 0 0 1
contains the contains c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 :, 2 9 0 0 0 0 1
substrate recruitment substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 () 2 9 0 0 0 0 1
position of position p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ().- 4 9 0 0 0 0 1
reduction from reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (),, 4 9 0 0 0 0 1
1-electron reduction 1-electron 1 1- 1-e 1-el BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 5 - 1 9 0 0 0 0 1
group. Protonation group. g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 0 0 0 0 1
amino acid amino a am ami amin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (- 2 10 0 0 0 0 1
bond) into bond) b bo bon bond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 )() 3 9 0 0 0 0 1
molecule (184). molecule m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (). 3 9 0 0 0 0 1
in many in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 (). 3 8 0 0 0 0 1
reactions, compound reactions, r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 0 0 0 0 1
group in group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 0 0 0 1
oxygen complex, oxygen o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 0 0 0 0 1
hydroxyl group hydroxyl h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 no 0 8 0 0 0 0 1
iron into iron i ir iro iron BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()(). 5 9 0 0 0 0 1
generalized reaction generalized g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 , 1 8 0 0 0 0 1
following O following f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 0 0 0 1
characterize due characterize c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 9 0 0 0 0 1
structures are structures s st str stru BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (). 3 6 0 0 0 0 1
Mammalian CYPs mammalian M Ma Mam Mamm BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 10 0 0 0 0 1
Lipid Metabolism lipid L Li Lip Lipi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 3 0 0 0 0 1
CYPs are cyps C CY CYP CYPs BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
including PUFAs including i in inc incl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
epoxidation are epoxidation e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 - 1 8 0 0 0 0 1
substrates. CYPs substrates. s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 .(- 3 7 0 0 0 0 1
hydroxylation) or hydroxylation) h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ).,- 4 7 0 0 0 0 1
epoxidation can epoxidation e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 . 1 8 0 0 0 0 1
exhibit variable exhibit e ex exh exhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
positional specificity. positional p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 .- 2 9 0 0 0 0 1
hydroxylation reactions hydroxylation h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 , 1 9 0 0 0 0 1
hydroxylation over hydroxylation h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ,-(). 5 10 0 0 0 0 1
Terminal hydroxylation terminal T Te Ter Term BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 - 1 7 0 0 0 0 1
hydroxyeicosatetraenoic acid hydroxyeicosatetraenoic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (-), 4 8 0 0 0 0 1
blood pressure blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 7 0 0 0 0 1
Additionally, terminal additionally, A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 ,- 2 9 0 0 0 0 1
(a catabolic (a ( (a (a (a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (), 3 8 0 0 0 0 1
eicosanoids (206, eicosanoids e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (,), 4 8 0 0 0 0 1
permeability barrier permeability p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
produces mono-hydroxylated produces p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -( 2 8 0 0 0 0 1
AA) with aa) A AA AA) AA) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 )(()). 6 9 0 0 0 0 1
and COXs and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 - 1 8 0 0 0 0 1
allylic methylene allylic a al all ally BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 ,- 2 9 0 0 0 0 1
carbons (producing carbons c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (-,--), 7 8 0 0 0 0 1
other positions other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (-).,- 6 9 0 0 0 0 1
products are products p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 9 0 0 0 0 1
into conjugated into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 4 0 0 0 0 1
Epoxidation of epoxidation E Ep Epo Epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 - 1 8 0 0 0 0 1
acids (EET). acids a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ().,, 5 8 0 0 0 0 1
undergo CYP-mediated undergo u un und unde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 -. 2 8 0 0 0 0 1
PUFAs are pufas P PU PUF PUFA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 7 0 0 0 0 1
inflammation (15). inflammation i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 (). 3 8 0 0 0 0 1
epoxide hydrolases epoxide e ep epo epox BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 () 2 8 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 2 11 no 0 8 0 1 0 0 0
9 9 9 9 9 9 9 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 no 0 0 0 1 0 0 0
A A a A A A A BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 2 0 no 0 10 1 1 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 1 1 0 0 0
FIGURE 3 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 ().().()(-). 12 10 1 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 . 1 10 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 8 .. 2 10 0 0 0 0 0
November 2020 november N No Nov Nove BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 2 10 no 0 10 1 0 0 0 0
10 10 10 1 10 10 10 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 2 11 no 0 10 1 0 0 0 0
and microsomal and a an and and BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()(). 5 8 0 0 0 0 1
epoxide hydrolases epoxide e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
possess different possess p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 9 0 0 0 0 1
Arachidonoylethanolamide also arachidonoylethanolamide A Ar Ara Arac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
and epoxidation and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,)., 5 9 0 0 0 0 1
EPA and epa E EP EPA EPA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ,- 2 8 0 0 0 0 1
inflammatory and inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 -(). 4 9 0 0 0 0 1
degraded by degraded d de deg degr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 8 0 0 0 0 1
(215), suggesting (215), ( (2 (21 (215 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (), 3 8 0 0 0 0 1
endocannabinoid pathways. endocannabinoid e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 8 0 0 0 0 1
CYPs catalyze cyps C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
sterols, some sterols, s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ,/ 2 7 0 0 0 0 1
hydroxylation steps. hydroxylation h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
is a is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
successive oxidations successive s su suc succ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 10 0 0 0 0 1
formic acid formic f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
(217). Similarly, (217). ( (2 (21 (217 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 ()., 4 9 0 0 0 0 1
the action the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 9 0 0 0 0 1
methyl group methyl m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
introduction of introduction i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ., 2 8 0 0 0 0 1
cholesterol side-chain cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -() 3 8 0 0 0 0 1
two hydroxylation two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 - 1 9 0 0 0 0 1
bond cleavage bond b bo bon bond BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 (). 3 9 0 0 0 0 1
is a is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 9 0 0 0 0 1
glucocorticoids and glucocorticoids g gl glu gluc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 5 0 0 0 0 1
CYP-mediated hydroxylation cyp-mediated C CY CYP CYP- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 - 1 7 0 0 0 0 1
cholesterol metabolism, cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 9 0 0 0 0 1
steroid hormones steroid s st ste ster BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
biosynthesis pathways biosynthesis b bi bio bios BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (-), 4 9 0 0 0 0 1
CYP8B1 (sterol cyp8b1 C CY CYP CYP8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 (-),( 5 8 0 0 0 0 1
sterol 27-hydroxylase, sterol s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 -,()- 5 8 0 0 0 0 1
hydroxylase) and hydroxylase) h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 )(-)(,). 8 9 0 0 0 0 1
Of these of O Of Of Of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 , 1 9 0 0 0 0 1
the terminal the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -(). 4 10 0 0 0 0 1
involved in involved i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 9 0 0 0 0 1
are CYP46A1 are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (-)- 4 7 0 0 0 0 1
hydroxylates cholesterol hydroxylates h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 (,)- 4 9 0 0 0 0 1
and 25-hydroxylase and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 -(,). 5 9 0 0 0 0 1
steroid hormone steroid s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ()(), 5 9 0 0 0 0 1
CYP17A1 (steroid cyp17a1 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 (-)(),(- 8 9 0 0 0 0 1
hydroxylase), CYP11B1 hydroxylase), h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ),(-), 6 8 0 0 0 0 1
(aldosterone synthase) (aldosterone ( (a (al (ald BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 3 ()()(). 7 8 0 0 0 0 1
Thus, CYPs thus, T Th Thu Thus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 , 1 8 0 0 0 0 1
both PUFA both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ., 2 8 0 0 0 0 1
CYP2A7 and cyp2a7 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 no 0 8 0 0 0 0 1
orphan enzymes. orphan o or orp orph BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 . 1 2 0 0 0 0 1
Human Aldo-Keto human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 -() 3 10 0 0 0 0 1
Hydroxysteroid Dehydrogenases hydroxysteroid H Hy Hyd Hydr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 () 2 9 0 0 0 0 1
AKRs: Nomenclature, akrs: A AK AKR AKRs BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 :,, 3 10 0 0 0 0 1
Aldo-keto reductases aldo-keto A Al Ald Aldo BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 -()- 4 8 0 0 0 0 1
dependent oxidoreductases. dependent d de dep depe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
carbonyl groups carbonyl c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
proposed for proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 ()., 4 9 0 0 0 0 1
families and families f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 . 1 10 0 0 0 0 1
have 40% have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 , 1 9 0 0 0 0 1
60% sequence 60% 6 60 60% 60% BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 . 1 9 0 0 0 0 1
TABLE 2 table T TA TAB TABL BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 (). 3 10 0 1 0 0 1
Enzyme Enzyme enzyme E En Enz Enzy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 3 0 1 0 0 1
Lipid substrate(s) lipid L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 () 2 10 0 1 0 0 1
Reaction(s) Reaction(s) reaction(s) R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 () 2 6 0 1 0 0 1
Refs. Refs. refs. R Re Ref Refs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 . 1 3 0 1 0 0 1
CYP1A1 CYP1A1 cyp1a1 C CY CYP CYP1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 2 0 1 0 0 1
AA, EPA, aa, A AA AA, AA, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,, 2 4 0 1 0 0 1
Epoxidation & epoxidation E Ep Epo Epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 10 0 1 0 0 1
(186) (186) (186) ( (1 (18 (186 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 () 2 2 0 1 0 0 1
CYP2C8 CYP2C8 cyp2c8 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 2 0 1 0 0 1
AA, EPA, aa, A AA AA, AA, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,,, 3 6 0 1 0 0 1
Epoxidation & epoxidation E Ep Epo Epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 10 0 1 0 0 1
(186-188) (186-188) (186-188) ( (1 (18 (186 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 (-) 3 3 0 1 0 0 1
CYP3A4 CYP3A4 cyp3a4 C CY CYP CYP3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 2 0 1 0 0 1
Sterols Sterols sterols S St Ste Ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 2 0 1 0 0 1
Hydroxylation Hydroxylation hydroxylation H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 5 0 1 0 0 1
(189-191) (189-191) (189-191) ( (1 (18 (189 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 (-) 3 3 0 1 0 0 1
CYP4A11 CYP4A11 cyp4a11 C CY CYP CYP4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 2 0 1 0 0 1
Lauric acid, lauric L La Lau Laur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 , 1 5 0 1 0 0 1
AA, EPA, aa, A AA AA, AA, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,,, 3 6 0 1 0 0 1
w-Hydroxylation w-Hydroxylation w-hydroxylation w w- w-H w-Hy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 - 1 8 0 1 0 0 1
w/w-1-Hydroxylation w/w-1-Hydroxylation w/w-1-hydroxylation w w/ w/w w/w- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 /-- 3 10 0 1 0 0 1
(188, 192), (188, ( (1 (18 (188 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 (,), 4 10 0 1 0 0 1
CYP4F2 CYP4F2 cyp4f2 C CY CYP CYP4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 3 0 0 0 0 1
AA, EPA, aa, A AA AA, AA, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,,, 3 7 0 0 0 0 1
w/w-1-Hydroxylation w/w-1-Hydroxylation w/w-1-hydroxylation w w/ w/w w/w- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 /-- 3 8 0 0 0 0 1
(188) (188) (188) ( (1 (18 (188 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 () 2 2 0 0 0 0 1
CYP5A1 CYP5A1 cyp5a1 C CY CYP CYP5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 3 0 0 0 0 1
(thromboxane synthase) (thromboxane ( (t (th (thr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 () 2 10 0 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 4 0 0 0 0 1
Isomerization Isomerization isomerization I Is Iso Isom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 0 0 0 0 1
(183) (183) (183) ( (1 (18 (183 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 () 2 4 0 0 0 0 1
CYP7A1 CYP7A1 cyp7a1 C CY CYP CYP7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
Cholesterol, 7-DHC cholesterol, C Ch Cho Chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,- 2 4 0 0 0 0 1
7a-Hydroxylation, epoxidation, 7a-hydroxylation, 7 7a 7a- 7a-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -,, 3 10 0 0 0 0 1
(161, 193, (161, ( (1 (16 (161 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 (,,) 4 3 0 0 0 0 1
CYP7B1 CYP7B1 cyp7b1 C CY CYP CYP7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
Oxysterols, steroids oxysterols, O Ox Oxy Oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 , 1 4 0 0 0 0 1
7a-Hydroxylation 7a-Hydroxylation 7a-hydroxylation 7 7a 7a- 7a-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 - 1 3 0 0 0 0 1
(195) (195) (195) ( (1 (19 (195 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 () 2 1 0 0 0 0 1
CYP8A1 CYP8A1 cyp8a1 C CY CYP CYP8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
(prostacyclin synthase) (prostacyclin ( (p (pr (pro BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 () 2 5 0 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
Isomerization Isomerization isomerization I Is Iso Isom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
(183) (183) (183) ( (1 (18 (183 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 4 0 0 0 0 1
CYP8B1 CYP8B1 cyp8b1 C CY CYP CYP8 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
Sterols Sterols sterols S St Ste Ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
12a-Hydroxylation 12a-Hydroxylation 12a-hydroxylation 1 12 12a 12a- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
(196) (196) (196) ( (1 (19 (196 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 3 0 0 0 0 1
CYP11A1 CYP11A1 cyp11a1 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
(P450scc) (P450scc) (p450scc) ( (P (P4 (P45 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 5 0 0 0 0 1
Cholesterol Cholesterol cholesterol C Ch Cho Chol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 6 0 0 0 0 1
Side-chain cleavage side-chain S Si Sid Side BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
(197) (197) (197) ( (1 (19 (197 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 3 0 0 0 0 1
CYP11B1 CYP11B1 cyp11b1 C CY CYP CYP1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
11-Deoxycortisol, 11-deoxycorticosterone 11-deoxycortisol, 1 11 11- 11-D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -,- 3 8 0 0 0 0 1
11b-Hydroxylation 11b-Hydroxylation 11b-hydroxylation 1 11 11b 11b- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 3 0 0 0 0 1
(198) (198) (198) ( (1 (19 (198 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 1 0 0 0 0 1
CYP11B2 CYP11B2 cyp11b2 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
11-Deoxycorticosterone 11-Deoxycorticosterone 11-deoxycorticosterone 1 11 11- 11-D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 4 0 0 0 0 1
11b-Hydroxylation, 18-hydroxylation 11b-hydroxylation, 1 11 11b 11b- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -,- 3 10 0 0 0 0 1
(198) (198) (198) ( (1 (19 (198 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 1 0 0 0 0 1
CYP17A1 CYP17A1 cyp17a1 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
Pregnenolone, progesterone pregnenolone, P Pr Pre Preg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 , 1 5 0 0 0 0 1
17-Hydroxylation 17-Hydroxylation 17-hydroxylation 1 17 17- 17-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 3 0 0 0 0 1
(199) (199) (199) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 1 0 0 0 0 1
CYP19A1 CYP19A1 cyp19a1 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
(P450arom/aromatase) (P450arom/aromatase) (p450arom/aromatase) ( (P (P4 (P45 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (/) 3 4 0 0 0 0 1
Testosterone Testosterone testosterone T Te Tes Test BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 9 0 0 0 0 1
Aromatization Aromatization aromatization A Ar Aro Arom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 10 0 0 0 0 1
(199) (199) (199) ( (1 (19 (199 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 4 0 0 0 0 1
CYP21A2 CYP21A2 cyp21a2 C CY CYP CYP2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Progesterone Progesterone progesterone P Pr Pro Prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 3 0 0 0 0 1
Hydroxylation Hydroxylation hydroxylation H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 3 0 0 0 0 1
(199) (199) (199) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
CYP24A1 CYP24A1 cyp24a1 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Calcitriol Calcitriol calcitriol C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
24-Hydroxylation 24-Hydroxylation 24-hydroxylation 2 24 24- 24-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 - 1 4 0 0 0 0 1
(200) (200) (200) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
CYP26A1 CYP26A1 cyp26a1 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
all-trans-Retinoic acid all-trans-retinoic a al all all- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 -- 2 6 0 0 0 0 1
Hydroxylation Hydroxylation hydroxylation H Hy Hyd Hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 3 0 0 0 0 1
(201) (201) (201) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
CYP27A1 CYP27A1 cyp27a1 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Sterols Sterols sterols S St Ste Ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
(25R)26-Hydroxylation and (25r)26-hydroxylation ( (2 (25 (25R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ()- 3 10 0 0 0 0 1
(197) (197) (197) ( (1 (19 (197 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
CYP39A1 CYP39A1 cyp39a1 C CY CYP CYP3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
24-hydroxycholesterol 24-hydroxycholesterol 24-hydroxycholesterol 2 24 24- 24-h BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 - 1 5 0 0 0 0 1
7a-Hydroxylation 7a-Hydroxylation 7a-hydroxylation 7 7a 7a- 7a-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 - 1 4 0 0 0 0 1
(17) (17) (17) ( (1 (17 (17) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
CYP46A1 CYP46A1 cyp46a1 C CY CYP CYP4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Cholesterol, desmosterol cholesterol, C Ch Cho Chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 6 0 0 0 0 1
24S-Hydroxylation, 24S-epoxidation 24s-hydroxylation, 2 24 24S 24S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -,- 3 8 0 0 0 0 1
(197, 202) (197, ( (1 (19 (197 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 (,) 3 2 0 0 0 0 1
CYP51A1 CYP51A1 cyp51a1 C CY CYP CYP5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
Lanosterol Lanosterol lanosterol L La Lan Lano BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
14a-Demethylation 14a-Demethylation 14a-demethylation 1 14 14a 14a- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 - 1 4 0 0 0 0 1
(203) (203) (203) ( (2 (20 (203 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
7-DHC, 7-dehydrocholesterol; 7-dhc, 7 7- 7-D 7-DH BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 -,-;,;,;,;,;,;,. 16 10 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 11 no 0 8 0 1 0 0 0
11 11 11 1 11 11 11 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 0 0 1 0 0 0
"AKR" followed "akr" " "A "AK "AKR BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 "", 3 8 0 0 0 0 1
and finally and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 7 0 0 0 0 1
nomenclature has nomenclature n no nom nome BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 0 0 0 0 1
multimers (228). multimers m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ().() 5 8 0 0 0 0 1
heavily in heavily h he hea heav BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,., 3 9 0 0 0 0 1
to follow to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .(). 4 9 0 0 0 0 1
There are there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
and seven and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
accept a accept a ac acc acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 10 0 0 0 0 1
metabolism of metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,, 2 9 0 0 0 0 1
detoxification of detoxification d de det deto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 8 0 0 0 0 1
products. Additionally, products. p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .,(,, 5 8 0 0 0 0 1
and AKR6A9) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 )- 2 9 0 0 0 0 1
(250). All (250). ( (2 (25 (250 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (). 3 9 0 0 0 0 1
lipid metabolism lipid l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 5 0 0 0 0 1
Human AKRs human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 8 0 0 0 0 1
AKR1B15 is akr1b15 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (). 3 7 0 0 0 0 1
AKR1C subfamily akr1c A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (,) 3 8 0 0 0 0 1
secreted in secreted s se sec secr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 8 0 0 0 0 1
lysosomes and lysosomes l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 9 0 0 0 0 1
cells (257). cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 7 0 0 0 0 1
membrane voltage membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ., 2 8 0 0 0 0 1
AKR7A2 associates akr7a2 A AK AKR AKR7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (). 3 8 0 0 0 0 1
AKR7A2 contains akr7a2 A AK AKR AKR7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 - 1 8 0 0 0 0 1
and likely and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 6 0 0 0 0 1
Mammalian AKRs: mammalian M Ma Mam Mamm BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 2 : 1 10 0 0 0 0 1
Crystal structures crystal C Cr Cry Crys BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 2 . 1 9 0 0 0 0 1
They comprise they T Th The They BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 (/) 3 10 0 0 0 0 1
8 which 8 8 8 8 8 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 3 -- 2 9 0 0 0 0 1
times. The times. t ti tim time BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 .-- 3 9 0 0 0 0 1
b-strands. The b-strands. b b- b-s b-st BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 -., 3 9 0 0 0 0 1
which the which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 8 0 0 0 0 1
(cofactor) are (cofactor) ( (c (co (cof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 (), 3 9 0 0 0 0 1
flexible loops flexible f fl fle flex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 9 0 0 0 0 1
specificity (259, specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 (,). 4 9 0 0 0 0 1
helices that helices h he hel heli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 . 1 9 0 0 0 0 1
monomeric, whereas monomeric, m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 ,, 2 8 0 0 0 0 1
respectively (258, respectively r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (,). 4 3 0 0 0 0 1
AKRs catalyze akrs A AK AKR AKRs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 8 0 0 0 0 1
alcohols. They alcohols. a al alc alco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 .. 2 9 0 0 0 0 1
However, the however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
abundance of abundance a ab abu abun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 0 0 0 0 1
can use can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 7 0 0 0 0 1
cofactor for cofactor c co cof cofa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 7 0 0 0 0 1
phosphoryl group phosphoryl p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 (,). 4 8 0 0 0 0 1
The stereospecific the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 10 0 0 0 0 1
the NADPH the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 8 0 0 0 0 1
bound in bound b bo bou boun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 -() 3 9 0 0 0 0 1
which promotes which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 --(), 5 9 0 0 0 0 1
substrate is substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 . 1 7 0 0 0 0 1
The reaction the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 - 1 8 0 0 0 0 1
which the which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 9 0 0 0 0 1
site of site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
Lys, Asp lys, L Ly Lys Lys, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 ,.- 3 9 0 0 0 0 1
catalysis involving catalysis c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 no 0 8 0 0 0 0 1
catalytic residues. catalytic c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ., 2 8 0 0 0 0 1
form of form f fo for form BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 8 0 0 0 0 1
TABLE 3 table T TA TAB TABL BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 :,,. 4 10 0 0 0 0 1
Gene Gene gene G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 6 no 0 2 0 0 0 0 1
Alternative protein alternative A Al Alt Alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 10 0 0 0 0 1
Expression sites expression E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 6 0 0 0 0 1
Example substrates example E Ex Exa Exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 7 0 0 0 0 1
Refs. Refs. refs. R Re Ref Refs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 . 1 2 0 0 0 0 1
AKR1A1 Aldehyde akr1a1 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 9 0 0 0 0 1
Brain, kidney, brain, B Br Bra Brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,,, 3 10 0 0 0 0 1
intestine intestine intestine i in int inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 3 0 0 0 0 1
4-HNE, acrolein, 4-hne, 4 4- 4-H 4-HN BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 -,,-,- 6 10 0 0 0 0 1
acid, phospholipid acid, a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 , 1 5 0 0 0 0 1
(229, 230), (229, ( (2 (22 (229 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 (,), 4 10 0 0 0 0 1
AKR1B1 Aldose akr1b1 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 / 1 10 0 0 0 0 1
synthase synthase synthase s sy syn synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 2 0 0 0 0 1
Ubiquitous Ubiquitous ubiquitous U Ub Ubi Ubiq BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 2 0 0 0 0 1
Glucose, 4-HNE glucose, G Gl Glu Gluc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 ,-,, 4 10 0 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 , 1 5 0 0 0 0 1
(229, 230), (229, ( (2 (22 (229 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 (,), 4 10 0 0 0 0 1
AKR1B10 Small akr1b10 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Small intestine, small S Sm Sma Smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 7 ,,, 3 7 0 0 0 0 1
cornea cornea cornea c co cor corn BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 1 0 0 0 0 1
Farnesal, retinoids, farnesal, F Fa Far Farn BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,,, 3 10 0 0 0 0 1
(229, 231-235), (229, ( (2 (22 (229 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 (,-), 5 2 0 0 0 0 1
AKR1B15 Aldo-keto akr1b15 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -/-- 4 10 0 0 0 0 1
reductase reductase reductase r re red redu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 2 0 0 0 0 1
Placenta, testis, placenta, P Pl Pla Plac BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,, 2 10 0 0 0 0 1
Androgens, estrogens, androgens, A An And Andr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,, 2 6 0 0 0 0 1
3-keto-acyl CoA 3-keto-acyl 3 3- 3-k 3-ke BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -- 2 8 0 0 0 0 1
(236) (236) (236) ( (2 (23 (236 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 () 2 10 0 0 0 0 1
AKR1C1 20a-HSD akr1c1 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 - 1 2 0 0 0 0 1
Kidney, lung, kidney, K Ki Kid Kidn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,,, 4 6 0 0 0 0 1
Progesterone, estrone, progesterone, P Pr Pro Prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,,-,- 5 10 0 0 0 0 1
(230, 237-239), (230, ( (2 (23 (230 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 (,-), 5 3 0 0 0 0 1
AKR1C2 Type akr1c2 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 - 1 3 0 0 0 0 1
Liver, brain, liver, L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,, 3 5 0 0 0 0 1
Progesterone, estrone, progesterone, P Pr Pro Prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,,- 3 8 0 0 0 0 1
(237, 238), (237, ( (2 (23 (237 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 (,), 4 2 0 0 0 0 1
AKR1C3 Type akr1c3 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 -/ 2 7 0 0 0 0 1
synthase synthase synthase s sy syn synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 1 0 0 0 0 1
Liver, lung, liver, L Li Liv Live BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,,, 4 10 0 0 0 0 1
breast, lymphocytes breast, b br bre brea BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 6 0 0 0 0 1
Progesterone, estrone, progesterone, P Pr Pro Prog BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 ,,-,, 5 10 0 0 0 0 1
PGD 2 pgd P PG PGD PGD BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 ,- 2 2 0 0 0 0 1
(238, 240-242), (238, ( (2 (23 (238 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,-), 5 10 0 0 0 0 1
AKR1C4 Type akr1c4 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 9 0 0 0 0 1
Liver Liver liver L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 2 0 0 0 0 1
3-Keto-5b-sterols, 3-Keto-5b-sterols, 3-keto-5b-sterols, 3 3- 3-K 3-Ke BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ---, 4 8 0 0 0 0 1
5a-dihydrotestosterone 5a-dihydrotestosterone 5a-dihydrotestosterone 5 5a 5a- 5a-d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 10 0 0 0 0 1
(230, 238), (230, ( (2 (23 (230 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,), 4 10 0 0 0 0 1
AKR1D1 Steroid akr1d1 A AK AKR AKR1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 - 1 5 0 0 0 0 1
Liver, placenta, liver, L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 ,, 2 4 0 0 0 0 1
D 4 d D D D D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 -, 2 10 0 0 0 0 1
(237, 243-245), (237, ( (2 (23 (237 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,-), 5 2 0 0 0 0 1
AKR1E2 AKR1E2 akr1e2 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
1,5-Anhydro-D-fructose reductase 1,5-anhydro-d-fructose 1 1, 1,5 1,5- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,--- 4 5 0 0 0 0 1
Liver, testis liver, L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 , 1 2 0 0 0 0 1
1,5-Anhydro-D-fructose 1,5-Anhydro-D-fructose 1,5-anhydro-d-fructose 1 1, 1,5 1,5- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,--- 4 4 0 0 0 0 1
(246, 247) (246, ( (2 (24 (246 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,) 3 1 0 0 0 0 1
KCNAB1 Potassium kcnab1 K KC KCN KCNA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -- 2 7 0 0 0 0 1
subunit-1 (Kvb1)/AKR6A3 subunit-1 s su sub subu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -()/ 4 4 0 0 0 0 1
Brain, heart brain, B Br Bra Brai BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 2 0 0 0 0 1
Lipid peroxidation-derived lipid L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 -()* 4 10 0 0 0 0 1
(248, 249) (248, ( (2 (24 (248 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 (,) 3 2 0 0 0 0 1
KCNAB2 Potassium kcnab2 K KC KCN KCNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -- 2 10 0 0 0 0 1
subunit-2 (Kvb2)/AKR6A5 subunit-2 s su sub subu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -()/ 4 5 0 0 0 0 1
Brain, spinal brain, B Br Bra Brai BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 , 1 4 0 0 0 0 1
Methylglyoxal, acrolein, methylglyoxal, M Me Met Meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 ,,-,,* 6 10 0 0 0 0 1
( 250-252) ( ( ( ( ( BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 (-) 3 2 0 0 0 0 1
KCNAB3 Potassium kcnab3 K KC KCN KCNA BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -- 2 10 0 1 0 0 1
subunit-3 (Kvb3)/AKR6A9 subunit-3 s su sub subu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -()/ 4 5 0 1 0 0 1
Brain Brain brain B Br Bra Brai BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 10 no 0 6 0 1 0 0 1
No data. no N No No No BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 10 0 1 0 0 1
(253) (253) (253) ( (2 (25 (253 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 6 0 1 0 0 1
AKR7A2 Aflatoxin akr7a2 A AK AKR AKR7 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 10 0 1 0 0 1
Ubiquitous Ubiquitous ubiquitous U Ub Ubi Ubiq BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 2 0 1 0 0 1
Aflatoxin B1, aflatoxin A Af Afl Afla BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 ,-,- 4 10 0 1 0 0 1
(230, 254) (230, ( (2 (23 (230 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 (,) 3 2 0 1 0 0 1
AKR7A3 Aflatoxin akr7a3 A AK AKR AKR7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 10 0 1 0 0 1
Liver, stomach, liver, L Li Liv Live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 ,,, 3 5 0 1 0 0 1
kidney kidney kidney k ki kid kidn BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 1 0 1 0 0 1
Aflatoxin B1 aflatoxin A Af Afl Afla BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 1
(255), (255), (255), ( (2 (25 (255 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 (), 3 5 0 1 0 0 1
*Evidence from *evidence * *E *Ev *Evi BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 *.-,---;-,---;,;,;, 19 10 0 1 0 0 1
(e.g., PGH (e.g., ( (e (e. (e.g BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 (..,,,). 8 1 0 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 11 no 0 8 0 1 0 0 0
12 12 12 1 12 12 12 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 0 0 1 0 0 0
with His with w wi wit with BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()(). 5 9 1 0 0 0 1
the substrate, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 1 0 0 0 1
cofactor. In cofactor. c co cof cofa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ., 2 9 1 0 0 0 1
(generated through (generated ( (g (ge (gen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 () 2 9 1 0 0 0 1
and abstracts and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
facilitating hydride facilitating f fa fac faci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ()(). 5 9 1 0 0 0 1
AKR1D subfamily akr1d A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 - 1 7 1 0 0 0 1
reduction of reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
the reversible the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ( 1 9 1 0 0 0 1
4C). They 4c). 4 4C 4C) 4C). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ). 2 9 1 0 0 0 1
His (265). his H Hi His His BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 9 1 0 0 0 1
deeper into deeper d de dee deep BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,- 2 9 1 0 0 0 1
pro-H of pro-h p pr pro pro- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 -(). 4 9 1 0 0 0 1
act as act a ac act act BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
double bond double d do dou doub BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (,). 4 8 1 0 0 0 1
Human AKR1B1 human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 7 1 0 0 0 1
PGD 2 pgd P PG PGD PGD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 , 1 9 1 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ()., 4 10 1 0 0 0 1
of these of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 1 0 0 1
of Lys, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,,, 3 9 0 1 0 0 1
although Tyr although a al alt alth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 - 1 8 0 1 0 0 1
reductase activity reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ()., 4 8 0 1 0 0 1
can participate can c ca can can BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -,. 3 8 0 1 0 0 1
Involvement of involvement I In Inv Invo BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 1 0 0 1
Human AKRs human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 8 1 0 0 0 1
carbonyls. Several carbonyls. c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 .- 2 9 1 0 0 0 1
aldehydes like aldehydes a al ald alde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 -()., 5 9 1 0 0 0 1
AKRs (1A1, akrs A AK AKR AKRs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 (,,,), 6 9 1 0 0 0 1
particularly phospholipid particularly p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (,). 4 10 1 0 0 0 1
mitigate the mitigate m mi mit miti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (,-), 5 9 1 0 0 0 1
and in and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 1 0 0 0 1
redox sensing redox r re red redo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 (). 3 3 1 0 0 0 1
Both AKR1B1 both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 8 1 0 0 0 1
activity (270, activity a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (,). 4 9 1 0 0 0 1
PGF 2a pgf P PG PGF PGF BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 . 1 9 1 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 3 10 no 0 10 1 0 0 0 1
B B b B B B B BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 1 0 0 0 1
C C c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 10 no 0 10 1 0 0 0 1
FIGURE 4 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 -():()().()- 12 10 1 1 0 0 1
bond by bond b bo bon bond BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 10 . 1 1 1 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 11 .. 2 10 1 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 3 11 no 0 8 1 1 0 0 0
13 13 13 1 13 13 13 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 11 no 0 0 1 1 0 0 0
reversible reduction reversible r re rev reve BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,-(). 5 7 0 0 0 0 1
Furthermore, AKR1B1 furthermore, F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 8 0 0 0 0 1
PGD 2 pgd P PG PGD PGD BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 . 1 9 0 0 0 0 1
However, the however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 10 0 0 0 0 1
this isomerization this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 0 0 0 1
D synthases d D D D D BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 (), 3 8 0 0 0 0 1
reduction reaction. reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 .,- 3 8 0 0 0 0 1
promote uterine promote p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 7 0 0 0 0 1
Six of six S Si Six Six BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 / 1 8 0 0 0 0 1
metabolism: AKR1B15, metabolism: m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 :, 2 7 0 0 0 0 1
subfamily (also subfamily s su sub subf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (; 2 8 0 0 0 0 1
HSDs), and hsds), H HS HSD HSDs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ),.- 4 8 0 0 0 0 1
androgens and androgens a an and andr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ().(-) 6 9 0 0 0 0 1
20a-reduction of 20a-reduction 2 20 20a 20a- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 -(), 4 9 0 0 0 0 1
AKR1C2 (Type akr1c2 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (-)- 4 9 0 0 0 0 1
and deactivates and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -().(- 6 9 0 0 0 0 1
HSD) exhibits hsd) H HS HSD HSD) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 )- 2 9 0 0 0 0 1
and estradiol and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 . 1 7 0 0 0 0 1
AKR1D1 and akr1d1 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (-) 3 7 0 0 0 0 1
in bile in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 .- 2 8 0 0 0 0 1
reduction of reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -. 2 9 0 0 0 0 1
changes the changes c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 0 , 1 9 0 0 0 0 1
with a with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 /., 3 9 0 0 0 0 1
the 3a-reduction the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,,- 4 8 0 0 0 0 1
configuration, a configuration, c co con conf BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,. 2 8 0 0 0 0 1
Other HSDs other O Ot Oth Othe BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 - 1 10 0 0 0 0 1
Dehydrogenase/Reductase (SDR) dehydrogenase/reductase D De Deh Dehy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 /() 3 10 0 0 0 0 1
Some HSDs some S So Som Some BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 :- 2 9 0 0 0 0 1
chain dehydrogenases/reductases chain c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 /(). 4 8 0 0 0 0 1
differences from differences d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,, 2 8 0 0 0 0 1
mechanism, and mechanism, m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ,(()). 6 9 0 0 0 0 1
Of note, of O Of Of Of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
reductases or reductases r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 , 1 9 0 0 0 0 1
preference for preference p pr pre pref BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 () 2 8 0 0 0 0 1
(H). This (h). ( (H (H) (H). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 (). 3 8 0 0 0 0 1
operate in operate o op ope oper BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 () 2 9 0 0 0 0 1
(274). Like (274). ( (2 (27 (274 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 ()., 4 9 0 0 0 0 1
proposed for proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ().,( 5 10 0 0 0 0 1
HSDs) remain hsds) H HS HSD HSDs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 ). 2 8 0 0 0 0 1
important functions important i im imp impo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 /(). 4 9 0 0 0 0 1
BIOSYNTHETIC PATHWAYS biosynthetic B BI BIO BIOS BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 10 0 1 0 0 1
LIPIDS LIPIDS lipids L LI LIP LIPI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 2 0 1 0 0 1
Oxygenated PUFA oxygenated O Ox Oxy Oxyg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 10 0 1 0 0 1
Phospholipids Phospholipids phospholipids P Ph Pho Phos BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 no 0 4 0 1 0 0 1
Classification of classification C Cl Cla Clas BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 10 0 0 0 0 1
and Docosanoids and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 3 0 0 0 0 1
The term the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 "". 3 9 0 0 0 0 1
encompasses a encompasses e en enc enco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -, 2 8 0 0 0 0 1
epoxy-, oxo-FAs, epoxy-, e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -,-,. 5 7 0 0 0 0 1
classified according classified c cl cla clas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 () 2 9 0 0 0 0 1
or docosanoids or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (),., 5 10 0 0 0 0 1
on. Following on. o on on. on. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 8 0 0 0 0 1
consortium, eicosanoids consortium, c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,,, 3 9 0 0 0 0 1
thromboxanes, lipoxins, thromboxanes, t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 ,,,-, 5 8 0 0 0 0 1
hydroxy-, hydroperoxy-, hydroxy-, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -,-,-,-(). 10 8 0 0 0 0 1
Likewise, docosanoids likewise, L Li Lik Like BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 ,-,,, 5 9 0 0 0 0 1
hydroxy-, hydroperoxy-, hydroxy-, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 -,-,-,-. 8 9 0 0 0 0 1
of these of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (). 3 9 0 0 0 0 1
Here, we here, H He Her Here BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 8 0 0 0 0 1
from AA from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,, 2 8 0 0 0 0 1
are the are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
enzymes involved enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 , 1 9 0 0 0 0 1
or different or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
reactions. Similarly, reactions. r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ., 2 9 0 0 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
described here. described d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 . 1 9 0 0 0 0 1
are discussed are a ar are are BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (,). 4 6 0 0 0 0 1
Release of release R Re Rel Rele BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 no 0 10 0 0 0 0 1
Biosynthesis Biosynthesis biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 2 0 0 0 0 1
Intracellular concentration intracellular I In Int Intr BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 8 0 0 0 0 1
through conjugation through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 () 2 7 0 0 0 0 1
esterification into esterification e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 8 0 0 0 0 1
pathways (like pathways p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (-). 4 8 0 0 0 0 1
PLs, typically pls, P PL PLs PLs, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ,-. 3 10 0 0 0 0 1
oxylipin biosynthesis oxylipin o ox oxy oxyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 no 0 8 0 0 0 0 1
PL via pl P PL PL PL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 (), 3 8 0 0 0 0 1
phospholipase C phospholipase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 (,). 4 8 0 0 0 0 1
enzymes are enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 :(), 4 9 0 0 0 0 1
(cPLA 2 (cpla ( (c (cP (cPL BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 7 (),-(),- 8 9 0 0 0 0 1
TABLE 4 table T TA TAB TABL BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 -/. 3 10 0 0 0 0 1
Gene Gene gene G Ge Gen Gene BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 9 no 0 1 0 0 0 0 1
Alternative protein alternative A Al Alt Alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 0 0 0 0 1
Substrates Substrates substrates S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
Reaction Reaction reaction R Re Rea Reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
Refs. Refs. refs. R Re Ref Refs BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 2 0 0 0 0 1
HSD3B1 Type hsd3b1 H HS HSD HSD3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -/-/ 4 8 0 0 0 0 1
3b-Hydroxy-D 5 3b-hydroxy-d 3 3b 3b- 3b-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 --- 3 4 0 0 0 0 1
Oxidation & oxidation O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
(276, 277), (276, ( (2 (27 (276 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,), 4 2 0 0 0 0 1
HSD3B2 Type hsd3b2 H HS HSD HSD3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -/-/ 4 8 0 0 0 0 1
3b-Hydroxy-D 5 3b-hydroxy-d 3 3b 3b- 3b-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 --- 3 4 0 0 0 0 1
Oxidation & oxidation O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
(277, 278), (277, ( (2 (27 (277 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 (,), 4 2 0 0 0 0 1
HSD3B7 Type hsd3b7 H HS HSD HSD3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -/ 2 5 0 0 0 0 1
3b-Hydroxy-D 5 3b-hydroxy-d 3 3b 3b- 3b-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 --- 3 4 0 0 0 0 1
Oxidation & oxidation O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 4 0 0 0 0 1
(279) (279) (279) ( (2 (27 (279 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 () 2 1 0 0 0 0 1
HSD11B1 Type hsd11b1 H HS HSD HSD1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 -/- 3 10 0 0 0 0 1
isozyme 1/SDR26C1 isozyme i is iso isoz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 / 1 3 0 0 0 0 1
11b-Hydroxysterols (e.g. 11b-hydroxysterols 1 11 11b 11b- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -(..), 6 10 0 0 0 0 1
Oxidation Oxidation oxidation O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 2 0 0 0 0 1
(280) (280) (280) ( (2 (28 (280 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 0 0 0 1
HSD11B2 Type hsd11b2 H HS HSD HSD1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -/- 3 10 0 1 0 0 1
isozyme 2/SDR9C3 isozyme i is iso isoz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 / 1 3 0 1 0 0 1
11b-Hydroxysterols (e.g. 11b-hydroxysterols 1 11 11b 11b- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 -(..), 6 10 0 1 0 0 1
Oxidation Oxidation oxidation O Ox Oxi Oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 no 0 2 0 1 0 0 1
(280) (280) (280) ( (2 (28 (280 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 () 2 1 0 1 0 0 1
HSD17B1 Type hsd17b1 H HS HSD HSD1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 -/-/ 4 10 0 1 0 0 1
SDR28C1 SDR28C1 sdr28c1 S SD SDR SDR2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 no 0 1 0 1 0 0 1
Estrogens and estrogens E Es Est Estr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 10 no 0 10 0 1 0 0 1
Reduction Reduction reduction R Re Red Redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 4 0 1 0 0 1
(281, 282) (281, ( (2 (28 (281 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 (,) 3 4 0 1 0 0 1
HSD17B4 Type hsd17b4 H HS HSD HSD1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 -/ 2 10 0 1 0 0 1
2/SDR8C1 2/SDR8C1 2/sdr8c1 2 2/ 2/S 2/SD BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 / 1 1 0 1 0 0 1
(24R,25R)-3a,7a,12a,24-Tetrahydroxy-5b- (24R,25R)-3a,7a,12a,24-Tetrahydroxy-5b- (24r,25r)-3a,7a,12a,24-tetrahydroxy-5b- ( (2 (24 (24R BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 (,)-,,,--- 10 10 0 1 0 0 1
cholestan-26-oyl-CoA cholestan-26-oyl-CoA cholestan-26-oyl-coa c ch cho chol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 --- 3 5 0 1 0 0 1
Reduction Reduction reduction R Re Red Redu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 10 0 1 0 0 1
(283) (283) (283) ( (2 (28 (283 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 () 2 6 0 1 0 0 1
HSD17B7 Type hsd17b7 H HS HSD HSD1 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 -/-/ 4 10 0 1 0 0 1
3b-Hydroxysterols, 17b-estradiol 3b-hydroxysterols, 3 3b 3b- 3b-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 -,- 3 6 0 1 0 0 1
Reduction Reduction reduction R Re Red Redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 no 0 1 0 1 0 0 1
(284, 285) (284, ( (2 (28 (284 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 (,) 3 2 0 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 4 11 no 0 8 0 1 0 0 0
14 14 14 1 14 14 14 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 0 0 1 0 0 0
acetylhydrolases (PAH-AH), acetylhydrolases a ac ace acet BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-),(), 7 8 1 0 0 0 1
(AdPLA), and (adpla), ( (A (Ad (AdP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (), 3 7 1 0 0 0 1
subgroups (291, subgroups s su sub subg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,). 4 9 1 0 0 0 1
translocates to translocates t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 9 1 0 0 0 1
and exhibits and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 10 1 0 0 0 1
position (293, position p po pos posi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,)., 5 9 1 0 0 0 1
membrane can membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,)., 5 9 1 0 0 0 1
enzymes are enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(, 3 8 1 0 0 0 1
298). PLA 298). 2 29 298 298) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ).(). 5 9 1 0 0 0 1
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 10 1 0 0 0 1
Arachidonic acid arachidonic A Ar Ara Arac BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 no 0 10 1 0 0 0 1
the actions the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 ,,, 3 8 1 0 0 0 1
enzymes (Figure enzymes e en enz enzy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ().- 4 9 1 0 0 0 1
oxygenation products oxygenation o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 ,, 2 8 1 0 0 0 1
prostaglandins, leukotrienes, prostaglandins, p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 ,,, 3 8 1 0 0 0 1
LOXs, and loxs, L LO LOX LOXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ,. 2 8 1 0 0 0 1
1950s-90's in 1950s-90's 1 19 195 1950 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 4 -', 3 9 1 0 0 0 1
Karolinska Institute karolinska K Ka Kar Karo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 , 1 9 1 0 0 0 1
Samuelsson and samuelsson S Sa Sam Samu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ., 2 8 1 0 0 0 1
Physiology and physiology P Ph Phy Phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 8 1 0 0 0 1
prostaglandins and prostaglandins p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 4 no 0 9 1 0 0 0 1
1985 to 1985 1 19 198 1985 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 4 ,., 3 9 1 0 0 0 1
research has research r re res rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 4 no 0 10 1 0 0 0 1
PUFAs from pufas P PU PUF PUFA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 4 ,, 2 8 1 0 0 0 1
proposed to proposed p pr pro prop BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 no 0 9 1 0 0 0 1
A A a A A A A BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 7 no 0 10 1 0 0 0 1
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 7 no 0 10 1 0 0 0 1
FIGURE 5 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 :()().,-;,; 11 10 1 1 0 0 1
Ep, epoxy; ep, E Ep Ep, Ep, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 ,;,;,;,-;,;, 12 9 1 1 0 0 1
hydrolase; 12-HEDH, hydrolase; h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ;-,-;,(:,);((: 14 9 1 1 0 0 1
lipocalin type, lipocalin l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ,:);-,-;-,-;,; 14 9 1 1 0 0 1
DiHETrE, dihydroxy-eicosatrienoic dihetre, D Di DiH DiHE BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 ,-;,-. 6 4 1 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 .. 2 10 1 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 4 11 no 0 8 1 1 0 0 0
15 15 15 1 15 15 15 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 0 1 1 0 0 0
various enzymes. various v va var vari BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 .,, 3 8 0 0 0 0 1
biosynthetic pathways, biosynthetic b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 7 0 0 0 0 1
biological actions biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
levels formed levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
monohydroxy-oxylipins. Furthermore, monohydroxy-oxylipins. m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -., 3 8 0 0 0 0 1
require amounts require r re req requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
levels detected levels l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
considered pharmacological. considered c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 3 0 0 0 0 1
COXs convert coxs C CO COX COXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 7 0 0 0 0 1
(Figure 5A). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()., 4 9 0 0 0 0 1
PGs and pgs P PG PGs PGs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,-. 3 8 0 0 0 0 1
CYP5A1 (thromboxane cyp5a1 C CY CYP CYP5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 () 2 8 0 0 0 0 1
types and types t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,,,,) 6 9 0 0 0 0 1
catalyzes the catalyzes c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
potent vasoconstrictor potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (, 2 9 0 0 0 0 1
301). CYP5A1 301). 3 30 301 301) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ). 2 7 0 0 0 0 1
malondialdehyde and malondialdehyde m ma mal malo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -. 2 7 0 0 0 0 1
CYP8A1 (prostacyclin cyp8a1 C CY CYP CYP8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ()( 3 8 0 0 0 0 1
in ovary, in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 ,,,,) 5 9 0 0 0 0 1
the isomerization the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (), 3 9 0 0 0 0 1
and inhibitor and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 6 0 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
AKR1B1 or akr1b1 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ,: 2 7 0 0 0 0 1
lipocalin-type PGD lipocalin-type l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(, 3 8 0 0 0 0 1
genitalia, heart, genitalia, g ge gen geni BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,,) 3 7 0 0 0 0 1
hematopoietic PGD hematopoietic h he hem hema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-, 3 8 0 0 0 0 1
cells and cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 )(,). 5 8 0 0 0 0 1
regulation of regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,, 2 8 0 0 0 0 1
the immune the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()., 4 8 0 0 0 0 1
reduction of reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,-, 3 8 0 0 0 0 1
contractions (237). contractions c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()., 4 8 0 0 0 0 1
reduction of reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
contractions (305). contractions c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()., 4 8 0 0 0 0 1
via the via v vi via via BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 7 0 0 0 0 1
isoforms: an isoforms: i is iso isof BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 :(-), 5 7 0 0 0 0 1
constitutive microsomal constitutive c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-) 3 8 0 0 0 0 1
cytosolic isoform cytosolic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()(). 5 8 0 0 0 0 1
and plays and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 8 0 0 0 0 1
Additionally, PGE additionally, A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 8 0 0 0 0 1
ketoreductase (PG-9KR) ketoreductase k ke ket keto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-)(). 6 4 0 0 0 0 1
COXs also coxs C CO COX COXs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 -,-,- 5 7 0 0 0 0 1
products, all products, p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 7 0 0 0 0 1
corresponding alcohols corresponding c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
turn reduced turn t tu tur turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 7 0 0 0 0 1
dehydrogenase (15-PGDH). dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-).- 5 7 0 0 0 0 1
ETEs are etes E ET ETE ETEs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (). 3 7 0 0 0 0 1
5-LOX converts 5-lox 5 5- 5-L 5-LO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 --(), 5 7 0 0 0 0 1
reduced into reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -(.., 5 8 0 0 0 0 1
GPX) or gpx) G GP GPX GPX) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 )() 3 8 0 0 0 0 1
leukotriene synthase leukotriene l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -. 2 8 0 0 0 0 1
(neutrophils, monocytes, (neutrophils, ( (n (ne (neu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (,,)- 5 8 0 0 0 0 1
dehydrogenase (5-HEDH) dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-)--- 6 7 0 0 0 0 1
HETE, a hete, H HE HET HETE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,(). 4 8 0 0 0 0 1
other hand, other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
(LTC 4 (ltc ( (L (LT (LTC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 (,)().,, 8 10 0 0 0 0 1
synthesized from synthesized s sy syn synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (- 2 8 0 0 0 0 1
S-transferase), g-glutamyl s-transferase), S S- S-t S-tr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 -),-() 6 8 0 0 0 0 1
2 (DPEP2). 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 5 ().- 4 8 0 0 0 0 1
and are and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (). 3 9 0 0 0 0 1
other hand, other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,- 2 8 0 0 0 0 1
through a through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
between two between b be bet betw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ().- 4 7 0 0 0 0 1
inflammatory properties inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
wound healing wound w wo wou woun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ()., 4 8 0 0 0 0 1
LTA 4 lta L LT LTA LTA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 () 2 8 0 0 0 0 1
into LTB into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,(). 4 6 0 0 0 0 1
15-LOXs converts 15-loxs 1 15 15- 15-L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 --(), 5 7 0 0 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ---. 4 8 0 0 0 0 1
15S-HpETE and 15s-hpete 1 15 15S 15S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ---, 4 8 0 0 0 0 1
produces a produces p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
lipoxins by lipoxins l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 .,- 3 8 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (,), 4 8 0 0 0 0 1
which is which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (,,) 4 10 0 0 0 0 1
similar to similar s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (). 3 9 0 0 0 0 1
thought to thought t th tho thou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 8 0 0 0 0 1
two steps two t tw two two BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 7 0 0 0 0 1
presumably a presumably p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 7 0 0 0 0 1
in eosinophils, in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 5 ,, 2 9 0 0 0 0 1
been shown been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -(). 4 7 0 0 0 0 1
12S-HpETE and 12s-hpete 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 --- 3 7 0 0 0 0 1
12R-LOX, respectively 12r-lox, 1 12 12R 12R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -,(). 5 8 0 0 0 0 1
be reduced be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
and both and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 --- 3 7 0 0 0 0 1
hydroxyeicosanoid dehydrogenase hydroxyeicosanoid h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (-)(). 6 7 0 0 0 0 1
hydroperoxides are hydroperoxides h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 , 1 8 0 0 0 0 1
epoxy-alcohols. eLOX3 epoxy-alcohols. e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 -.- 3 8 0 0 0 0 1
hepoxilin A hepoxilin h he hep hepo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 --.,- 5 8 0 0 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 8 0 0 0 0 1
eLOX3, but elox3, e eL eLO eLOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ,--(,). 7 7 0 0 0 0 1
Hepoxilins A hepoxilins H He Hep Hepo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
A 3 a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 5 ,(). 4 8 0 0 0 0 1
conjugated with conjugated c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
A 3 a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 5 -,- 3 8 0 0 0 0 1
(319). The (319). ( (3 (31 (319 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ().-() 6 8 0 0 0 0 1
has also has h ha has has BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 8 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 7 0 0 0 0 1
neutrophils across neutrophils n ne neu neut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 no 0 7 0 0 0 0 1
lumen (320). lumen l lu lum lume BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 (). 3 1 0 0 0 0 1
CYPs generate cyps C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 --- 3 8 0 0 0 0 1
HETE through hete H HE HET HETE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ()., 4 8 0 0 0 0 1
epoxyeicosatrienoic acids epoxyeicosatrienoic e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 () 2 8 0 0 0 0 1
epoxidation of epoxidation e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 . 1 7 0 0 0 0 1
epoxygenases include epoxygenases e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ,,(). 5 8 0 0 0 0 1
are further are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ( 1 8 0 0 0 0 1
hydrolases) into hydrolases) h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 )(). 4 8 0 0 0 0 1
that EPA that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 7 0 0 0 0 1
reactions, which reactions, r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,-,-, 5 8 0 0 0 0 1
and dihydroxy-derivatives. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -. 2 3 0 0 0 0 1
"E-resolvins", another "e-resolvins", " "E "E- "E-r BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 "-",, 5 8 0 0 0 0 1
generated from generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ().- 4 8 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 8 0 0 0 0 1
acid (18R-HEPE), acid a ac aci acid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (-), 4 9 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 4 11 no 0 8 0 1 0 0 0
16 16 16 1 16 16 16 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 0 0 1 0 0 0
termed resolvins termed t te ter term BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(-). 5 9 1 0 0 0 1
acetylation of acetylation a ac ace acet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
lipoxygenase-type reaction lipoxygenase-type l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -, 2 9 1 0 0 0 1
that acetylated that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --(). 5 8 1 0 0 0 1
However, acetylated however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,-, 3 9 1 0 0 0 1
and 18R-HEPE and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 9 1 0 0 0 1
COX-2 is cox-2 C CO COX COX- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -- 2 9 1 0 0 0 1
in a in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 0 -. 2 9 1 0 0 0 1
However, whether however, H Ho How Howe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,- 2 9 1 0 0 0 1
vivo and vivo v vi viv vivo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
unknown. Microbial unknown. u un unk unkn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 1 0 0 0 1
18R-HEPE during 18r-hepe 1 18 18R 18R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 -.- 3 8 1 0 0 0 1
produced through produced p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
and mammalian and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ()., 4 8 1 0 0 0 1
also potential also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -, 2 9 1 0 0 0 1
involved are involved i in inv invo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 3 1 0 0 0 1
18R-HEPE can 18r-hepe 1 18 18R 18R- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 --- 3 6 1 0 0 0 1
hydroperoxy intermediate hydroperoxy h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,- 2 8 1 0 0 0 1
intermediate (323). intermediate i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 8 1 0 0 0 1
into resolvin into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 10 1 0 0 0 1
be hydrolyzed be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ().- 4 8 1 0 0 0 1
of resolvin of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 1 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 8 1 0 0 0 1
(Figure 5B), (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (),- 4 8 1 0 0 0 1
(aside from (aside ( (a (as (asi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (-).- 5 8 1 0 0 0 1
is also is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 1 0 0 0 1
collectively called collectively c co col coll BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 --(). 5 8 1 0 0 0 1
E-resolvins are e-resolvins E E- E-r E-re BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 -- 2 9 0 1 0 0 1
promote the promote p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 (,). 4 7 0 1 0 0 1
Both lipoxins both B Bo Bot Both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 9 0 1 0 0 1
pro-resolving mediators pro-resolving p pr pro pro- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -(), 4 9 0 1 0 0 1
families of families f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 10 0 1 0 0 1
resolution of resolution r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 9 0 1 0 0 1
extremely low extremely e ex ext extr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 6 0 1 0 0 1
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 10 0 0 0 0 1
Oxygenation of oxygenation O Ox Oxy Oxyg BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 no 0 7 1 0 0 0 1
docosanoids (hydroxy-, docosanoids d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (-,-,). 7 9 1 0 0 0 1
is also is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 1 0 0 0 1
docosanoids, including docosanoids, d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 , 1 8 1 0 0 0 1
maresins, D-resolvins, maresins, m ma mar mare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,-,(). 6 8 1 0 0 0 1
biosynthesis has biosynthesis b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 -, 2 9 1 0 0 0 1
generating 14S-hydroperoxy-DHA generating g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 --(-),- 7 8 1 0 0 0 1
epoxy intermediate. epoxy e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 . 1 9 1 0 0 0 1
or an or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 no 0 9 1 0 0 0 1
maresin 1, maresin m ma mar mare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,(,). 5 10 1 0 0 0 1
D-resolvins both d-resolvins D D- D-r D-re BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 6 ---- 4 8 1 0 0 0 1
hydroperoxide (17S-HpDoHE). hydroperoxide h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 (-). 4 7 1 0 0 0 1
hydroperoxide into hydroperoxide h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ,--- 4 8 1 0 0 0 1
followed by followed f fo fol foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 () 2 9 1 0 0 0 1
generate protectin generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 ().,- 5 9 1 0 0 0 1
reduced into reduced r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 , 1 9 1 0 0 0 1
precursor for precursor p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 -.,- 4 9 1 0 0 0 1
generate two generate g ge gen gene BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 (), 3 9 1 0 0 0 1
FIGURE 6 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 -().,-;, 8 9 1 1 0 0 1
hydroperoxy; Ep, hydroperoxy; h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 ;,;,(:,:,:);,;, 15 10 1 1 0 0 1
synthase; GGT, synthase; s sy syn synt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 ;,-;,. 6 4 1 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 11 .. 2 10 1 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 4 11 no 0 8 1 1 0 0 0
17 17 17 1 17 17 17 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 11 no 0 0 1 1 0 0 0
undergo further undergo u un und unde BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
(Figure 6). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ()., 4 10 0 0 0 0 1
described pathways described d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
conjugation by conjugation c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,, 2 9 0 0 0 0 1
protectin and protectin p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -,,, 4 8 0 0 0 0 1
respectively (CTR respectively r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 9 0 0 0 0 1
conjugates are conjugates c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
similar to similar s si sim simi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 4 0 0 0 0 1
Oxygenation of oxygenation O Ox Oxy Oxyg BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 0 0 0 1
Oxidized Phospholipids oxidized O Ox Oxi Oxid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 4 0 0 0 0 1
The classical the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
phospholipids starts phospholipids p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
through the through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 9 0 0 0 0 1
enzymes discussed enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 0 0 0 0 1
oxygenated PUFA oxygenated o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
the action the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 -. 2 5 0 0 0 0 1
The generation the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 7 0 0 0 0 1
documented in documented d do doc docu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 , 1 9 0 0 0 0 1
and immune and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ().- 4 8 0 0 0 0 1
activated neutrophils, activated a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 ,(-). 5 8 0 0 0 0 1
Similarly, PGD similarly, S Si Sim Simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ,-- 3 8 0 0 0 0 1
PGH 2 pgh P PG PGH PGH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
lysoPLs (334). lysopls l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ().,- 5 9 0 0 0 0 1
(335). For (335). ( (3 (33 (335 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ()., 4 9 0 0 0 0 1
endogenous generation endogenous e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 8 0 0 0 0 1
esterified into esterified e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (.., 4 8 0 0 0 0 1
minutes) via minutes) m mi min minu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 )(). 4 5 0 0 0 0 1
15-LOXs also 15-loxs 1 15 15- 15-L BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 - 1 8 0 0 0 0 1
other pathways. other o ot oth othe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 8 0 0 0 0 1
membrane PLs membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,).,- 6 8 0 0 0 0 1
oxygenate the oxygenate o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 , 1 7 0 0 0 0 1
oxygenated PUFA oxygenated o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 no 0 8 0 0 0 0 1
can be can c ca can can BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (). 3 5 0 0 0 0 1
Recent studies recent R Re Rec Rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -,--, 5 8 0 0 0 0 1
12S-LOX can 12s-lox 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 --- 3 9 0 0 0 0 1
by iPLA by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 (,). 4 10 0 0 0 0 1
These reactions these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 -- 2 8 0 0 0 0 1
proposed to proposed p pr pro prop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
signaling mediators signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 .-- 3 9 0 0 0 0 1
converted into converted c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 - 1 9 0 0 0 0 1
(338). Cytochrome (338). ( (3 (33 (338 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 (). 3 8 0 0 0 0 1
plasmalogenase, and plasmalogenase, p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 ,- 2 7 0 0 0 0 1
eicosanoid-lysoPLs under eicosanoid-lysopls e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 -(). 4 9 0 0 0 0 1
These findings these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
oxPLs (Figure oxpls o ox oxP oxPL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 (). 3 9 0 0 0 0 1
contribution of contribution c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 9 0 0 0 0 1
other mediators other o ot oth othe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 0 . 1 3 0 0 0 0 1
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ,, 2 10 0 0 0 0 1
Steroid Hormones steroid S St Ste Ster BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 3 0 0 0 0 1
Oxysterols Oxysterols oxysterols O Ox Oxy Oxys BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 10 0 1 0 0 1
Oxysterols are oxysterols O Ox Oxy Oxys BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 8 0 1 0 0 1
metabolism: they metabolism: m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 : 1 10 0 1 0 0 1
its precursors its i it its its BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ().-(-) 7 9 0 1 0 0 1
from cholesterol from f fr fro from BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 10 0 1 0 0 1
in the in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 ()(, 4 10 0 0 0 0 1
220). (25R)26-Hydroxycholesterol 220). 2 22 220 220) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ).()-(-), 9 8 0 0 0 0 1
called 27-hydroxycholesterol, called c ca cal call BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -,---- 6 8 0 0 0 0 1
(25R)26-oic acid (25r)26-oic ( (2 (25 (25R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ()-(-) 6 8 0 0 0 0 1
by CYP27A1 by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
alternative pathway alternative a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (-). 4 9 0 0 0 0 1
CYP7A1 is cyp7a1 C CY CYP CYP7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 , 1 9 0 0 0 0 1
CYP27A1 is cyp27a1 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 . 1 8 0 0 0 0 1
CYP46A1 is cyp46a1 C CY CYP CYP4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 , 1 8 0 0 0 0 1
function is function f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 , 1 8 0 0 0 0 1
converting cholesterol converting c co con conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
blood brain blood b bl blo bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(-), 5 8 0 0 0 0 1
more polar more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (,, 3 8 0 0 0 0 1
341). CYP11A1, 341). 3 34 341 341) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ).,, 4 8 0 0 0 0 1
membrane protein. membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 8 0 0 0 0 1
tissue and tissue t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
step process step s st ste step BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(-) 4 8 0 0 0 0 1
20R,22R-dihydroxycholesterol as 20r,22r-dihydroxycholesterol 2 20 20R 20R, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 ,-(,-) 6 9 0 0 0 0 1
(342, 343) (342, ( (3 (34 (342 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (,)(). 6 10 0 0 0 0 1
discussed in discussed d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 4 0 0 0 0 1
While most while W Wh Whi Whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 5 "" 2 9 0 0 0 0 1
in CYP in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 5 ,- 2 8 0 0 0 0 1
(CH25H), the (ch25h), ( (C (CH (CH2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 (),- 4 7 0 0 0 0 1
hydroxycholesterol (25-HC) hydroxycholesterol h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (-), 4 9 0 0 0 0 1
CYP, but cyp, C CY CYP CYP, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 ,- 2 9 0 0 0 0 1
cofactors to cofactors c co cof cofa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (). 3 8 0 0 0 0 1
expressed in expressed e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -- 2 9 0 0 0 0 1
bacterial and bacterial b ba bac bact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(-).- 6 8 0 0 0 0 1
metabolized by metabolized m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 ,-, 3 8 0 0 0 0 1
Epstein Barr epstein E Ep Eps Epst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 5 5 ().,- 5 8 0 0 0 0 1
diHC acts dihc d di diH diHC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 8 0 0 0 0 1
cells (349, cells c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (,).,- 6 9 0 0 0 0 1
is through is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -(), 4 8 0 0 0 0 1
enzyme has enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 - 1 9 0 0 0 0 1
hydroxylase and hydroxylase h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 -(,). 5 9 0 0 0 0 1
Oxysterols can oxysterols O Ox Oxy Oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 no 0 9 0 0 0 0 1
reactions catalyzed reactions r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 (,). 4 9 0 0 0 0 1
may be may m ma may may BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 1 0 0 5 5 no 0 9 0 0 0 0 1
cholesterol biosynthesis cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 -- 2 9 0 0 0 0 1
(SLOS, 7-dehydrocholesterol (slos, ( (S (SL (SLO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 (,-) 4 8 0 0 0 0 1
desmosterolosis (3b-hydroxysterol-D desmosterolosis d de des desm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 5 (---) 5 9 0 0 0 0 1
where there where w wh whe wher BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ,.., 4 10 0 0 0 0 1
CYP7A1 in cyp7a1 C CY CYP CYP7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 , 1 8 0 0 0 0 1
is deficient. is i is is is BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 . 1 2 0 0 0 0 1
Bile Acid bile B Bi Bil Bile BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 10 0 0 0 0 1
There are there T Th The Ther BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 9 0 0 0 0 1
pathways of pathways p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 no 0 9 0 0 0 0 1
multiple oxidation multiple m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 (,,-). 6 10 0 0 0 0 1
enzymes, key enzymes, e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 , 1 8 0 0 0 0 1
hydroxysteroid dehydrogenase hydroxysteroid h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 () 2 9 0 0 0 0 1
chain dehydrogenase/reductase chain c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 /() 3 9 0 0 0 0 1
by aldo-keto by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -(). 4 9 0 0 0 0 1
pathways that pathways p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ,,- 3 8 0 0 0 0 1
trihydroxycholan-24-oic acid trihydroxycholan-24-oic t tr tri trih BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 ---,,- 6 9 0 0 0 0 1
triol which triol t tr tri trio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 0 0 0 0 1
product 5,6-epoxycholesterol product p pr pro prod BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 ,-(,). 6 6 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 11 no 0 8 0 1 0 0 0
18 18 18 1 18 18 18 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 0 0 1 0 0 0
While the while W Wh Whi Whil BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 1 0 0 0 1
(359), at (359), ( (3 (35 (359 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 (),. 4 10 1 0 0 0 1
initiated by initiated i in ini init BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 9 1 0 0 0 1
the liver. the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .- 2 8 1 0 0 0 1
generate 7a,12a-dihydroxycholesterol generate g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ,-(,-), 7 8 1 0 0 0 1
be preceded be b be be be BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 9 1 0 0 0 1
hydroxy-5-ene structure hydroxy-5-ene h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -----,- 7 8 1 0 0 0 1
hydroxycholest-4-en-3-one (7a-HCO) hydroxycholest-4-en-3-one h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ----(-),- 9 6 1 0 0 0 1
dihydroxycholest-4-en-3-one (7a,12a-diHCO), dihydroxycholest-4-en-3-one d di dih dihy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ----(,-), 9 7 1 0 0 0 1
(Figure 8). (figure ( (F (Fi (Fig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 (). 3 9 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 1 0 0 0 1
resulting in resulting r re res resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 1 0 0 0 1
tissue in tissue t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ().- 4 9 1 0 0 0 1
reductions which reductions r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ()- 3 7 1 0 0 0 1
hydroxylation and hydroxylation h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ()- 3 8 1 0 0 0 1
3a,7a,12a-trihydroxy-5b-cholanestan-(25R)26-oic acid. 3a,7a,12a-trihydroxy-5b-cholanestan-(25r)26-oic 3 3a 3a, 3a,7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,,----()-.- 11 8 1 0 0 0 1
ring reductions ring r ri rin ring BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 , 1 8 1 0 0 0 1
CYP27A1 carries cyp27a1 C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ()-.- 5 7 1 0 0 0 1
shortening of shortening s sh sho shor BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 1 0 0 0 1
through the through t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -- 2 8 1 0 0 0 1
(BACS, SLC27A5) (bacs, ( (B (BA (BAC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (,)-(, 6 8 1 0 0 0 1
SLC27A2). Following slc27a2). S SL SLC SLC2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ).--- 5 8 1 0 0 0 1
racemase (AMACR) racemase r ra rac race BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 () 2 8 1 0 0 0 1
of D of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -(). 4 8 1 0 0 0 1
The D the T Th The The BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 1 0 0 0 1
(DBP), which (dbp), ( (D (DB (DBP BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 (),-- 5 9 1 0 0 0 1
HSD17B4 activity. hsd17b4 H HS HSD HSD1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .,,-- 5 8 1 0 0 0 1
24-oxo-5b-cholestan-(25R)26-oyl-CoA is 24-oxo-5b-cholestan-(25r)26-oyl-coa 2 24 24- 24-o BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ----()-- 8 8 1 0 0 0 1
enzyme peroxisomal enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 () 2 9 1 0 0 0 1
acid ready acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,, 2 10 1 0 0 0 1
free acid free f fr fre free BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 -()(,). 7 9 1 0 0 0 1
The acidic the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 ()- 3 8 1 0 0 0 1
(25R)26-carboxylation of (25r)26-carboxylation ( (2 (25 (25R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ()- 3 8 1 0 0 0 1
many other many m ma man many BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 (). 3 8 1 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 (). 3 8 1 0 0 0 1
exception is exception e ex exc exce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,- 2 8 1 0 0 0 1
hydroxylase in hydroxylase h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 . 1 8 1 0 0 0 1
tissues, not tissues, t ti tis tiss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,(,),- 6 9 1 0 0 0 1
chain oxysterols chain c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 8 1 0 0 0 1
generates chenodeoxycholic generates g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 , 1 8 1 0 0 0 1
CYP8B1 has cyp8b1 C CY CYP CYP8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .- 2 7 1 0 0 0 1
reduction and reduction r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 9 1 0 0 0 1
pathway with pathway p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
3-oxo-4-ene or 3-oxo-4-ene 3 3- 3-o 3-ox BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 ------. 7 6 1 0 0 0 1
Steroid Hormone steroid S St Ste Ster BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 no 0 10 0 1 0 0 1
The classical the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 (), 3 10 0 1 0 0 1
cortisol (glucocorticoid), cortisol c co cor cort BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (),() 5 9 0 1 0 0 1
17b-estradiol (female 17b-estradiol 1 17 17b 17b- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 -() 3 8 0 1 0 0 1
FIGURE 7 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 .(),- 5 9 1 0 0 0 1
are oxygenated are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (),(),()-.* 11 9 1 0 0 0 1
plasmalogen lysophospholipids plasmalogen p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 ()-.()-- 8 9 1 0 0 0 1
hydrolysis of hydrolysis h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 .(),-- 6 10 1 0 0 0 1
are oxygenated are a ar are are BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -,-,--.()-- 11 9 1 0 0 0 1
plasmalogen phospholipids, plasmalogen p pl pla plas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 ,.,;,;,-;, 10 9 1 0 0 0 1
ester; CEH, ester; e es est este BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 ;,;,/;,. 8 5 1 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 . 1 4 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 11 no 0 8 0 1 0 0 0
19 19 19 1 19 19 19 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 0 0 1 0 0 0
FIGURE 8 figure F FI FIG FIGU BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 .""()- 6 10 1 1 0 0 1
CYP7A1, the cyp7a1, C CY CYP CYP7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,""()-()-.""() 14 9 1 1 0 0 1
CYP7B1 is cyp7b1 C CY CYP CYP7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -. 2 1 1 1 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 . 1 4 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 .. 2 10 1 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 9 no 0 8 1 1 0 0 0
20 20 20 2 20 20 20 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 9 no 0 0 1 1 0 0 0
cholesterol through cholesterol c ch cho chol BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ()(, 4 10 1 0 0 0 1
365). Pregnenolone 365). 3 36 365 365) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ). 2 7 1 0 0 0 1
cholesterol represents cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 1 0 0 0 1
steroid hormone steroid s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 8 1 0 0 0 1
progesterone on progesterone p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 9 1 0 0 0 1
17a-hydroxypregnenolone on 17a-hydroxypregnenolone 1 17 17a 17a- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -. 2 9 1 0 0 0 1
pathways use pathways p pa pat path BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 - 1 8 1 0 0 0 1
enzymes as enzymes e en enz enzy BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -., 3 10 1 0 0 0 1
which generates which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
placenta, when placenta, p pl pla plac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 , 1 8 1 0 0 0 1
pregnancy. Further pregnancy. p pr pre preg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .- 2 10 1 0 0 0 1
CYP17A1 leads cyp17a1 C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
testosterone and17b-estradiol. testosterone t te tes test BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 -. 2 9 1 0 0 0 1
oxidations and oxidations o ox oxi oxid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 1 0 0 0 1
FIGURE 9 figure F FI FIG FIGU BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 .,,,,, 6 10 1 0 0 0 1
and 17b-estradiol. and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 -. 2 1 1 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 . 1 4 1 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 10 no 0 10 1 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 10 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 10 no 0 8 0 1 0 0 0
21 21 21 2 21 21 21 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 10 no 0 0 0 1 0 0 0
HSD17B3, respectively, hsd17b3, H HS HSD HSD1 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,, 2 9 0 0 0 0 1
estrogens. Besides estrogens. e es est estr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
organs it organs o or org orga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
brain and brain b br bra brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 (,). 4 8 0 0 0 0 1
general term general g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
brain or brain b br bra brai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
genomic effects genomic g ge gen geno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 10 0 0 0 0 1
this review this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
metabolism in metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 9 0 0 0 0 1
excellent reviews excellent e ex exc exce BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 (,-). 5 9 0 0 0 0 1
CONCLUDING REMARKS concluding C CO CON CONC BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 10 0 0 0 0 1
Enzymatically oxidized enzymatically E En Enz Enzy BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
with critical with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
signaling mediators signaling s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
regulated and regulated r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,, 2 8 0 0 0 0 1
CYPs, and cyps, C CY CYP CYPs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 ,. 2 8 0 0 0 0 1
have led have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 8 0 0 0 0 1
biosynthetic routes. biosynthetic b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
and their and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,. 2 9 0 0 0 0 1
These include these T Th The Thes BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 --() 4 8 0 0 0 0 1
macrophages, the macrophages, m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 ,-, 3 8 0 0 0 0 1
the mechanistic the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,- 2 10 0 0 0 0 1
HEPE required hepe H HE HEP HEPE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 -, 2 9 0 0 0 0 1
of orphan of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,/ 2 8 0 0 0 0 1
endocannabinoids. The endocannabinoids. e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
multiply oxygenated multiply m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 , 1 8 0 0 0 0 1
extremely low extremely e ex ext extr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,. 2 9 0 0 0 0 1
also true also a al als also BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
Research on research R Re Res Rese BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 1 no 0 7 0 0 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 , 1 8 0 0 0 0 1
greatly from greatly g gr gre grea BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ., 2 8 0 0 0 0 1
still major still s st sti stil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 8 0 0 0 0 1
roles in roles r ro rol role BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 7 0 0 0 0 1
neurodegeneration. Here, neurodegeneration. n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 ., 2 8 0 0 0 0 1
of oxygenated of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ,() 3 8 0 0 0 0 1
functions to functions f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 8 0 0 0 0 1
connections between connections c co con conn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
encompassing the encompassing e en enc enco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 9 0 0 0 0 1
examining the examining e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 . 1 8 0 0 0 0 1
the progression the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 no 0 7 0 0 0 0 1
neurodegenerative disease, neurodegenerative n ne neu neur BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 , 1 8 0 0 0 0 1
analyzed together. analyzed a an ana anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 7 0 0 0 0 1
oxysterols are oxysterols o ox oxy oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 , 1 7 0 0 0 0 1
especially as especially e es esp espe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 0 0 0 0 1
regulator of regulator r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 8 0 0 0 0 1
systems are systems s sy sys syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 no 0 8 0 0 0 0 1
cholesterol metabolism cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 -. 2 8 0 0 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 - 1 8 0 0 0 0 1
lead to lead l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 .,- 3 9 0 0 0 0 1
LOX oxygenation lox L LO LOX LOX BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 no 0 8 0 0 0 0 1
novel lipids novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
possess the possess p po pos poss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 8 0 0 0 0 1
biosyntheses (e.g., biosyntheses b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 (..,). 6 8 0 0 0 0 1
route could route r ro rou rout BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
oxysterols. That oxysterols. o ox oxy oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ., 2 9 0 0 0 0 1
could be could c co cou coul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 no 0 8 0 0 0 0 1
alkaline conditions alkaline a al alk alka BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ., 2 8 0 0 0 0 1
substrate promiscuity substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 no 0 8 0 0 0 0 1
production of production p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 4 no 0 9 0 0 0 0 1
dissection of dissection d di dis diss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 () 2 9 0 0 0 0 1
lipids. Clearly, lipids. l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ., 2 10 0 0 0 0 1
the molecular, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,, 2 8 0 0 0 0 1
oxidized lipids. oxidized o ox oxi oxid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 . 1 2 0 0 0 0 1
AUTHOR CONTRIBUTIONS author A AU AUT AUTH BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 0 0 0 0 1
AH planned ah A AH AH AH BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 .,, 3 8 0 0 0 0 1
manuscript with manuscript m ma man manu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 . 1 7 0 0 0 0 1
contributed to contributed c co con cont BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 . 1 10 0 0 0 0 1
ACKNOWLEDGMENTS ACKNOWLEDGMENTS acknowledgments A AC ACK ACKN BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 no 0 10 0 0 0 0 1
AAH acknowledges aah A AA AAH AAH BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 (). 3 9 0 0 0 0 1
Swansea was swansea S Sw Swa Swan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
Sciences Research sciences S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 7 (,// 4 9 0 0 0 0 1
1 to 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 7 //). 4 9 0 0 0 0 1
from Barts from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 . 1 10 0 0 0 0 1
Holder and holder H Ho Hol Hold BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 7 no 0 9 0 0 0 0 1
LIPID MAPS lipid L LI LIP LIPI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 7 (///). 6 4 0 0 0 0 1
REFERENCES REFERENCES references R RE REF REFE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
1. Tilley 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 .,,.: 5 8 0 0 0 0 1
inflammation and inflammation i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 7 0 0 0 0 1
thromboxanes. J thromboxanes. t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 .()():-.:./ 11 9 0 0 0 0 1
2. Slatter 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 .,,-,,, 7 10 0 0 0 0 1
A, et a, A A, A, A, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 ,. 2 9 0 0 0 0 1
in coagulation in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 8 .()():. 7 8 0 0 0 0 1
doi: 10.1172/jci.insight.98459 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 :./.. 5 4 0 0 0 0 1
3. Buckley 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 .,,. 4 9 0 0 0 0 1
mechanisms in mechanisms m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .() 3 9 0 0 0 0 1
(3):315-27. doi: (3):315-27. ( (3 (3) (3): BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 ():-.:./.... 12 6 0 0 0 0 1
4. Choi 4. 4 4. 4. 4. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 .,,. 4 8 0 0 0 0 1
inflammation. Biochim inflammation. i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 .() 3 8 0 0 0 0 1
(4):393-7. doi: (4):393-7. ( (4 (4) (4): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 ():-.:./.... 12 5 0 0 0 0 1
5. Lauder 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 .,-,,,', 8 8 0 0 0 0 1
Farewell D, farewell F Fa Far Fare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 ,. 2 9 0 0 0 0 1
support calcium-dependent support s su sup supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 5 9 - 1 8 0 0 0 0 1
hemostasis. Sci hemostasis. h he hem hemo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 .()():.:./ 10 8 0 0 0 0 1
scisignal.aan2787 scisignal.aan2787 scisignal.aan2787 s sc sci scis BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 9 . 1 2 0 0 0 0 1
6. Stachenfeld 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 ... 3 10 0 0 0 0 1
Sci Rev sci S Sc Sci Sci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 ()():-.:./. 11 8 0 0 0 0 1
7. Kuo 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 .,,,. 5 7 0 0 0 0 1
Homeostasis by homeostasis H Ho Hom Home BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 .():-. 6 8 0 0 0 0 1
doi: 10.1007/978-1-4939-2895-8_5 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 :./---- 7 4 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 5 11 no 0 8 0 1 0 0 0
22 22 22 2 22 22 22 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 11 no 0 0 0 1 0 0 0
8. Bereshchenko 8. 8 8. 8. 8. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,.,, 6 9 0 0 0 0 1
and Immunity. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .():():.:./ 11 8 0 0 0 0 1
fimmu.2018.01332 fimmu.2018.01332 fimmu.2018.01332 f fi fim fimm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .. 2 2 0 0 0 0 1
9. Lefebvre 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,,. 6 10 0 0 0 0 1
acid receptors acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1152/physrev.00010.2008 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 :./.. 5 3 0 0 0 0 1
10. Studer 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,,,,. 8 8 0 0 0 0 1
Conjugated bile conjugated C Co Con Conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 -- 2 8 0 0 0 0 1
primary rodent primary p pr pri prim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()():-.:./ 11 9 0 0 0 0 1
hep.24681 hep.24681 hep.24681 h he hep hep. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 . 1 1 0 0 0 0 1
11. Griffiths 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.:. 5 9 0 0 0 0 1
(2019) 47(2):517-26. (2019) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ()():-.:./ 10 5 0 0 0 0 1
12. Garavito 12. 1 12 12. 12. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.: 4 9 0 0 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
Acta (BBA) acta A Ac Act Acta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ()-()(-):-.:./ 14 8 0 0 0 0 1
s1388-1981(99)00147-x s1388-1981(99)00147-x s1388-1981(99)00147-x s s1 s13 s138 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 -()- 4 2 0 0 0 0 1
13. Vecchio 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,. 5 8 0 0 0 0 1
substrate promiscuity substrate s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -:- 3 8 0 0 0 0 1
residues lining residues r re res resi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .() 3 7 0 0 0 0 1
(29):24619-30. doi: (29):24619-30. ( (2 (29 (29) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ():-.:./.. 10 5 0 0 0 0 1
14. Kuhn 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,. 4 8 0 0 0 0 1
biological relevance. biological b bi bio biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/j.bbalip.2014.10.002 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 :./.... 7 4 0 0 0 0 1
15. Spector 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,. 3 7 0 0 0 0 1
polyunsaturated fatty polyunsaturated p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 .() 3 8 0 0 0 0 1
(4):356-65. doi: (4):356-65. ( (4 (4) (4): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ():-.:./.... 12 5 0 0 0 0 1
16. Mikulska-Ruminska 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .-,,,,,,. 9 10 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ,, 2 8 0 0 0 0 1
Lipoxygenase Family lipoxygenase L Li Lip Lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1021/acs.jcim.9b00006 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 :./.. 5 3 0 0 0 0 1
17. Pandak 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,.: 4 9 0 0 0 0 1
just an just j ju jus just BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 ().()():-.:./ 13 9 0 0 0 0 1
j.livres.2019.05.001 j.livres.2019.05.001 j.livres.2019.05.001 j j. j.l j.li BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .... 4 2 0 0 0 0 1
18. Kutzner 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,,,. 7 9 0 0 0 0 1
Mammalian ALOX15 mammalian M Ma Mam Mamm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 7 0 0 0 0 1
specificity with specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 . 1 9 0 0 0 0 1
Lipids (2017) lipids L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ()():-.:./.... 14 7 0 0 0 0 1
19. Simard-Bisson 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .-,,,. 6 7 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 no 0 7 0 0 0 0 1
Human Skin human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 -. 2 7 0 0 0 0 1
Cytochem (2018) cytochem C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ()():-.:./ 10 7 0 0 0 0 1
20. Funk 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,. 5 8 0 0 0 0 1
human 12-lipoxygenase human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 -.()():- 8 8 0 0 0 0 1
6. doi: 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .:./... 7 3 0 0 0 0 1
21. Chen 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,. 4 8 0 0 0 0 1
recombinant histidine-tagged recombinant r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -- 2 8 0 0 0 0 1
a baculovirus/insect a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 5 0 /.()():-. 9 8 0 0 0 0 1
doi: 10.1111/j.1432-1033.1993.tb17988.x doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 :./.-... 8 4 0 0 0 0 1
22. Weisinger 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,-,,,,,. 9 9 0 0 0 0 1
12S-Lipoxygenase is 12s-lipoxygenase 1 12 12S 12S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 - 1 8 0 0 0 0 1
survival. Exp survival. s su sur surv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()():-.:./ 11 7 0 0 0 0 1
j.yexcr.2013.04.001 j.yexcr.2013.04.001 j.yexcr.2013.04.001 j j. j.y j.ye BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 .... 4 2 0 0 0 0 1
23. Boeglin 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,.-: 6 8 0 0 0 0 1
mechanistic evidence, mechanistic m me mec mech BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ,,. 3 8 0 0 0 0 1
Sci U.S.A. sci S Sc Sci Sci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ...()():-.:./... 16 7 0 0 0 0 1
24. Sun 24. 2 24 24. 24. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,,,,. 8 9 0 0 0 0 1
12(R)-lipoxygenase and 12(r)-lipoxygenase 1 12 12( 12(R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ()-.,, 6 9 0 0 0 0 1
and gene and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1074/jbc.273.50.33540 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 :./... 6 3 0 0 0 0 1
25. Zheng 25. 2 25 25. 25. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,,,,. 8 8 0 0 0 0 1
Lipoxygenases mediate lipoxygenases L Li Lip Lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 no 0 8 0 0 0 0 1
formation: a formation: f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 :- 2 8 0 0 0 0 1
construction of construction c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 .() 3 8 0 0 0 0 1
(27):24046-56. doi: (27):24046-56. ( (2 (27 (27) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ():-.:./.. 10 5 0 0 0 0 1
26. Schneider 26. 2 26 26. 26. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 .,,,. 5 8 0 0 0 0 1
localization of localization l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 -. 2 8 0 0 0 0 1
(2001) 386(2):268-74. (2001) ( (2 (20 (200 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 0 ()():-.:./.. 12 6 0 0 0 0 1
27. Garcia-Verdugo 27. 2 27 27. 27. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .-,,,,, 7 9 0 0 0 0 1
Chignard M, chignard C Ch Chi Chig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ,.- 3 8 0 0 0 0 1
respiratory epithelial respiratory r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .()():-.:./ 11 9 0 0 0 0 1
09031936.00023111 09031936.00023111 09031936.00023111 0 09 090 0903 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 . 1 2 0 0 0 0 1
28. Wuest 28. 2 28 28. 28. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,. 6 9 0 0 0 0 1
regulation of regulation r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 /-. 3 8 0 0 0 0 1
Atherosclerosis (2012) atherosclerosis A At Ath Athe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ()():-.:./.... 14 10 0 0 0 0 1
29. Turk 29. 2 29 29. 29. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,.- 8 9 0 0 0 0 1
lipoxygenase products lipoxygenase l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .() 3 8 0 0 0 0 1
(12):7068-76. (12):7068-76. (12):7068-76. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ():-. 5 1 0 0 0 0 1
30. Sigal 30. 3 30 30. 30. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,. 7 8 0 0 0 0 1
Expression of expression E Ex Exp Expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 - 1 7 0 0 0 0 1
immunological evidence immunological i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 - 1 9 0 0 0 0 1
related. J related. r re rel rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .()():-. 8 5 0 0 0 0 1
31. Conrad 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,. 6 9 0 0 0 0 1
cytokines regulate cytokines c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 -. 2 9 0 0 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ()():-.:./... 13 8 0 0 0 0 1
32. Spanbroek 32. 3 32 32. 32. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,,.- 9 9 0 0 0 0 1
determines eicosanoid determines d de det dete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -- 2 9 0 0 0 0 1
lipoxygenase and lipoxygenase l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 --. 3 9 0 0 0 0 1
Acad Sci acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ...()():-.:./. 14 8 0 0 0 0 1
33. Brash 33. 3 33 33. 33. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,.- 5 9 0 0 0 0 1
in humans. in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 5 .()():-.:./ 11 9 0 0 0 0 1
pnas.94.12.6148 pnas.94.12.6148 pnas.94.12.6148 p pn pna pnas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ... 3 2 0 0 0 0 1
34. Matsumoto 34. 3 34 34. 34. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,. 7 9 0 0 0 0 1
Molecular cloning molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 -. 2 9 0 0 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ()():-.:./... 13 8 0 0 0 0 1
35. Colamorea 35. 3 35 35. 35. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .-. 3 9 0 0 0 0 1
Biochem Biophys biochem B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ()():-.:./ 10 7 0 0 0 0 1
bbrc.1999.1732 bbrc.1999.1732 bbrc.1999.1732 b bb bbr bbrc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .. 2 1 0 0 0 0 1
36. Spanbroek 36. 3 36 36. 36. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .-() 4 9 0 0 0 0 1
hematopoietic progenitors hematopoietic h he hem hema BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 .() 3 8 0 0 0 0 1
(12):3857-65. doi: (12):3857-65. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ():-.:./... 11 5 0 0 0 0 1
37. Krieg 37. 3 37 37. 37. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,. 4 8 0 0 0 0 1
epidermis-type lipoxygenases epidermis-type e ep epi epid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 -.:, 4 8 0 0 0 0 1
mapping, and mapping, m ma map mapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,.()():-.:./ 12 8 0 0 0 0 1
geno.2001.6519 geno.2001.6519 geno.2001.6519 g ge gen geno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .. 2 1 0 0 0 0 1
38. Zheng 38. 3 38 38. 38. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,.- 4 9 0 0 0 0 1
unveiled: typical unveiled: u un unv unve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 : 1 9 0 0 0 0 1
and synthetic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .() 3 8 0 0 0 0 1
(51):39866-75. doi: (51):39866-75. ( (5 (51 (51) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ():-.:./.. 10 5 0 0 0 0 1
39. UniProt 39. 3 39 39. 39. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ..:. 4 9 0 0 0 0 1
Res (2019) res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 5 ()():-.:.// 11 6 0 0 0 0 1
40. Choi 40. 4 40 40. 40. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,. 5 9 0 0 0 0 1
15S-lipoxygenase: Reinterpretation 15s-lipoxygenase: 1 15 15S 15S- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 -:. 3 9 0 0 0 0 1
(2008) 70(3):1023-32. (2008) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 ()():-.:./. 11 5 0 0 0 0 1
41. Gilbert 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,,,. 8 9 0 0 0 0 1
The structure the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 5 -.()():-. 9 8 0 0 0 0 1
doi: 10.1126/science.1197203 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 :./. 4 3 0 0 0 0 1
42. Kobe 42. 4 42 42. 42. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,. 6 9 0 0 0 0 1
of human of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 --.() 5 9 0 0 0 0 1
(12):8562-9. doi: (12):8562-9. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ():-.:./.. 10 5 0 0 0 0 1
43. Walther 43. 4 43 43. 43. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,.- 7 9 0 0 0 0 1
domain of domain d do dom doma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -- 2 8 0 0 0 0 1
enzymatic activity enzymatic e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 5 . 1 8 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 5 ()():-.:./. 11 8 0 0 0 0 1
44. Walther 44. 4 44 44. 44. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,,.-- 8 9 0 0 0 0 1
barrel domain barrel b ba bar barr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 - 1 9 0 0 0 0 1
is not is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 no 0 9 0 0 0 0 1
regulatory functions. regulatory r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .()():-.:./ 11 9 0 0 0 0 1
j.abb.2011.09.004 j.abb.2011.09.004 j.abb.2011.09.004 j j. j.a j.ab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 .... 4 2 0 0 0 0 1
45. Hammarberg 45. 4 45 45. 45. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 .,,,.- 6 9 0 0 0 0 1
of 5-lipoxygenase of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 - 1 8 0 0 0 0 1
enzyme activity. enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 .()():-.:./ 11 8 0 0 0 0 1
jbc.M006136200 jbc.M006136200 jbc.m006136200 j jb jbc jbc. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 5 . 1 1 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 6 11 no 0 8 0 1 0 0 0
23 23 23 2 23 23 23 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 11 no 0 0 0 1 0 0 0
46. Chen 46. 4 46 46. 46. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.-"-"- 8 9 0 0 0 0 1
is essential is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .() 3 9 0 0 0 0 1
(1):811-8. doi: (1):811-8. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 ():-.:./. 9 5 0 0 0 0 1
47. Brinckmann 47. 4 47 47. 47. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,. 7 9 0 0 0 0 1
Membrane Translocation membrane M Me Mem Memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
Calcium-Dependent and calcium-dependent C Ca Cal Calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 -. 2 8 0 0 0 0 1
Blood (1998) blood B Bl Blo Bloo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ()():-.:./... 13 6 0 0 0 0 1
48. Bender 48. 4 48 48. 48. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,. 6 8 0 0 0 0 1
Membrane-dependent Activities membrane-dependent M Me Mem Memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 --- 3 8 0 0 0 0 1
Counterpart: IMPLICATIONS counterpart: C Co Cou Coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 : 1 6 0 0 0 0 1
ATHEROSCLEROSIS. J atherosclerosis. A AT ATH ATHE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .()():-. 8 6 0 0 0 0 1
doi: 10.1074/jbc.M116.741454 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :./.. 5 3 0 0 0 0 1
49. Basavarajappa 49. 4 49 49. 49. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,, 6 9 0 0 0 0 1
O. Roles o. O O. O. O. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 .-()-- 6 9 0 0 0 0 1
protein (FLAP) protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (). 3 9 0 0 0 0 1
S A s S S S S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 ()():-.:./. 11 7 0 0 0 0 1
50. Hafner 50. 5 50 50. 50. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,,. 8 9 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
activating protein activating a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 .()():-. 8 9 0 0 0 0 1
doi: 10.1016/j.bbalip.2015.08.010 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :./.... 7 4 0 0 0 0 1
51. Luo 51. 5 51 51. 51. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,-,.- 7 9 0 0 0 0 1
lipoxygenase as lipoxygenase l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 10 0 0 0 0 1
Acad Sci acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ()():-.:./. 11 8 0 0 0 0 1
52. Sun 52. 5 52 52. 52. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,.- 5 7 0 0 0 0 1
Phosphorylation in phosphorylation P Ph Pho Phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 . 1 8 0 0 0 0 1
(2019) 2019:2749173. (2019) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 ():.:.// 8 6 0 0 0 0 1
53. Smyrniotis 53. 5 53 53. 53. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,. 6 10 0 0 0 0 1
activates the activates a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 8 0 0 0 0 1
acid and acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 ()--(),(),(),()-. 17 9 0 0 0 0 1
Biochemistry (2014) biochemistry B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ()():-.:./ 10 7 0 0 0 0 1
54. Wenzel 54. 5 54 54. 54. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,,. 8 9 0 0 0 0 1
Wardens Ferroptosis wardens W Wa War Ward BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 no 0 9 0 0 0 0 1
Signals. Cell signals. S Si Sig Sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 .()():-.:./.... 15 9 0 0 0 0 1
55. Snodgrass 55. 5 55 55. 55. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.- 4 9 0 0 0 0 1
Human Macrophages. human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 .()::.:./ 9 8 0 0 0 0 1
fphar.2019.00719 fphar.2019.00719 fphar.2019.00719 f fp fph fpha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 .. 2 2 0 0 0 0 1
56. Droege 56. 5 56 56. 56. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,. 6 9 0 0 0 0 1
Dynamics of dynamics D Dy Dyn Dyna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ---. 4 8 0 0 0 0 1
Biochemistry (2017) biochemistry B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 ()():-.:./.. 12 8 0 0 0 0 1
57. Hagmann 57. 5 57 57. 57. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,. 5 8 0 0 0 0 1
distribution of distribution d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -:- 3 8 0 0 0 0 1
association by association a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 , 1 9 0 0 0 0 1
and 13-HPODE, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -,-. 4 7 0 0 0 0 1
Prostaglandins (1993) prostaglandins P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ()():-.:./-()- 14 8 0 0 0 0 1
58. Siebert 58. 5 58 58. 58. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,. 6 8 0 0 0 0 1
characterization of characterization c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 --. 3 9 0 0 0 0 1
J (2001) j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 ()():-.:./-: 12 7 0 0 0 0 1
59. Aleem 59. 5 59 59. 59. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,,. 8 9 0 0 0 0 1
Human platelet human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 -,, 3 9 0 0 0 0 1
binding and binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -.()():-. 9 9 0 0 0 0 1
doi: 10.1016/j.jmb.2007.11.086 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :./.... 7 3 0 0 0 0 1
60. Hafner 60. 6 60 60. 60. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,, 7 8 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .-.() 5 8 0 0 0 0 1
(12):1097-111. doi: (12):1097-111. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 ():-.:./.. 10 5 0 0 0 0 1
61. Ivanov 61. 6 61 61. 61. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,,. 8 9 0 0 0 0 1
Ligand-induced formation ligand-induced L Li Lig Liga BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 -/- 3 8 0 0 0 0 1
lipoxygenase: a lipoxygenase: l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :? 2 10 0 0 0 0 1
(2012) 80(3):703-12. (2012) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 ()():-.:./. 11 5 0 0 0 0 1
62. Lehnert 62. 6 62 62. 62. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,.- 4 9 0 0 0 0 1
of H-atom of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 -.()():- 8 9 0 0 0 0 1
305. doi: 305. 3 30 305 305. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .:./--- 7 4 0 0 0 0 1
63. Neau 63. 6 63 63. 63. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,,,,,. 7 9 0 0 0 0 1
The 1.85 the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 .- 2 9 0 0 0 0 1
lipoxygenase product lipoxygenase l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1021/bi900084m doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 :./ 3 2 0 0 0 0 1
64. Collazo 64. 6 64 64. 64. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .,. 3 9 0 0 0 0 1
Soybean Lipoxygenase-1 soybean S So Soy Soyb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 - 1 9 0 0 0 0 1
Channel. J channel. C Ch Cha Chan BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 0 .()():-.:./.. 13 9 0 0 0 0 1
65. Coffa 65. 6 65 65. 65. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,. 4 9 0 0 0 0 1
oxygenation stereospecificity oxygenation o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 : 1 9 0 0 0 0 1
the position the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .() 3 9 0 0 0 0 1
(44):15579-84. doi: (44):15579-84. ( (4 (44 (44) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 ():-.:./. 9 5 0 0 0 0 1
66. Schwarz 66. 6 66 66. 66. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,,. 7 9 0 0 0 0 1
basis for basis b ba bas basi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .- 2 9 0 0 0 0 1
lipoxygenase to lipoxygenase l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -- 2 8 0 0 0 0 1
mutagenesis. J mutagenesis. m mu mut muta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-.:./ 11 7 0 0 0 0 1
jbc.M005114200 jbc.M005114200 jbc.m005114200 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 . 1 1 0 0 0 0 1
67. Walther 67. 6 67 67. 67. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,. 5 9 0 0 0 0 1
specificity by specificity s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -. 2 9 0 0 0 0 1
Chem Biol chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ()():-.:./-()- 14 8 0 0 0 0 1
68. Newcomer 68. 6 68 68. 68. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,. 3 10 0 0 0 0 1
catalysis. Protein catalysis. c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-.:./. 12 8 0 0 0 0 1
69. Ivanov 69. 6 69 69. 69. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,. 4 8 0 0 0 0 1
arachidonic acid arachidonic a ar ara arac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 --().()():-. 12 8 0 0 0 0 1
doi: 10.1016/j.gene.2015.07.073 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 :./.... 7 4 0 0 0 0 1
70. Yu 70. 7 70 70. 70. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,. 6 9 0 0 0 0 1
gene ALOXE3 gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 6 6 no 0 8 0 0 0 0 1
isomerase. Proc isomerase. i is iso isom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-.:./ 11 9 0 0 0 0 1
pnas.1633612100 pnas.1633612100 pnas.1633612100 p pn pna pnas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 . 1 2 0 0 0 0 1
71. Rouzer 71. 7 71 71. 71. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,. 4 8 0 0 0 0 1
leukocytes possesses leukocytes l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -. 2 9 0 0 0 0 1
Proc Natl proc P Pr Pro Proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ()():-.:./... 13 9 0 0 0 0 1
72. Shimizu 72. 7 72 72. 72. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,,. 7 8 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 : 1 8 0 0 0 0 1
evidence for evidence e ev evi evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -. 2 9 0 0 0 0 1
Sci U sci S Sc Sci Sci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ()():-.:./... 13 7 0 0 0 0 1
73. Ueda 73. 7 73 73. 73. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,. 5 8 0 0 0 0 1
abstraction in abstraction a ab abs abst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 8 0 0 0 0 1
porcine leukocytes. porcine p po por porc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-.:./- 12 9 0 0 0 0 1
6980(86)90141-3 6980(86)90141-3 6980(86)90141-3 6 69 698 6980 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ()- 3 2 0 0 0 0 1
74. MacMillan 74. 7 74 74. 74. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,,,. 8 8 0 0 0 0 1
Eosinophil 15-lipoxygenase eosinophil E Eo Eos Eosi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 -.() 4 9 0 0 0 0 1
269(43):26663-8. 269(43):26663-8. 269(43):26663-8. 2 26 269 269( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 ():-. 5 2 0 0 0 0 1
75. Hong 75. 7 75 75. 75. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,. 6 8 0 0 0 0 1
docosatrienes and docosatrienes d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 - 1 8 0 0 0 0 1
murine brain, murine m mu mur muri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,,.-. 5 9 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 ()():-.:./. 11 8 0 0 0 0 1
76. Kuhn 76. 7 76 76. 76. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,,,. 8 9 0 0 0 0 1
Requirement of requirement R Re Req Requ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 - 1 8 0 0 0 0 1
HETE by hete H HE HET HETE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/0014-5793(86)80752-9 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 :./-()- 7 4 0 0 0 0 1
77. Lepley 77. 7 77 77. 77. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.- 4 9 0 0 0 0 1
leukotriene A4. leukotriene l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 . 1 8 0 0 0 0 1
enzyme and enzyme e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .()():-. 8 8 0 0 0 0 1
78. Wiesner 78. 7 78 78. 78. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,. 6 8 0 0 0 0 1
inactivation of inactivation i in ina inac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -- 2 9 0 0 0 0 1
covalent modification covalent c co cov cova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .() 3 9 0 0 0 0 1
(3):304-15. doi: (3):304-15. ( (3 (3) (3): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ():-.:./-()- 12 5 0 0 0 0 1
79. Kohli 79. 7 79 79. 79. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.: 4 8 0 0 0 0 1
inflammation. Br inflammation. i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 .()():-.:./.- 13 8 0 0 0 0 1
5381.2009.00290.x 5381.2009.00290.x 5381.2009.00290.x 5 53 538 5381 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 ... 3 2 0 0 0 0 1
80. Arita 80. 8 80 80. 80. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,,,,. 8 9 0 0 0 0 1
Resolvin E1, resolvin R Re Res Reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ,- 2 7 0 0 0 0 1
eicosapentaenoic acid, eicosapentaenoic e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 ,,,-- 5 9 0 0 0 0 1
induced colitis. induced i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ....()():-. 11 8 0 0 0 0 1
doi: 10.1073/pnas.0409271102 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 :./. 4 3 0 0 0 0 1
81. Forsell 81. 8 81 81. 81. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,. 5 9 0 0 0 0 1
anandamide into anandamide a an ana anan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -- 2 7 0 0 0 0 1
transferases. Lipids transferases. t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 .()():-.:./--- 14 9 0 0 0 0 1
82. Kim 82. 8 82 82. 82. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,.,- 5 9 0 0 0 0 1
docosahexaenoic acid docosahexaenoic d do doc doco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 -. 2 7 0 0 0 0 1
Prostaglandins Leukot prostaglandins P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ()():-.:./ 10 9 0 0 0 0 1
j.plefa.2012.08.002 j.plefa.2012.08.002 j.plefa.2012.08.002 j j. j.p j.pl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 6 .... 4 2 0 0 0 0 1
83. Schewe 83. 8 83 83. 83. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 .,,,. 5 9 0 0 0 0 1
reticulocytes which reticulocytes r re ret reti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 . 1 9 0 0 0 0 1
Lett (1975) lett L Le Let Lett BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 6 ()():-.:./-()- 14 7 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 7 11 no 0 8 0 1 0 0 0
24 24 24 2 24 24 24 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 11 no 0 0 0 1 0 0 0
84. Belkner 84. 8 84 84. 84. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,. 7 9 0 0 0 0 1
lipoproteins by lipoproteins l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .() 3 8 0 0 0 0 1
(1):251-61. doi: (1):251-61. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ():-.:./.-... 13 6 0 0 0 0 1
85. Kuhn 85. 8 85 85. 85. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,,. 8 8 0 0 0 0 1
Overexpression, purification overexpression, O Ov Ove Over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 8 0 0 0 0 1
15-lipoxygenase. Biochim 15-lipoxygenase. 1 15 15- 15-l BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -.()():-.:./ 12 8 0 0 0 0 1
0005-2760(93)90085-n 0005-2760(93)90085-n 0005-2760(93)90085-n 0 00 000 0005 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 -()- 4 2 0 0 0 0 1
86. Huang 86. 8 86 86. 86. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,. 5 8 0 0 0 0 1
lysophospholipids by lysophospholipids l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,, 2 8 0 0 0 0 1
rabbit reticulocyte. rabbit r ra rab rabb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .()():-.:./ 11 9 0 0 0 0 1
jf073016i jf073016i jf073016i j jf jf0 jf07 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 no 0 1 0 0 0 0 1
87. Hutchins 87. 8 87 87. 87. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,. 3 9 0 0 0 0 1
in murine in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 :. 2 9 0 0 0 0 1
Res (2012) res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-.:./. 11 6 0 0 0 0 1
88. Liu 88. 8 88 88. 88. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,.- 7 8 0 0 0 0 1
Mediated Oxidation mediated M Me Med Medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 -- 2 8 0 0 0 0 1
Unknown Lipid unknown U Un Unk Unkn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 .()():- 7 8 0 0 0 0 1
27. doi: 27. 2 27 27. 27. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .:./.... 8 4 0 0 0 0 1
89. Ikei 89. 8 89 89. 89. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,,. 8 10 0 0 0 0 1
of human of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --: 3 8 0 0 0 0 1
platelet activation. platelet p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-.:./ 11 8 0 0 0 0 1
jlr.M026385 jlr.M026385 jlr.m026385 j jl jlr jlr. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 . 1 1 0 0 0 0 1
90. Hada 90. 9 90 90. 90. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,. 5 9 0 0 0 0 1
platelet 12-lipoxygenase platelet p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 8 0 0 0 0 1
Biochim Biophys biochim B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()-()():-. 10 8 0 0 0 0 1
doi: 10.1016/0005-2760(91)90128-5 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./-()- 7 4 0 0 0 0 1
91. Romano 91. 9 91 91. 91. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,. 7 8 0 0 0 0 1
Lipoxin synthase lipoxin L Li Lip Lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 8 0 0 0 0 1
(1993) 296( (1993) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ()():-.:./ 10 5 0 0 0 0 1
92. Anton 92. 9 92 92. 92. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,. 3 9 0 0 0 0 1
epidermis. J epidermis. e ep epi epid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-.:./.- 13 8 0 0 0 0 1
1747.2000.00903.x 1747.2000.00903.x 1747.2000.00903.x 1 17 174 1747 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ... 3 2 0 0 0 0 1
93. Deng 93. 9 93 93. 93. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,,. 8 9 0 0 0 0 1
biosynthesis and biosynthesis b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,- 2 9 0 0 0 0 1
pro-resolving mediator pro-resolving p pr pro pro- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -.()(): 7 8 0 0 0 0 1
e102362. doi: e102362. e e1 e10 e102 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 .:./.. 6 5 0 0 0 0 1
94. Liu 94. 9 94 94. 94. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,.- 8 8 0 0 0 0 1
catalyzes the catalyzes c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -- 2 9 0 0 0 0 1
eicosanoid-lysolipids that eicosanoid-lysolipids e ei eic eico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -. 2 8 0 0 0 0 1
Chem (2020) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-.:./.. 12 7 0 0 0 0 1
95. Yu 95. 9 95 95. 95. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,. 5 8 0 0 0 0 1
distinct substrate distinct d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 : 1 8 0 0 0 0 1
lipoxygenases in lipoxygenases l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/j.abb.2006.09.002 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./.... 7 3 0 0 0 0 1
96. Snodgrass 96. 9 96 96. 96. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .- 2 8 0 0 0 0 1
and CCL17 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .() 3 7 0 0 0 0 1
9:1906:1906. doi: 9:1906:1906. 9 9: 9:1 9:19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ::.:./.. 8 5 0 0 0 0 1
97. Therland 97. 9 97 97. 97. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .- 2 9 0 0 0 0 1
adult human adult a ad adu adul BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
receptors. J receptors. r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .()():-.:./ 11 7 0 0 0 0 1
01.asn.0000124673.79934.24 01.asn.0000124673.79934.24 01.asn.0000124673.79934.24 0 01 01. 01.a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 .... 4 3 0 0 0 0 1
98. Kirkby 98. 9 98 98. 98. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,-,.- 10 9 0 0 0 0 1
MS/MS confirms ms/ms M MS MS/ MS/M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 /- 2 8 0 0 0 0 1
expression pattern expression e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 --. 3 8 0 0 0 0 1
One (2013) one O On One One BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ()():.:./.. 11 7 0 0 0 0 1
99. Kirkby 99. 9 99 99. 99. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,-,,,. 9 9 0 0 0 0 1
Systematic study systematic S Sy Sys Syst BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 -:- 3 8 0 0 0 0 1
kappaB and kappab k ka kap kapp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
(2016) 113(2):434-9. (2016) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ()():-.:./. 11 6 0 0 0 0 1
100. Grosser 100. 1 10 100 100. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,. 4 9 0 0 0 0 1
consequences of consequences c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -:. 3 9 0 0 0 0 1
J Clin j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 ()():-.:./ 10 7 0 0 0 0 1
101. Tang 101. 1 10 101 101. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,. 7 8 0 0 0 0 1
Cyclooxygenase-2 in cyclooxygenase-2 C Cy Cyc Cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 - 1 7 0 0 0 0 1
restrains atherogenesis restrains r re res rest BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .() 3 8 0 0 0 0 1
(17):1761-9. doi: (17):1761-9. ( (1 (17 (17) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ():-.:./.. 10 6 0 0 0 0 1
102. Hla 102. 1 10 102 102. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.-. 5 9 0 0 0 0 1
(1992) 89(16):7384-8. (1992) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 ()():-.:./... 13 6 0 0 0 0 1
103. O'Neill 103. 1 10 103 103. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .',-. 5 7 0 0 0 0 1
cyclooxygenase-1 and cyclooxygenase-1 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 --. 3 7 0 0 0 0 1
(1993) 330(2):156-60. (1993) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 ()():-.:./-()- 14 6 0 0 0 0 1
104. Pablos 104. 1 10 104 104. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,-. 7 8 0 0 0 0 1
Cyclooxygenase-1 and cyclooxygenase-1 C Cy Cyc Cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 --. 3 7 0 0 0 0 1
Immunol (1999) immunol I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ()():-.:./.-... 15 8 0 0 0 0 1
105. Zidar 105. 1 10 105 105. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,,. 7 9 0 0 0 0 1
normal human normal n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 --,- 4 8 0 0 0 0 1
inducible isoform? inducible i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 ?()():-.:./ 11 8 0 0 0 0 1
j.1582-4934.2008.00430.x j.1582-4934.2008.00430.x j.1582-4934.2008.00430.x j j. j.1 j.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 .-... 5 3 0 0 0 0 1
106. Ryan 106. 1 10 106 106. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,,. 7 8 0 0 0 0 1
Activated Human activated A Ac Act Acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 - 1 7 0 0 0 0 1
Cyclooxygenase Inhibitors cyclooxygenase C Cy Cyc Cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 .() 3 8 0 0 0 0 1
174(8):5134.2-. doi: 174(8):5134.2-. 1 17 174 174( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ():.-.:./...- 13 6 0 0 0 0 1
107. Picot 107. 1 10 107 107. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,.- 5 9 0 0 0 0 1
protein prostaglandin protein p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -.()():-. 9 8 0 0 0 0 1
doi: 10.1038/367243a0 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./ 3 2 0 0 0 0 1
108. Rimon 108. 1 10 108 108. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,,,. 8 9 0 0 0 0 1
interfere with interfere i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 8 0 0 0 0 1
cyclooxygenase-1. Proc cyclooxygenase-1. c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -....()():-. 12 7 0 0 0 0 1
doi: 10.1073/pnas.0909765106 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./. 4 3 0 0 0 0 1
109. Sidhu 109. 1 10 109 109. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,.- 6 8 0 0 0 0 1
crystal structures: crystal c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 5 :-- 3 8 0 0 0 0 1
1 homodimers. 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 5 .()():-.:./ 11 8 0 0 0 0 1
110. Kurumbail 110. 1 11 110 110. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,,,. 8 10 0 0 0 0 1
Structural basis structural S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 -- 2 8 0 0 0 0 1
inflammatory agents. inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .()():-.:./ 11 8 0 0 0 0 1
111. Rowlinson 111. 1 11 111 111. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,, 6 9 0 0 0 0 1
AS, et as, A AS AS, AS, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 ,.- 3 8 0 0 0 0 1
interactions with interactions i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 --.()():-. 10 9 0 0 0 0 1
doi: 10.1074/jbc.M305481200 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./. 4 3 0 0 0 0 1
112. Vecchio 112. 1 11 112 112. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,. 3 8 0 0 0 0 1
oxygenation by oxygenation o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 -.()():-. 9 8 0 0 0 0 1
doi: 10.1074/jbc.M111.230367 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./.. 5 3 0 0 0 0 1
113. Xu 113. 1 11 113 113. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,, 6 9 0 0 0 0 1
RM, et rm, R RM RM, RM, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ,. 2 9 0 0 0 0 1
a two-water-mediated a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 7 5 ---.() 6 7 0 0 0 0 1
(10):6799-808. doi: (10):6799-808. ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ():-.:./.. 10 5 0 0 0 0 1
114. Lucido 114. 1 11 114 114. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,. 5 9 0 0 0 0 1
Aspirin-Acetylated Human aspirin-acetylated A As Asp Aspi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 --: 3 8 0 0 0 0 1
Products with products P Pr Pro Prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 .()():-. 8 9 0 0 0 0 1
doi: 10.1021/acs.biochem.5b01378 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./.. 5 3 0 0 0 0 1
115. Orlando 115. 1 11 115 115. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.- 4 7 0 0 0 0 1
Cyclooxygeanse-2 by cyclooxygeanse-2 C Cy Cyc Cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 - 1 8 0 0 0 0 1
Tone. J tone. T To Ton Tone BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 .()():-.:./.. 13 8 0 0 0 0 1
116. Xiao 116. 1 11 116 116. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,. 4 8 0 0 0 0 1
prostaglandin H prostaglandin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 --.()():-. 10 8 0 0 0 0 1
doi: 10.1074/jbc.273.12.6801 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./... 6 3 0 0 0 0 1
117. Michael 117. 1 11 117 117. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,. 4 8 0 0 0 0 1
prostaglandin endoperoxide prostaglandin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 --. 3 8 0 0 0 0 1
Lipid Mediators lipid L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ()-:-.:./-()- 13 8 0 0 0 0 1
118. Spencer 118. 1 11 118 118. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,,. 6 8 0 0 0 0 1
localization of localization l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 -- 2 8 0 0 0 0 1
immunoelectron microscopy. immunoelectron i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .()():-. 8 7 0 0 0 0 1
doi: 10.1074/jbc.273.16.9886 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./... 6 3 0 0 0 0 1
119. Yuan 119. 1 11 119 119. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.-- 5 8 0 0 0 0 1
biosynthetic system biosynthetic b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .() 3 8 0 0 0 0 1
(9):5606-20. doi: (9):5606-20. ( (9 (9) (9): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ():-.:./.. 10 5 0 0 0 0 1
120. Rouzer 120. 1 12 120 120. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,.:. 5 9 0 0 0 0 1
J Lipid j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 5 ()():-.:./.- 12 9 0 0 0 0 1
121. Otto 121. 1 12 121 121. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,.- 5 8 0 0 0 0 1
endoperoxide synthases-1 endoperoxide e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 -- 2 7 0 0 0 0 1
endoplasmic reticulum. endoplasmic e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 .()():-. 8 7 0 0 0 0 1
122. Sevigny 122. 1 12 122 122. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 .,,,-. 6 8 0 0 0 0 1
turnover of turnover t tu tur turn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 -.()(-):-. 10 7 0 0 0 0 1
doi: 10.1016/j.febslet.2006.10.073 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 :./.... 7 4 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 7 11 no 0 8 0 1 0 0 0
25 25 25 2 25 25 25 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 11 no 0 0 0 1 0 0 0
123. Kim 123. 1 12 123 123. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,.,- 6 8 0 0 0 0 1
nitrosylates, and nitrosylates, n ni nit nitr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ,-.()():- 9 8 0 0 0 0 1
70. doi: 70. 7 70 70. 70. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .:./. 5 3 0 0 0 0 1
124. Qiao 124. 1 12 124 124. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,. 6 9 0 0 0 0 1
cyclooxygenase-2 rather cyclooxygenase-2 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --. 3 8 0 0 0 0 1
Chem (2018) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-.:./ 10 5 0 0 0 0 1
125. Yuan 125. 1 12 125 125. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,. 6 8 0 0 0 0 1
monomers of monomers m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -.... 5 7 0 0 0 0 1
(2006) 103(16):6142-7. (2006) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ()():-.:./. 11 6 0 0 0 0 1
126. Dong 126. 1 12 126 126. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,. 7 8 0 0 0 0 1
Human cyclooxygenase-2 human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 7 0 0 0 0 1
conformational heterodimer. conformational c co con conf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-. 8 7 0 0 0 0 1
doi: 10.1074/jbc.M111.231969 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./.. 5 3 0 0 0 0 1
127. Zou 127. 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,,,. 8 8 0 0 0 0 1
cyclooxygenase-1 activity cyclooxygenase-1 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 - 1 7 0 0 0 0 1
allosterically regulated allosterically a al all allo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .() 3 8 0 0 0 0 1
(7):1336-47. doi: (7):1336-47. ( (7 (7) (7): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ():-.:./. 9 4 0 0 0 0 1
128. Smith 128. 1 12 128 128. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,.,- 5 8 0 0 0 0 1
inflammatory drugs, inflammatory i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 , 1 8 0 0 0 0 1
cyclooxygenases-1 and cyclooxygenases-1 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --.()():-.:./ 13 8 0 0 0 0 1
jbc.TM118.006295 jbc.TM118.006295 jbc.tm118.006295 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .. 2 1 0 0 0 0 1
129. Marnett 129. 1 12 129 129. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ...() 5 8 0 0 0 0 1
(5):545-52. doi: (5):545-52. ( (5 (5) (5): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ():-.:./-()- 12 5 0 0 0 0 1
130. Silva 130. 1 13 130 130. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,.- 5 9 0 0 0 0 1
combined radical/carbocationic combined c co com comb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 / 1 7 0 0 0 0 1
cyclooxygenation by cyclooxygenation c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .: 2 8 0 0 0 0 1
Computation Model computation C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ()()():-. 9 7 0 0 0 0 1
doi: 10.1007/s00214-003-0476-9 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./--- 6 3 0 0 0 0 1
131. Cebriań-Prats 131. 1 13 131 131. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .-,-,. 6 8 0 0 0 0 1
Details of details D De Det Deta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 7 0 0 0 0 1
Prostaglandin G2 prostaglandin P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 -.() 4 7 0 0 0 0 1
(1):2063-74. doi: (1):2063-74. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ():-.:./. 9 5 0 0 0 0 1
132. O'Connor 132. 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .',,. 5 8 0 0 0 0 1
autooxidative cyclization autooxidative a au aut auto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 - 1 8 0 0 0 0 1
bicyclic endoperoxides. bicyclic b bi bic bicy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-. 8 7 0 0 0 0 1
doi: 10.1021/ja00324a028 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./ 3 2 0 0 0 0 1
133. Rouzer 133. 1 13 133 133. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,. 3 8 0 0 0 0 1
polyunsaturated fatty polyunsaturated p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .() 3 7 0 0 0 0 1
(6):2239-304. doi: (6):2239-304. ( (6 (6) (6): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 ():-.:./ 8 4 0 0 0 0 1
134. Smith 134. 1 13 134 134. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,. 3 8 0 0 0 0 1
synthases-1 and synthases-1 s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --.()-:-. 9 8 0 0 0 0 1
doi: 10.1016/s0090-6980(02)00025-4 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./-()- 7 4 0 0 0 0 1
135. Bailey 135. 1 13 135 135. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,.- 6 8 0 0 0 0 1
and 15-HETE, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -,, 3 7 0 0 0 0 1
cyclooxygenase pathway cyclooxygenase c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
Res (1983) res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-. 7 3 0 0 0 0 1
136. Setty 136. 1 13 136 136. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,.- 5 9 0 0 0 0 1
acid and acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 8 0 0 0 0 1
catalyzed by catalyzed c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/0005-2760(85)90106-7 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 :./-()- 7 3 0 0 0 0 1
137. Schneider 137. 1 13 137 137. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,, 6 9 0 0 0 0 1
N, et n, N N, N, N, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ,.- 3 8 0 0 0 0 1
cyclooxygenases-1 and cyclooxygenases-1 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 --.. 4 8 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 ()():-.:./. 11 7 0 0 0 0 1
138. Thuresson 138. 1 13 138 138. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,. 4 8 0 0 0 0 1
arrangements of arrangements a ar arr arra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 0 0 0 0 1
prostaglandin endoperoxide prostaglandin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 - 1 8 0 0 0 0 1
oxygenated products. oxygenated o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 .()():-.:./ 11 8 0 0 0 0 1
jbc.275.12.8501 jbc.275.12.8501 jbc.275.12.8501 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ... 3 1 0 0 0 0 1
139. Loll 139. 1 13 139 139. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,. 4 10 0 0 0 0 1
from the from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 0 0 0 0 1
Struct Biol struct S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-.:./- 11 6 0 0 0 0 1
140. Lecomte 140. 1 14 140 140. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .,,,,. 6 9 0 0 0 0 1
prostaglandin endoperoxide prostaglandin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 -(-). 5 8 0 0 0 0 1
Chem (1994) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ()():-. 7 3 0 0 0 0 1
141. Gimenez-Bastida 141. 1 14 141 141. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .-,,,,. 7 8 0 0 0 0 1
Residual cyclooxygenase residual R Re Res Resi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 --- 3 8 0 0 0 0 1
prostaglandins that prostaglandins p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()():- 7 8 0 0 0 0 1
41. doi: 41. 4 41 41. 41. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .:./. 5 3 0 0 0 0 1
142. Ricciotti 142. 1 14 142 142. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,.. 4 8 0 0 0 0 1
T h t T T T T BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 ()():-.:./ 10 10 0 0 0 0 1
ATVBAHA.110.207449 ATVBAHA.110.207449 atvbaha.110.207449 A AT ATV ATVB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .. 2 2 0 0 0 0 1
143. Laneuville 143. 1 14 143 143. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 8 0 0 0 0 1
acid substrate acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 - 1 7 0 0 0 0 1
synthase-1 and synthase-1 s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 --.--(,/,)- 11 6 0 0 0 0 1
octadecatrienoic acids octadecatrienoic o oc oct octa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 -.() 4 7 0 0 0 0 1
(33):19330-6. doi: (33):19330-6. ( (3 (33 (33) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-.:./... 11 4 0 0 0 0 1
144. Yuan 144. 1 14 144 144. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 6 0 0 0 0 1
Cyclooxygenase Allosterism, cyclooxygenase C Cy Cyc Cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,-- 3 7 0 0 0 0 1
Monomers of monomers M Mo Mon Mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 .() 3 6 0 0 0 0 1
(15):10046-55. doi: (15):10046-55. ( (1 (15 (15) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-.:./. 9 4 0 0 0 0 1
145. Dong 145. 1 14 145 145. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,. 7 7 0 0 0 0 1
Acids Compete acids A Ac Aci Acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 7 0 0 0 0 1
Catalytic Subunits catalytic C Ca Cat Cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 . 1 7 0 0 0 0 1
Biol Chem biol B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ()():-.:./.. 12 6 0 0 0 0 1
146. Mulugeta 146. 1 14 146 146. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,. 7 8 0 0 0 0 1
Identification and identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 - 1 7 0 0 0 0 1
formed by formed f fo for form BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ---. 4 7 0 0 0 0 1
J Lipid j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 ()():-.:./. 11 6 0 0 0 0 1
147. Yu 147. 1 14 147 147. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,. 4 7 0 0 0 0 1
from anandamide from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -.()():-. 9 7 0 0 0 0 1
doi: 10.1074/jbc.272.34.21181 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./... 6 3 0 0 0 0 1
148. Kozak 148. 1 14 148 148. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,. 4 6 0 0 0 0 1
endocannabinoid, 2-arachidonylglycerol, endocannabinoid, e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,-, 3 7 0 0 0 0 1
cyclooxygenase-2. J cyclooxygenase-2. c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -.()():-.:./ 12 7 0 0 0 0 1
jbc.M007088200 jbc.M007088200 jbc.m007088200 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 . 1 1 0 0 0 0 1
149. Prusakiewicz 149. 1 14 149 149. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,. 5 8 0 0 0 0 1
N-arachidonylglycine by n-arachidonylglycine N N- N-a N-ar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 --. 3 7 0 0 0 0 1
(2002) 296(3):612-7. (2002) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ()():-.:./-()- 14 6 0 0 0 0 1
150. de 150. 1 15 150 150. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,.- 7 7 0 0 0 0 1
products of products p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 --- 3 7 0 0 0 0 1
identified in identified i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ..()():-. 9 7 0 0 0 0 1
doi: 10.1194/jlr.M094235 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./. 4 2 0 0 0 0 1
151. Nelson 151. 1 15 151 151. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,. 7 7 0 0 0 0 1
Comparison of comparison C Co Com Comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 () 2 7 0 0 0 0 1
genomes, including genomes, g ge gen geno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,, 2 7 0 0 0 0 1
and alternative-splice and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -.()():-. 9 7 0 0 0 0 1
doi: 10.1097/00008571-200401000-00001 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./-- 5 4 0 0 0 0 1
152. Nebert 152. 1 15 152 152. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,. 4 8 0 0 0 0 1
disease. Philos disease. d di dis dise BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():. 7 7 0 0 0 0 1
doi: 10.1098/rstb.2012.0431 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.. 5 3 0 0 0 0 1
153. Nebert 153. 1 15 153 153. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,, 6 7 0 0 0 0 1
FP, et fp, F FP FP, FP, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,.:. 4 7 0 0 0 0 1
(1987) 6(1):1-11. (1987) ( (1 (19 (198 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ()():-.:./... 13 4 0 0 0 0 1
154. Nelson 154. 1 15 154 154. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ...() 5 7 0 0 0 0 1
(1):59-65. doi: (1):59-65. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ():-.:./---- 12 4 0 0 0 0 1
155. Sim 155. 1 15 155 155. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,-.() 6 7 0 0 0 0 1
Nomenclature website: nomenclature N No Nom Nome BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 :- 2 7 0 0 0 0 1
associated effects. associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():-.:./- 12 7 0 0 0 0 1
7364-4-4-278 7364-4-4-278 7364-4-4-278 7 73 736 7364 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 --- 3 1 0 0 0 0 1
156. Anzenbacher 156. 1 15 156 156. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,. 3 7 0 0 0 0 1
xenobiotics. Cell xenobiotics. x xe xen xeno BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()(-):-.:./ 12 7 0 0 0 0 1
pl00000897 pl00000897 pl00000897 p pl pl0 pl00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 no 0 1 0 0 0 0 1
157. Nishimura 157. 1 15 157 157. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,. 6 8 0 0 0 0 1
of mRNA of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 - 1 7 0 0 0 0 1
sensitivity real-time sensitivity s se sen sens BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -.() 4 8 0 0 0 0 1
(5):369-75. doi: (5):369-75. ( (5 (5) (5): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ():-.:./.. 10 4 0 0 0 0 1
158. Renaud 158. 1 15 158 158. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,.- 6 8 0 0 0 0 1
divergent expression divergent d di div dive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 . 1 7 0 0 0 0 1
(2011) 124(2):261-77. (2011) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ()():-.:.// 11 5 0 0 0 0 1
159. Sangar 159. 1 15 159 159. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,. 4 7 0 0 0 0 1
cytochrome P450s cytochrome c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 : 1 7 0 0 0 0 1
toxicity. Expert toxicity. t to tox toxi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():-. 8 6 0 0 0 0 1
doi: 10.1517/17425255.2010.503955 doi: d do doi doi: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.. 5 3 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 8 11 no 0 8 0 1 0 0 0
26 26 26 2 26 26 26 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 11 no 0 0 0 1 0 0 0
160. Srejber 160. 1 16 160 160. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,, 6 9 0 0 0 0 1
P, et p, P P, P, P, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,.-: 4 8 0 0 0 0 1
the membrane's the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ',, 3 9 0 0 0 0 1
redox partners. redox r re red redo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .():-.:./ 9 8 0 0 0 0 1
j.jinorgbio.2018.03.002 j.jinorgbio.2018.03.002 j.jinorgbio.2018.03.002 j j. j.j j.ji BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 .... 4 3 0 0 0 0 1
161. Erickson 161. 1 16 161 161. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.- 4 9 0 0 0 0 1
liver: partial liver: l li liv live BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 :- 2 9 0 0 0 0 1
cholesterol vesicles. cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-. 8 6 0 0 0 0 1
162. Loeper 162. 1 16 162 162. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,,,. 8 10 0 0 0 0 1
Cytochromes P-450 cytochromes C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 -: 2 8 0 0 0 0 1
several autoantibodies. several s se sev seve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-.:./ 11 9 0 0 0 0 1
0016-5085(93)90853-5 0016-5085(93)90853-5 0016-5085(93)90853-5 0 00 001 0016 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -()- 4 2 0 0 0 0 1
163. Neve 163. 1 16 163 163. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,-. 4 9 0 0 0 0 1
cytochrome P450 cytochrome c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .() 3 8 0 0 0 0 1
(22):17130-5. doi: (22):17130-5. ( (2 (22 (22) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ():-.:./. 9 5 0 0 0 0 1
164. Leung 164. 1 16 164 164. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,. 6 8 0 0 0 0 1
cytochrome P450 cytochrome c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 : 1 9 0 0 0 0 1
alternative subcellular alternative a al alt alte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 8 0 0 0 0 1
carcinogenesis. Cancer carcinogenesis. c ca car carc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 .()():-.:./- 12 8 0 0 0 0 1
5472.CAN-04-3771 5472.CAN-04-3771 5472.can-04-3771 5 54 547 5472 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .-- 3 2 0 0 0 0 1
165. Li 165. 1 16 165 165. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,,,. 8 9 0 0 0 0 1
cytochrome P450 cytochrome c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 : 1 8 0 0 0 0 1
Epigenetic mechanisms epigenetic E Ep Epi Epig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 . 1 8 0 0 0 0 1
J Environ j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 ():- 4 8 0 0 0 0 1
214. doi: 214. 2 21 214 214. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .:./.. 6 5 0 0 0 0 1
166. Nelson 166. 1 16 166 166. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.().. 7 9 0 0 0 0 1
Chichester: John chichester: C Ch Chi Chic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 :,(().-.:./ 11 8 0 0 0 0 1
9780470015902.a0005667.pub3 9780470015902.a0005667.pub3 9780470015902.a0005667.pub3 9 97 978 9780 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 .. 2 3 0 0 0 0 1
167. Williams 167. 1 16 167 167. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,. 6 8 0 0 0 0 1
microsomal cytochrome microsomal m mi mic micr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 : 1 8 0 0 0 0 1
membrane binding membrane m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-. 8 9 0 0 0 0 1
doi: 10.1016/s1097-2765(00)80408-6 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 :./-()- 7 4 0 0 0 0 1
168. Annalora 168. 1 16 168 168. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,,. 7 8 0 0 0 0 1
Crystal structure crystal C Cr Cry Crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 0 , 1 9 0 0 0 0 1
vitamin D vitamin v vi vit vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-.:./ 11 8 0 0 0 0 1
j.jmb.2009.11.057 j.jmb.2009.11.057 j.jmb.2009.11.057 j j. j.j j.jm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 .... 4 2 0 0 0 0 1
169. Pochapsky 169. 1 16 169 169. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,./ 5 9 0 0 0 0 1
function relationships function f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .() 3 9 0 0 0 0 1
(8):1273-96. doi: (8):1273-96. ( (8 (8) (8): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ():-.:./.. 10 5 0 0 0 0 1
170. Ohkura 170. 1 17 170 170. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,,,. 7 9 0 0 0 0 1
Flexible structure flexible F Fl Fle Flex BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 : 1 9 0 0 0 0 1
CYP3A4 heme cyp3a4 C CY CYP CYP3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .()():-. 8 7 0 0 0 0 1
171. Hoch 171. 1 17 171 171. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,. 3 9 0 0 0 0 1
p4504a fatty p4504a p p4 p45 p450 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1074/jbc.M009969200 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 :./. 4 3 0 0 0 0 1
172. Hsu 172. 1 17 172 172. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,. 5 8 0 0 0 0 1
Cytochrome P450 cytochrome C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 () 2 7 0 0 0 0 1
Octane Discloses octane O Oc Oct Octa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 -. 2 9 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 0 ()():-.:./.. 12 8 0 0 0 0 1
173. Schwarz 173. 1 17 173 173. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,.- 5 9 0 0 0 0 1
reconstituted mitochondrial reconstituted r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 ( 1 8 0 0 0 0 1
CYP11B1) as cyp11b1) C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ) 1 9 0 0 0 0 1
ST-EPR. Biochemistry st-epr. S ST ST- ST-E BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 -.()():-.:./ 12 8 0 0 0 0 1
174. Szczesna-Skorupa 174. 1 17 174 174. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .-,,. 5 9 0 0 0 0 1
transfer analysis transfer t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 no 0 9 0 0 0 0 1
living cells. living l li liv livi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-.:./ 11 8 0 0 0 0 1
jbc.M301489200 jbc.M301489200 jbc.m301489200 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 . 1 1 0 0 0 0 1
175. Hu 175. 1 17 175 175. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,. 4 8 0 0 0 0 1
membranes. Drug membranes. m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-.:./ 11 8 0 0 0 0 1
dmd.110.034942 dmd.110.034942 dmd.110.034942 d dm dmd dmd. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .. 2 1 0 0 0 0 1
176. Li 176. 1 17 176 176. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,. 4 9 0 0 0 0 1
complexes in complexes c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 .()():-.:./ 11 9 0 0 0 0 1
pmic.201100001 pmic.201100001 pmic.201100001 p pm pmi pmic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 . 1 1 0 0 0 0 1
177. Kandel 177. 1 17 177 177. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,.- 4 9 0 0 0 0 1
P450-mediated drug p450-mediated P P4 P45 P450 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 -.() 4 8 0 0 0 0 1
(9):1474-86. doi: (9):1474-86. ( (9 (9) (9): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 0 ():-.:./ 8 4 0 0 0 0 1
178. Davydov 178. 1 17 178 178. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 .,,,. 5 9 0 0 0 0 1
cytochromes P450 cytochromes c cy cyt cyto BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 : 1 7 0 0 0 0 1
cytochromes P450 cytochromes c cy cyt cyto BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 ,,. 3 8 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 ()():-.:./.. 12 7 0 0 0 0 1
179. Connick 179. 1 17 179 179. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,. 4 9 0 0 0 0 1
CYP1A2, CYP2B4, cyp1a2, C CY CYP CYP1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,,-: 4 8 0 0 0 0 1
of Specific of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():-. 8 8 0 0 0 0 1
doi: 10.1124/dmd.117.078642 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.. 5 3 0 0 0 0 1
180. Zhang 180. 1 18 180 180. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 9 0 0 0 0 1
The full-length the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 - 1 7 0 0 0 0 1
reductase domains reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 . 1 8 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 ()():-.:./.. 12 8 0 0 0 0 1
181. Isin 181. 1 18 181 181. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,. 3 9 0 0 0 0 1
enzymes. Biochim enzymes. e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():-.:./ 11 8 0 0 0 0 1
j.bbagen.2006.07.003 j.bbagen.2006.07.003 j.bbagen.2006.07.003 j j. j.b j.bb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .... 4 2 0 0 0 0 1
182. Lamb 182. 1 18 182 182. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,. 3 8 0 0 0 0 1
superfamily. Philos superfamily. s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()():. 7 9 0 0 0 0 1
doi: 10.1098/rstb.2012.0434 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.. 5 3 0 0 0 0 1
183. Hecker 183. 1 18 183 183. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,. 3 9 0 0 0 0 1
A2 biosynthesis. a2 A A2 A2 A2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .()():-. 8 6 0 0 0 0 1
184. Cook 184. 1 18 184 184. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,.- 7 8 0 0 0 0 1
Cytochromes P450: cytochromes C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 :,,, 4 8 0 0 0 0 1
Application. In: application. A Ap App Appl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 .:,. 4 8 0 0 0 0 1
Structural Biology. structural S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 .()..-.:./ 10 8 0 0 0 0 1
bs.apcsb.2016.07.003 bs.apcsb.2016.07.003 bs.apcsb.2016.07.003 b bs bs. bs.a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .... 4 2 0 0 0 0 1
185. Guengerich 185. 1 18 185 185. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ..-. 4 8 0 0 0 0 1
ACS Catal acs A AC ACS ACS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 8 5 ()():-.:./. 11 7 0 0 0 0 1
186. Fer 186. 1 18 186 186. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 9 0 0 0 0 1
of eicosapentaenoic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 8 0 0 0 0 1
cytochromes P450. cytochromes c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .()():-. 8 7 0 0 0 0 1
doi: 10.1016/j.abb.2008.01.002 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.... 7 3 0 0 0 0 1
187. Barbosa-Sicard 187. 1 18 187 187. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .-,,,,, 7 9 0 0 0 0 1
WH. Eicosapentaenoic wh. W WH WH. WH. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 . 1 8 0 0 0 0 1
CYP2C subfamily. cyp2c C CY CYP CYP2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/j.bbrc.2005.02.103 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 :./.... 7 3 0 0 0 0 1
188. Arnold 188. 1 18 188 188. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 9 0 0 0 0 1
Arachidonic acid-metabolizing arachidonic A Ar Ara Arac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 - 1 8 0 0 0 0 1
{omega}-3 fatty {omega}-3 { {o {om {ome BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -.()():-.:./ 12 9 0 0 0 0 1
jbc.M110.118406 jbc.M110.118406 jbc.m110.118406 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .. 2 1 0 0 0 0 1
189. Honda 189. 1 18 189 189. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 9 0 0 0 0 1
Cholesterol 25-hydroxylation cholesterol C Ch Cho Chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 -.() 4 8 0 0 0 0 1
(8):1509-16. doi: (8):1509-16. ( (8 (8) (8): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-.:./. 9 4 0 0 0 0 1
190. Griffiths 190. 1 19 190 190. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,-,, 8 10 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .: 2 9 0 0 0 0 1
Cyp27a1-/-mouse brain cyp27a1-/-mouse C Cy Cyp Cyp2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -/-. 4 8 0 0 0 0 1
Lipids (2019) lipids L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ()():-.:./.... 14 7 0 0 0 0 1
191. Bodin 191. 1 19 191 191. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,,. 8 9 0 0 0 0 1
Metabolism of metabolism M Me Met Meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 -.() 4 9 0 0 0 0 1
(35):31534-40. doi: (35):31534-40. ( (3 (35 (35) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-.:./. 9 5 0 0 0 0 1
192. Kawashima 192. 1 19 192 192. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .-,: 4 8 0 0 0 0 1
complete genomic complete c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 8 0 0 0 0 1
protein. Arch protein. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .()():-.:./ 11 7 0 0 0 0 1
abbi.2000.1831 abbi.2000.1831 abbi.2000.1831 a ab abb abbi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .. 2 1 0 0 0 0 1
193. Shinkyo 193. 1 19 193 193. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,. 7 9 0 0 0 0 1
of 7-dehydrocholesterol of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -- 2 9 0 0 0 0 1
P450 7A1 p450 P P4 P45 P450 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 . 1 9 0 0 0 0 1
Chem (2011) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ()():-.:./.. 12 7 0 0 0 0 1
194. Bjorkhem 194. 1 19 194 194. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,-,,, 7 8 0 0 0 0 1
Tallman K, tallman T Ta Tal Tall BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ,.-- 4 7 0 0 0 0 1
dehydrocholesterol in dehydrocholesterol d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .() 3 8 0 0 0 0 1
(6):1165-72. doi: (6):1165-72. ( (6 (6) (6): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 ():-.:./. 9 4 0 0 0 0 1
195. Schwarz 195. 1 19 195 195. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,. 6 9 0 0 0 0 1
characterization of characterization c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -. 2 8 0 0 0 0 1
Chem (1997) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ()():-.:./... 13 7 0 0 0 0 1
196. Gafvels 196. 1 19 196 196. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .- 2 8 0 0 0 0 1
hydroxylase gene hydroxylase h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 (): 3 8 0 0 0 0 1
P-450 gene p-450 P P- P-4 P-45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -.()():-.:./ 12 9 0 0 0 0 1
geno.1998.5606 geno.1998.5606 geno.1998.5606 g ge gen geno BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 5 .. 2 1 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 9 11 no 0 8 0 1 0 0 0
27 27 27 2 27 27 27 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 11 no 0 0 0 1 0 0 0
197. Pikuleva 197. 1 19 197 197. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ..-. 4 8 0 0 0 0 1
Dispos (2006) dispos D Di Dis Disp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./.. 12 6 0 0 0 0 1
198. Coulter 198. 1 19 198 198. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,. 3 10 0 0 0 0 1
vivo: 3. vivo: v vi viv vivo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :. 2 9 0 0 0 0 1
(P450c21) and (p450c21) ( (P (P4 (P45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ()/(/) 6 8 0 0 0 0 1
integrated concept integrated i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 9 0 0 0 0 1
(1998) 139(12):5144-50. (1998) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():-.:./... 13 6 0 0 0 0 1
199. Payne 199. 1 19 199 199. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,. 3 9 0 0 0 0 1
from cholesterol from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():- 7 9 0 0 0 0 1
70. doi: 70. 7 70 70. 70. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .:./.- 6 3 0 0 0 0 1
200. Omdahl 200. 2 20 200 200. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,. 4 8 0 0 0 0 1
pathway: expression, pathway: p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :,,.() 6 8 0 0 0 0 1
(1):139-66. doi: (1):139-66. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ():-.:./.... 12 6 0 0 0 0 1
201. White 201. 2 20 201 201. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,-,,,. 9 9 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ---- 4 8 0 0 0 0 1
hydroxylase. J hydroxylase. h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-.:./ 11 7 0 0 0 0 1
jbc.271.47.29922 jbc.271.47.29922 jbc.271.47.29922 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ... 3 2 0 0 0 0 1
202. Goyal 202. 2 20 202 202. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,.- 7 8 0 0 0 0 1
dehydrocholesterol and dehydrocholesterol d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
Lipid Res lipid L Li Lip Lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./. 11 7 0 0 0 0 1
203. Lepesheva 203. 2 20 203 203. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,.- 4 9 0 0 0 0 1
(CYP51), a (cyp51), ( (C (CY (CYP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 (),.() 6 8 0 0 0 0 1
1770(3):467-77. doi: 1770(3):467-77. 1 17 177 1770 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ():-.:./.... 12 6 0 0 0 0 1
204. Fer 204. 2 20 204 204. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,-,,,. 9 9 0 0 0 0 1
Cytochromes P450 cytochromes C Cy Cyt Cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 7 0 0 0 0 1
enzymes in enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 : 1 7 0 0 0 0 1
metabolism. J metabolism. m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():-.:./.- 13 8 0 0 0 0 1
JLR200 JLR200 jlr200 J JL JLR JLR2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 no 0 0 0 0 0 0 1
205. Wu 205. 2 20 205 205. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,.- 7 9 0 0 0 0 1
pressure regulation: pressure p pr pre pres BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :.()():-. 9 9 0 0 0 0 1
doi: 10.1097/CRD.0b013e3182961659 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :./. 4 4 0 0 0 0 1
206. Kikuta 206. 2 20 206 206. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,.- 5 9 0 0 0 0 1
hydroxylases. Prostaglandins hydroxylases. h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()-:-. 7 8 0 0 0 0 1
doi: 10.1016/s0090-6980(02)00039-4 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :./-()- 7 4 0 0 0 0 1
207. Hardwick 207. 2 20 207 207. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ..() 4 9 0 0 0 0 1
acid metabolism acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .() 3 8 0 0 0 0 1
(12):2263-75. doi: (12):2263-75. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ():-.:./.... 12 5 0 0 0 0 1
208. Ohno 208. 2 20 208 208. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Essential role essential E Es Ess Esse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
acylceramide, the acylceramide, a ac acy acyl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,. 2 9 0 0 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ...()():-.:./. 14 9 0 0 0 0 1
209. Laethem 209. 2 20 209 209. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,. 6 9 0 0 0 0 1
(S)-, 19(R)-, (s)-, ( (S (S) (S)- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()-,()-,()-- 12 9 0 0 0 0 1
cytochrome P450 cytochrome c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-. 8 7 0 0 0 0 1
210. Oliw 210. 2 21 210 210. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ..- 3 10 0 0 0 0 1
human hepatic human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()(- 5 8 0 0 0 0 1
3):258-63. doi: 3):258-63. 3 3) 3): 3):2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ):-.:./-()- 11 5 0 0 0 0 1
211. Brash 211. 2 21 211 211. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,.-,-, 10 9 0 0 0 0 1
and 13-HETE and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -- 2 8 0 0 0 0 1
metabolism in metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 :, 2 9 0 0 0 0 1
the stereochemistry the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -. 2 8 0 0 0 0 1
Biophys (1995) biophys B Bi Bio Biop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./.. 12 7 0 0 0 0 1
212. Morisseau 212. 2 21 212 212. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ... 3 9 0 0 0 0 1
(2013) 95(1):91-5. (2013) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():-.:./.... 14 6 0 0 0 0 1
213. Snider 213. 2 21 213 213. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 7 0 0 0 0 1
metabolism by metabolism m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 7 0 0 0 0 1
enzymes to enzymes e en enz enzy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 no 0 8 0 0 0 0 1
ethanolamides. J ethanolamides. e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-.:./ 11 8 0 0 0 0 1
jpet.107.119321 jpet.107.119321 jpet.107.119321 j jp jpe jpet BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 .. 2 1 0 0 0 0 1
214. Sridar 214. 2 21 214 214. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,.- 5 9 0 0 0 0 1
and polymorphically and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
(2011) 39(5):782-8. (2011) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():-.:./.. 12 5 0 0 0 0 1
215. McDougle 215. 2 21 215 215. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Anti-inflammatory w-3 anti-inflammatory A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 --. 3 8 0 0 0 0 1
(2017) 114(30):E6034-E43. (2017) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()():-.:./. 11 6 0 0 0 0 1
216. Watson 216. 2 21 216 216. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,.- 5 8 0 0 0 0 1
endocannabinoids & endocannabinoids e en end endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
(2019) 143:106337. (2019) ( (2 (20 (201 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ():.:./... 10 7 0 0 0 0 1
217. Shyadehi 217. 2 21 217 217. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
The mechanism the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 7 0 0 0 0 1
recombinant sterol recombinant r re rec reco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -( 2 8 0 0 0 0 1
are: lanosterol are: a ar are are: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 :-,-,). 7 8 0 0 0 0 1
(1996) 271(21):12445-50. (1996) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ()():-.:./... 13 6 0 0 0 0 1
218. Strushkevich 218. 2 21 218 218. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,, 6 8 0 0 0 0 1
HW. Structural hw. H HW HW. HW. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 . 1 8 0 0 0 0 1
monooxygenase system. monooxygenase m mo mon mono BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()():-. 8 8 0 0 0 0 1
doi: 10.1073/pnas.1019441108 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./. 4 3 0 0 0 0 1
219. Griffiths 219. 2 21 219 219. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,.: 4 8 0 0 0 0 1
genes, enzymes genes, g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.() 4 7 0 0 0 0 1
147:106381. doi: 147:106381. 1 14 147 147: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 :.:./... 8 6 0 0 0 0 1
220. Russell 220. 2 22 220 220. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ..,,. 5 10 0 0 0 0 1
Biochem (2003) biochem B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ():-.:./.... 12 8 0 0 0 0 1
221. Cali 221. 2 22 221 221. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,.-. 5 8 0 0 0 0 1
mitochondrial cytochrome mitochondrial m mi mit mito BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
in bile in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 .()():-. 8 7 0 0 0 0 1
222. Lund 222. 2 22 222 222. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 8 0 0 0 0 1
hydroxylase, a hydroxylase, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ,. 2 8 0 0 0 0 1
Acad Sci acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()():-.:./... 13 7 0 0 0 0 1
223. Mast 223. 2 22 223 223. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
Broad substrate broad B Br Bro Broa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 8 0 0 0 0 1
cholesterol degradation cholesterol c ch cho chol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-. 8 8 0 0 0 0 1
doi: 10.1021/bi035512f doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./ 3 2 0 0 0 0 1
224. Bodin 224. 2 22 224 224. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
Metabolism of metabolism M Me Met Meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 -.() 4 8 0 0 0 0 1
(35):31534-40. doi: (35):31534-40. ( (3 (35 (35) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ():-.:./. 9 4 0 0 0 0 1
225. Tuckey 225. 2 22 225 225. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,.- 4 8 0 0 0 0 1
cytochromes P-450scc. cytochromes c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -.()():-.:./ 12 8 0 0 0 0 1
j.1432-1033.1993.tb18235.x j.1432-1033.1993.tb18235.x j.1432-1033.1993.tb18235.x j j. j.1 j.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 .-... 5 3 0 0 0 0 1
226. Petrunak 226. 2 22 226 226. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,. 5 8 0 0 0 0 1
steroidogenic cytochrome steroidogenic s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .() 3 8 0 0 0 0 1
(47):32952-64. doi: (47):32952-64. ( (4 (47 (47) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ():-.:./.. 10 5 0 0 0 0 1
227. Jez 227. 2 22 227 227. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 8 0 0 0 0 1
reductase superfamily. reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()():-. 8 7 0 0 0 0 1
doi: 10.1016/s0006-2952(97)84253-0 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./-()- 7 3 0 0 0 0 1
228. Hyndman 228. 2 22 228 228. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,.- 6 7 0 0 0 0 1
reductase superfamily reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()-:- 6 7 0 0 0 0 1
31. doi: 31. 3 31 31. 31. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .:./-()- 8 4 0 0 0 0 1
229. Spite 229. 2 22 229 229. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
Substrate specificity substrate S Su Sub Subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
phospholipid aldehydes. phospholipid p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()():-.:./ 11 7 0 0 0 0 1
BJ20061743 BJ20061743 bj20061743 B BJ BJ2 BJ20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 no 0 1 0 0 0 0 1
230. O'Connor 230. 2 23 230 230. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .',,,. 6 8 0 0 0 0 1
the function the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
reductase and reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 7 0 0 0 0 1
members. Biochem members. m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:./ 11 8 0 0 0 0 1
231. Cao 231. 2 23 231 231. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,. 4 8 0 0 0 0 1
human aldose human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -.()():-. 9 8 0 0 0 0 1
doi: 10.1074/jbc.273.19.11429 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./... 6 3 0 0 0 0 1
232. Endo 232. 2 23 232 232. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
studies of studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,-: 3 7 0 0 0 0 1
substrates and substrates s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .() 3 8 0 0 0 0 1
(1):1-9. doi: (1):1-9. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ():-.:./.... 12 4 0 0 0 0 1
233. Huang 233. 2 23 233 233. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,.- 9 9 0 0 0 0 1
reductases in reductases r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .():.:.// 9 9 0 0 0 0 1
234. Ruiz 234. 2 23 234 234. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,.- 6 9 0 0 0 0 1
retinoic Acid retinoic r re ret reti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()::. 6 8 0 0 0 0 1
doi: 10.3389/fphar.2012.00058 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./.. 5 3 0 0 0 0 1
235. Barski 235. 2 23 235 235. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 8 0 0 0 0 1
and its and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .() 3 8 0 0 0 0 1
40(4):553-624. doi: 40(4):553-624. 4 40 40( 40(4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ():-.:./ 8 5 0 0 0 0 1
236. Weber 236. 2 23 236 236. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 8 0 0 0 0 1
Aldo-keto Reductase aldo-keto A Al Ald Aldo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 -():- 5 7 0 0 0 0 1
reductase with reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 ---. 4 8 0 0 0 0 1
J Biol j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 5 ()():-.:./.. 12 7 0 0 0 0 1
237. Byrns 237. 2 23 237 237. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ..- 3 8 0 0 0 0 1
parturition. Front parturition. p pa par part BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()::.:./.. 11 8 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 9 11 no 0 8 0 1 0 0 0
28 28 28 2 28 28 28 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 11 no 0 0 0 1 0 0 0
238. Penning 238. 2 23 238 238. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
3alpha-hydroxysteroid dehydrogenase 3alpha-hydroxysteroid 3 3a 3al 3alp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 -(-) 4 8 0 0 0 0 1
aldo-keto reductase aldo-keto a al ald aldo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -: 2 9 0 0 0 0 1
reveals roles reveals r re rev reve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 10 0 0 0 0 1
Biochem J biochem B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./-: 12 8 0 0 0 0 1
239. Burczynski 239. 2 23 239 239. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 9 0 0 0 0 1
species-and Michael species-and s sp spe spec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 --- 3 8 0 0 0 0 1
AKR1C1 reduces akr1c1 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ,---- 5 7 0 0 0 0 1
nonenal to nonenal n no non none BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 ,---.()():-. 12 8 0 0 0 0 1
doi: 10.1074/jbc.M006655200 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :./. 4 3 0 0 0 0 1
240. Lyon 240. 2 24 240 240. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,.- 6 8 0 0 0 0 1
constitutive and constitutive c co con cons BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 no 0 9 0 0 0 0 1
neuroblastoma SH-SY5Y neuroblastoma n ne neu neur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -.()():-. 9 7 0 0 0 0 1
doi: 10.1016/j.neuint.2012.10.007 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :./.... 7 4 0 0 0 0 1
241. Suzuki-Yamamoto 241. 2 24 241 241. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .-,,,-, 7 9 0 0 0 0 1
T, Ito t, T T, T, T, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ,,., 4 8 0 0 0 0 1
prostaglandin F prostaglandin p pr pro pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 .()():-.:./ 11 8 0 0 0 0 1
s0014-5793(99)01551-3 s0014-5793(99)01551-3 s0014-5793(99)01551-3 s s0 s00 s001 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 -()- 4 2 0 0 0 0 1
242. Penning 242. 2 24 242 242. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ..-():. 7 9 0 0 0 0 1
Expert Opin expert E Ex Exp Expe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ()():-.:./ 10 7 0 0 0 0 1
13543776.2017.1379503 13543776.2017.1379503 13543776.2017.1379503 1 13 135 1354 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 .. 2 2 0 0 0 0 1
243. Kondo 243. 2 24 243 243. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Cloning and cloning C Cl Clo Clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 --- 3 8 0 0 0 0 1
reductase and reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 9 0 0 0 0 1
(1994) 219(1-2):357-63. (1994) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()(-):-.:./.-... 16 7 0 0 0 0 1
244. Chen 244. 2 24 244 244. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,. 4 9 0 0 0 0 1
of human of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -().()():-. 11 9 0 0 0 0 1
doi: 10.1016/j.steroids.2011.01.003 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :./.... 7 4 0 0 0 0 1
245. Nikolaou 245. 2 24 245 245. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 . 1 8 0 0 0 0 1
hepatocytes and hepatocytes h he hep hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -. 2 8 0 0 0 0 1
Metabolism (2019) metabolism M Me Met Meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ():-.:./... 11 7 0 0 0 0 1
246. Sakuma 246. 2 24 246 246. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,. 4 9 0 0 0 0 1
hepatic NADPH-dependent hepatic h he hep hepa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -,-- 4 8 0 0 0 0 1
D-fructose. J d-fructose. D D- D-f D-fr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 -.()():-.:./ 12 7 0 0 0 0 1
oxfordjournals.jbchem.a021909 oxfordjournals.jbchem.a021909 oxfordjournals.jbchem.a021909 o ox oxf oxfo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 .. 2 3 0 0 0 0 1
247. Azuma 247. 2 24 247 247. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,,. 8 9 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 9 0 0 0 0 1
family specifically family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .() 3 8 0 0 0 0 1
(7):527-33. doi: (7):527-33. ( (7 (7) (7): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ():-.:.// 9 4 0 0 0 0 1
248. England 248. 2 24 248 248. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,,. 7 8 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 0 0 0 1
human heart. human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():-.:./ 11 9 0 0 0 0 1
pnas.92.14.6309 pnas.92.14.6309 pnas.92.14.6309 p pn pna pnas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ... 3 1 0 0 0 0 1
249. Pan 249. 2 24 249 249. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,. 6 9 0 0 0 0 1
Kv1.1 channel kv1.1 K Kv Kv1 Kv1. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ..() 4 8 0 0 0 0 1
(13):8634-42. doi: (13):8634-42. ( (1 (13 (13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ():-.:./. 9 5 0 0 0 0 1
250. Tipparaju 250. 2 25 250 250. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 9 0 0 0 0 1
and substrate and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -- 2 9 0 0 0 0 1
channel. Biochemistry channel. c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():-.:./ 11 8 0 0 0 0 1
251. Xie 251. 2 25 251 251. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,. 6 9 0 0 0 0 1
carbonyl groups carbonyl c ca car carb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (). 3 8 0 0 0 0 1
(2011) 191(1-3):255-60. (2011) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 ()(-):-.:./.... 15 6 0 0 0 0 1
252. Rasband 252. 2 25 252 252. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,. 3 9 0 0 0 0 1
channels in channels c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .()():-.:./ 11 9 0 0 0 0 1
1096-9861(20000101)429:1<166::aid-cne13>3.0.co;2-y 1096-9861(20000101)429:1<166::aid-cne13>3.0.co;2-y 1096-9861(20000101)429:1<166::aid-cne13>3.0.co;2-y 1 10 109 1096 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 0 -():::-..;- 11 6 0 0 0 0 1
253. Leicher 253. 2 25 253 253. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,. 5 9 0 0 0 0 1
gene product gene g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 0 0 0 0 0 0 9 0 .-. 3 9 0 0 0 0 1
Chem (1998) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:./... 13 7 0 0 0 0 1
254. Ireland 254. 2 25 254 254. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,., 6 9 0 0 0 0 1
and catalytic and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 - 1 9 0 0 0 0 1
superfamily: evidence superfamily: s su sup supe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 :- 2 9 0 0 0 0 1
human liver human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 -. 2 9 0 0 0 0 1
J (1998) j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 ()():-.:./ 10 6 0 0 0 0 1
255. Knight 255. 2 25 255 255. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 .,,,,. 6 8 0 0 0 0 1
cloning, expression cloning, c cl clo clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 ,- 2 7 0 0 0 0 1
metabolizing member metabolizing m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 -,. 3 8 0 0 0 0 1
Carcinogenesis (1999) carcinogenesis C Ca Car Carc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ()():-.:.//.. 13 8 0 0 0 0 1
256. Matsunaga 256. 2 25 256 256. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 9 0 0 0 0 1
9,10-Phenanthrenequinone promotes 9,10-phenanthrenequinone 9 9, 9,1 9,10 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ,-- 3 8 0 0 0 0 1
reductases with reductases r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 .()():-. 8 8 0 0 0 0 1
doi: 10.1007/s00441-011-1304-5 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :./--- 6 3 0 0 0 0 1
257. Luo 257. 2 25 257 257. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,.- 8 9 0 0 0 0 1
family 1, family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,-- 3 9 0 0 0 0 1
pathway. Biochem pathway. p pa pat path BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:./ 11 8 0 0 0 0 1
258. Kelly 258. 2 25 258 258. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,. 5 8 0 0 0 0 1
heterodimeric rat heterodimeric h he het hete BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
Golgi apparatus golgi G Go Gol Golg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
proteins. Biochem proteins. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:./ 11 8 0 0 0 0 1
259. Penning 259. 2 25 259 259. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,. 4 8 0 0 0 0 1
Biology of biology B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 --. 3 8 0 0 0 0 1
Rev (2019) rev R Re Rev Rev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ()():-.:./.- 12 6 0 0 0 0 1
260. Ma 260. 2 26 260 260. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,.- 4 8 0 0 0 0 1
dehydrogenase to dehydrogenase d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 - 1 8 0 0 0 0 1
chimeras: changing chimeras: c ch chi chim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 :. 2 8 0 0 0 0 1
Acad Sci acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()():-.:./... 13 8 0 0 0 0 1
261. Gulbis 261. 2 26 261 261. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 9 0 0 0 0 1
channel beta channel c ch cha chan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:./-() 14 9 0 0 0 0 1
80805-3 80805-3 80805-3 8 80 808 8080 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 - 1 1 0 0 0 0 1
262. Liu 262. 2 26 262 262. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,. 6 9 0 0 0 0 1
coenzymes to coenzymes c co coe coen BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -. 2 9 0 0 0 0 1
Chem Biol chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()-(-):-.:./- 13 8 0 0 0 0 1
(00)00248-9 (00)00248-9 (00)00248-9 ( (0 (00 (00) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ()- 3 1 0 0 0 0 1
263. Di 263. 2 26 263 263. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 10 0 0 0 0 1
aldo-keto reductase aldo-keto a al ald aldo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -. 2 9 0 0 0 0 1
(2006) 400(1):105-14. (2006) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ()():-.:./ 10 5 0 0 0 0 1
264. Jez 264. 2 26 264 264. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,. 6 8 0 0 0 0 1
anatomy of anatomy a an ana anat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -.() 4 8 0 0 0 0 1
3)(Pt 3):625-36. 3)(pt 3 3) 3)( 3)(P BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 )():-.:./ 9 5 0 0 0 0 1
265. Di 265. 2 26 265 265. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,. 5 9 0 0 0 0 1
catalytic mechanism catalytic c ca cat cata BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -(). 4 9 0 0 0 0 1
Endocrinol (2009) endocrinol E En End Endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()(-):-.:./.... 15 8 0 0 0 0 1
266. Nagata 266. 2 26 266 266. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,. 6 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,- 2 9 0 0 0 0 1
1B1-prostaglandin D2 1b1-prostaglandin 1 1B 1B1 1B1- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 -(). 4 9 0 0 0 0 1
(2011) 278(8):1288-98. (2011) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ()():-.:./.-... 15 7 0 0 0 0 1
267. Wang 267. 2 26 267 267. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,.- 8 9 0 0 0 0 1
family 1 family f fa fam fami BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 9 0 0 0 0 1
eliminating carbonyls. eliminating e el eli elim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:./ 11 9 0 0 0 0 1
jbc.M109.022897 jbc.M109.022897 jbc.m109.022897 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 .. 2 2 0 0 0 0 1
268. Li 268. 2 26 268 268. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,.- 5 9 0 0 0 0 1
against the against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 9 0 0 0 0 1
intracellular reactive intracellular i in int intr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 -. 2 9 0 0 0 0 1
Interact (2012) interact I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 ()():-.:./.... 14 7 0 0 0 0 1
269. Li 269. 2 26 269 269. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,. 3 9 0 0 0 0 1
against hydrogen against a ag aga agai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 - 1 9 0 0 0 0 1
associated with associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -. 2 9 0 0 0 0 1
(2012) 33(5):1368-74. (2012) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ()():-.:./.... 14 6 0 0 0 0 1
270. Kabututu 270. 2 27 270 270. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 9 0 0 0 0 1
Prostaglandin F2alpha prostaglandin P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 -, 2 9 0 0 0 0 1
and 1B7. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()():-.:.// 12 7 0 0 0 0 1
271. Komoto 271. 2 27 271 271. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,. 5 9 0 0 0 0 1
human prostaglandin human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ().() 5 8 0 0 0 0 1
(8):2188-98. doi: (8):2188-98. ( (8 (8) (8): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 ():-.:./ 8 4 0 0 0 0 1
272. Zhou 272. 2 27 272 272. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,.- 8 10 0 0 0 0 1
of human of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 -. 2 8 0 0 0 0 1
FASEB J faseb F FA FAS FASE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()():-.:./.- 12 7 0 0 0 0 1
273. Rizner 273. 2 27 273 273. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,. 6 8 0 0 0 0 1
AKR1C3 may akr1c3 A AK AKR AKR1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 no 0 8 0 0 0 0 1
cancer. Mol cancer. c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .()(-):-.:./ 12 8 0 0 0 0 1
j.mce.2005.10.009 j.mce.2005.10.009 j.mce.2005.10.009 j j. j.m j.mc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 5 .... 4 2 0 0 0 0 1
274. Penning 274. 2 27 274 274. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 ..- 3 8 0 0 0 0 1
regulation: insights regulation: r re reg regu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 :. 2 9 0 0 0 0 1
Mol Biol mol M Mo Mol Mol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ()(-):-.:./.... 15 8 0 0 0 0 1
275. Persson 275. 2 27 275 275. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 .,,,,,,. 8 10 0 0 0 0 1
(short-chain dehydrogenase/reductase (short-chain ( (s (sh (sho BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 (-/) 4 8 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 10 11 no 0 8 0 1 0 0 0
29 29 29 2 29 29 29 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 0 0 1 0 0 0
initiative. Chem initiative. i in ini init BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .()(-):-.:./ 12 8 0 0 0 0 1
j.cbi.2008.10.040 j.cbi.2008.10.040 j.cbi.2008.10.040 j j. j.c j.cb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 .... 4 2 0 0 0 0 1
276. Dumont 276. 2 27 276 276. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-,,,., 8 9 0 0 0 0 1
expression, and expression, e ex exp expr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,- 2 9 0 0 0 0 1
dehydrogenase/delta 5-delta dehydrogenase/delta d de deh dehy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 /-. 3 9 0 0 0 0 1
(1992) 99(4):415-21. (1992) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()():-.:./-. 12 6 0 0 0 0 1
277. Labrie 277. 2 27 277 277. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,-,,., 8 10 0 0 0 0 1
and tissue-specific and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --/ 3 9 0 0 0 0 1
5-ene-4-ene isomerase 5-ene-4-ene 5 5- 5-e 5-en BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 --- 3 8 0 0 0 0 1
steroidogenic tissues. steroidogenic s st ste ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1016/0960-0760(92)90308-6 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./-()- 7 4 0 0 0 0 1
278. Rheaume 278. 2 27 278 278. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Structure and structure S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
exclusive 3 exclusive e ex exc excl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -/-- 4 9 0 0 0 0 1
human adrenals human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .()():-. 8 7 0 0 0 0 1
doi: 10.1210/mend-5-8-1147 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./--- 6 3 0 0 0 0 1
279. Schwarz 279. 2 27 279 279. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,. 7 9 0 0 0 0 1
bile acid bile b bi bil bile BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --()-()- 8 7 0 0 0 0 1
oxidoreductase is oxidoreductase o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 9 0 0 0 0 1
Invest (2000) invest I In Inv Inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ()():-.:./ 10 6 0 0 0 0 1
280. Odermatt 280. 2 28 280 280. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,.- 7 9 0 0 0 0 1
sequences of sequences s se seq sequ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
orientation in orientation o or ori orie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .() 3 8 0 0 0 0 1
274(40):28762-70. doi: 274(40):28762-70. 2 27 274 274( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./... 11 5 0 0 0 0 1
281. Luu 281. 2 28 281 281. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Characterization of characterization C Ch Cha Char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
assignment of assignment a as ass assi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 : 1 8 0 0 0 0 1
with distinct with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 '-.() 5 8 0 0 0 0 1
(8):1301-9. doi: (8):1301-9. ( (8 (8) (8): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./--- 11 4 0 0 0 0 1
282. He 282. 2 28 282 282. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 0 0 0 1
multifunctional 17beta-hydroxysteroid multifunctional m mu mul mult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -(). 4 8 0 0 0 0 1
Gene (2016) gene G Ge Gen Gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 0 ()():-.:./.... 14 7 0 0 0 0 1
283. van 283. 2 28 283 283. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .--: 4 9 0 0 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
deficiency. Proc deficiency. d de def defi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....()():-.:./ 14 9 0 0 0 0 1
pnas.95.5.2128 pnas.95.5.2128 pnas.95.5.2128 p pn pna pnas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ... 3 1 0 0 0 0 1
284. Nokelainen 284. 2 28 284 284. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,. 5 9 0 0 0 0 1
estrogenic mouse estrogenic e es est estr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -/- 3 8 0 0 0 0 1
reductase (m17HSD7), reductase r re red redu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 (),- 4 8 0 0 0 0 1
associated protein associated a as ass asso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ().()():-. 10 8 0 0 0 0 1
doi: 10.1210/mend.12.7.0134 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./... 6 3 0 0 0 0 1
285. Marijanovic 285. 2 28 285 285. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Closing the closing C Cl Clo Clos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 :-, 3 9 0 0 0 0 1
unknown enzyme unknown u un unk unkn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 . 1 8 0 0 0 0 1
(2003) 17(9):1715-25. (2003) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()():-.:./.- 12 5 0 0 0 0 1
286. Fahy 286. 2 28 286 286. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,, 7 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 8 0 0 0 0 1
lipids. J lipids. l li lip lipi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .()():-.:./.- 13 9 0 0 0 0 1
JLR200 JLR200 jlr200 J JL JLR JLR2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 no 0 0 0 0 0 0 1
287. Sud 287. 2 28 287 287. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,.: 9 9 0 0 0 0 1
MAPS structure maps M MA MAP MAPS BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 .()(): 6 8 0 0 0 0 1
D527-32. doi: d527-32. D D5 D52 D527 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -.:.// 6 4 0 0 0 0 1
288. Urquhart 288. 2 28 288 288. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,. 4 8 0 0 0 0 1
oxygenation by oxygenation o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -,. 3 8 0 0 0 0 1
Biochim Biophys biochim B Bi Bio Bioc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()():-.:./ 10 7 0 0 0 0 1
j.bbalip.2014.12.015 j.bbalip.2014.12.015 j.bbalip.2014.12.015 j j. j.b j.bb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 .... 4 2 0 0 0 0 1
289. Abraham 289. 2 28 289 289. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 0 0 0 1
Stimulation of stimulation S St Sti Stim BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 no 0 9 0 0 0 0 1
interleukin 2-dependent interleukin i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -.()():- 8 8 0 0 0 0 1
204. doi: 204. 2 20 204 204. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .:./ 4 4 0 0 0 0 1
290. Tang 290. 2 29 290 290. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 0 0 0 1
phospholipase C phospholipase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 no 0 8 0 0 0 0 1
release and release r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -. 2 9 0 0 0 0 1
Physiol Heart physiol P Ph Phy Phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()():-.:./ 10 7 0 0 0 0 1
ajpheart.00491.2005 ajpheart.00491.2005 ajpheart.00491.2005 a aj ajp ajph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 .. 2 2 0 0 0 0 1
291. Dennis 291. 2 29 291 291. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 0 0 0 1
enzymes: physical enzymes: e en enz enzy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 :,,, 4 8 0 0 0 0 1
chemical inhibition, chemical c ch che chem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.() 4 8 0 0 0 0 1
(10):6130-85. doi: (10):6130-85. ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-.:./ 8 4 0 0 0 0 1
292. Vasquez 292. 2 29 292 292. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,. 4 9 0 0 0 0 1
of human of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .():-.:./ 9 8 0 0 0 0 1
j.jbior.2017.10.009 j.jbior.2017.10.009 j.jbior.2017.10.009 j j. j.j j.jb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 .... 4 2 0 0 0 0 1
293. Clark 293. 2 29 293 293. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 9 0 0 0 0 1
arachidonic acid-selective arachidonic a ar ara arac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 -()- 4 8 0 0 0 0 1
translocation domain translocation t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .() 3 7 0 0 0 0 1
(6):1043-51. doi: (6):1043-51. ( (6 (6) (6): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ():-.:./-()- 12 5 0 0 0 0 1
294. Hirabayashi 294. 2 29 294 294. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,. 4 8 0 0 0 0 1
physiological role physiological p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .() 3 8 0 0 0 0 1
27(8):1168-73. doi: 27(8):1168-73. 2 27 27( 27(8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ():-.:./.. 10 4 0 0 0 0 1
295. Strokin 295. 2 29 295 295. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,. 4 9 0 0 0 0 1
release in release r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 0 0 0 1
phospholipase A2 phospholipase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 8 0 0 0 0 1
Pharmacol (2003) pharmacol P Ph Pha Phar BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ()():-.:./.. 12 7 0 0 0 0 1
296. Cheon 296. 2 29 296 296. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 9 0 0 0 0 1
phospholipid and phospholipid p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 - 1 8 0 0 0 0 1
phospholipase A(2)-VIA phospholipase p ph pho phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ()-(())-. 9 8 0 0 0 0 1
(2012) 1821(9):1278-86. (2012) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ()():-.:./.... 14 6 0 0 0 0 1
297. Fonteh 297. 2 29 297 297. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,. 7 8 0 0 0 0 1
Evidence that evidence E Ev Evi Evid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 8 0 0 0 0 1
release and release r re rel rele BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .() 3 8 0 0 0 0 1
(11):5438-46. (11):5438-46. (11):5438-46. ( (1 (11 (11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-. 5 1 0 0 0 0 1
298. Murase 298. 2 29 298 298. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 9 0 0 0 0 1
Secreted Phospholipase secreted S Se Sec Secr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 , 1 8 0 0 0 0 1
Suppresses Colitis, suppresses S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,.() 4 8 0 0 0 0 1
(13):6895-911. doi: (13):6895-911. ( (1 (13 (13) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-.:./.. 10 5 0 0 0 0 1
299. Murakami 299. 2 29 299 299. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ... 3 8 0 0 0 0 1
Acad Ser acad A Ac Aca Acad BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ()():-.:./.. 12 8 0 0 0 0 1
300. Needleman 300. 3 30 300 300. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,. 7 8 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 no 0 7 0 0 0 0 1
thromboxane A2 thromboxane t th thr thro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .() 3 7 0 0 0 0 1
(5561):558-60. doi: (5561):558-60. ( (5 (55 (556 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-.:./ 8 4 0 0 0 0 1
301. Nusing 301. 3 30 301 301. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 8 0 0 0 0 1
Localization of localization L Lo Loc Loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 no 0 8 0 0 0 0 1
antibody Tu antibody a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .() 3 8 0 0 0 0 1
(3):249-54. doi: (3):249-54. ( (3 (3) (3): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-.:./ 8 4 0 0 0 0 1
302. Miyata 302. 3 30 302 302. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,. 7 8 0 0 0 0 1
cloning and cloning c cl clo clon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 . 1 8 0 0 0 0 1
Res Commun res R Re Res Res BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ()():-.:./.. 12 7 0 0 0 0 1
303. Urade 303. 3 30 303 303. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.:. 5 9 0 0 0 0 1
Vitam Horm vitam V Vi Vit Vita BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ():-.:./-()- 12 7 0 0 0 0 1
304. Joo 304. 3 30 304 304. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.. 4 9 0 0 0 0 1
Inflamm (2012) inflamm I In Inf Infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ():.:.// 8 6 0 0 0 0 1
305. Ziganshin 305. 3 30 305 305. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,, 6 8 0 0 0 0 1
Burnstock G. burnstock B Bu Bur Burn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 . 1 8 0 0 0 0 1
adenosine 5'-triphosphate. adenosine a ad ade aden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 '-.()():-. 10 7 0 0 0 0 1
doi: 10.1097/01.AOG.0000161314.50808.dd doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 :./.... 7 4 0 0 0 0 1
306. Sampey 306. 3 30 306 306. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,.-: 6 9 0 0 0 0 1
the inducible the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .() 3 8 0 0 0 0 1
(3):114-7. doi: (3):114-7. ( (3 (3) (3): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ():-.:./ 8 3 0 0 0 0 1
307. Dennis 307. 3 30 307 307. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.. 4 9 0 0 0 0 1
Rev Immunol rev R Re Rev Rev BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ()():-.:./ 10 6 0 0 0 0 1
308. Schieber 308. 3 30 308 308. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,.- 5 10 0 0 0 0 1
ketoreductase from ketoreductase k ke ket keto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .. 2 9 0 0 0 0 1
Eur J eur E Eu Eur Eur BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 ()():-.:./.-... 15 9 0 0 0 0 1
309. Powell 309. 3 30 309 309. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,.,, 5 9 0 0 0 0 1
hydroxyeicosatetraenoic acids hydroxyeicosatetraenoic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 () 2 8 0 0 0 0 1
(oxo-ETEs) derived (oxo-etes) ( (o (ox (oxo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 (-).() 6 8 0 0 0 0 1
1851(4):340-55. doi: 1851(4):340-55. 1 18 185 1851 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ():-.:./.... 12 5 0 0 0 0 1
310. Powell 310. 3 31 310 310. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,.--,,,- 10 9 0 0 0 0 1
potent stimulator potent p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -,, 3 9 0 0 0 0 1
polymerization, and polymerization, p po pol poly BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ,. 2 8 0 0 0 0 1
Cell Mol cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ()():-.:./... 13 7 0 0 0 0 1
311. Hallstrand 311. 3 31 311 311. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,. 3 9 0 0 0 0 1
asthma. Curr asthma. a as ast asth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .()():-.:./ 11 8 0 0 0 0 1
ACI.0b013e32833489c3 ACI.0b013e32833489c3 aci.0b013e32833489c3 A AC ACI ACI. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 . 1 2 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 10 11 no 0 8 0 1 0 0 0
30 30 30 3 30 30 30 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 11 no 0 0 0 1 0 0 0
312. Capra 312. 3 31 312 312. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,. 7 8 0 0 0 0 1
Transcellular biosynthesis transcellular T Tr Tra Tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 9 0 0 0 0 1
Acta (2015) acta A Ac Act Acta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()():-.:./.... 14 7 0 0 0 0 1
313. Chandrasekharan 313. 3 31 313 313. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,-.:' 6 9 0 0 0 0 1
inflammation. J inflammation. i in inf infl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .():-.:./. 10 9 0 0 0 0 1
314. Martin 314. 3 31 314 314. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,. 6 8 0 0 0 0 1
leukotriene B4 leukotriene l le leu leuk BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 . 1 8 0 0 0 0 1
alveolar spaces alveolar a al alv alve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .() 3 9 0 0 0 0 1
84(5):1609-19. doi: 84(5):1609-19. 8 84 84( 84(5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./ 8 4 0 0 0 0 1
315. Feltenmark 315. 3 31 315 315. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,, 6 9 0 0 0 0 1
C, et c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,. 2 9 0 0 0 0 1
via the via v vi via via BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 --. 3 9 0 0 0 0 1
Natl Acad natl N Na Nat Natl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ...()():-.:./. 14 8 0 0 0 0 1
316. Claesson 316. 3 31 316 316. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ..- 3 9 0 0 0 0 1
lipoxygenase-1 in lipoxygenase-1 l li lip lipo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -. 2 7 0 0 0 0 1
Prostaglandins Other prostaglandins P Pr Pro Pros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()(-):-.:./ 11 8 0 0 0 0 1
j.prostaglandins.2008.12.003 j.prostaglandins.2008.12.003 j.prostaglandins.2008.12.003 j j. j.p j.pr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 .... 4 3 0 0 0 0 1
317. Nigam 317. 3 31 317 317. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 10 0 0 0 0 1
The rat the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 -- 2 9 0 0 0 0 1
synthase activity. synthase s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .()():-.:./ 11 8 0 0 0 0 1
jbc.M307576200 jbc.M307576200 jbc.m307576200 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 . 1 1 0 0 0 0 1
318. Cronin 318. 3 31 318 318. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,. 4 8 0 0 0 0 1
identical to identical i id ide iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1194/jlr.M009639 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./. 4 3 0 0 0 0 1
319. Pace-Asciak 319. 3 31 319 319. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .-,,,,,,. 9 9 0 0 0 0 1
glutathione conjugate glutathione g gl glu glut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 : 1 9 0 0 0 0 1
nervous system. nervous n ne ner nerv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ....()():-. 11 7 0 0 0 0 1
doi: 10.1073/pnas.87.8.3037 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./... 6 3 0 0 0 0 1
320. Mrsny 320. 3 32 320 320. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 : 1 9 0 0 0 0 1
neutrophil migration neutrophil n ne neu neut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .... 4 9 0 0 0 0 1
(2004) 101(19):7421-6. (2004) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()():-.:./. 11 6 0 0 0 0 1
321. Serhan 321. 3 32 321 321. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,. 7 9 0 0 0 0 1
functional sets functional f fu fun func BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
generated from generated g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -- 2 8 0 0 0 0 1
antiinflammatory drugs antiinflammatory a an ant anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .() 3 8 0 0 0 0 1
192(8):1197-204. doi: 192(8):1197-204. 1 19 192 192( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./... 11 5 0 0 0 0 1
322. Arita 322. 3 32 322 322. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,. 4 9 0 0 0 0 1
oxygenase to oxygenase o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -: 2 8 0 0 0 0 1
oxygenase products oxygenase o ox oxy oxyg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 8 0 0 0 0 1
Biophys Res biophys B Bi Bio Biop BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()():-.:./.... 14 8 0 0 0 0 1
323. Tjonahen 323. 3 32 323 323. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Resolvin E2: resolvin R Re Res Reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 :-: 3 9 0 0 0 0 1
human 5-lipoxygenase human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 -.() 4 9 0 0 0 0 1
(11):1193-202. doi: (11):1193-202. ( (1 (11 (11) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./.... 12 6 0 0 0 0 1
324. Oh 324. 3 32 324 324. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,.-: 6 9 0 0 0 0 1
aspirin and aspirin a as asp aspi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .() 3 9 0 0 0 0 1
1811(11):737-47. doi: 1811(11):737-47. 1 18 181 1811 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ():-.:./.... 12 6 0 0 0 0 1
325. Isobe 325. 3 32 325 325. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Identification and identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 - 1 8 0 0 0 0 1
mediator resolvin mediator m me med medi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,,-. 4 8 0 0 0 0 1
(2012) 287(13):10525-34. (2012) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 0 ()():-.:./.. 12 6 0 0 0 0 1
326. Serhan 326. 3 32 326 326. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,.:- 5 8 0 0 0 0 1
resolving superfamily resolving r re res reso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1172/JCI97943 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./ 3 2 0 0 0 0 1
327. Dalli 327. 3 32 327 327. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
novel 13S,14S-epoxy-maresin novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ,-- 3 7 0 0 0 0 1
maresin 1 maresin m ma mar mare BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 (),(), 6 8 0 0 0 0 1
macrophage phenotype. macrophage m ma mac macr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 .()():-.:./.- 13 8 0 0 0 0 1
227728 227728 227728 2 22 227 2277 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 0 no 0 0 0 0 0 0 1
328. Aursnes 328. 3 32 328 328. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,,. 8 9 0 0 0 0 1
Synthesis of synthesis S Sy Syn Synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 0 ,- 2 9 0 0 0 0 1
Protectins by protectins P Pr Pro Prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 .()():-. 8 8 0 0 0 0 1
doi: 10.1021/acs.jnatprod.5b00574 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 0 :./.. 5 4 0 0 0 0 1
329. Jouvene 329. 3 32 329 329. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 .,,,,,. 7 8 0 0 0 0 1
Biosynthetic metabolomes biosynthetic B Bi Bio Bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 -. 2 8 0 0 0 0 1
FASEB J faseb F FA FAS FASE BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ()():-.:./. 11 7 0 0 0 0 1
330. Hammond 330. 3 33 330 330. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,'.:, 6 7 0 0 0 0 1
characterization and characterization c ch cha char BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .() 3 7 0 0 0 0 1
(10):2403-12. doi: (10):2403-12. ( (1 (10 (10) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ():-.:./.... 12 5 0 0 0 0 1
331. Maskrey 331. 3 33 331 331. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,-,,-,, 8 9 0 0 0 0 1
Taylor GW, taylor T Ta Tay Tayl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 6 ,. 2 7 0 0 0 0 1
hydroxyphosphatidylethanolamines via hydroxyphosphatidylethanolamines h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .() 3 8 0 0 0 0 1
282(28):20151-63. doi: 282(28):20151-63. 2 28 282 282( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ():-.:./. 9 5 0 0 0 0 1
332. Morgan 332. 3 33 332 332. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,'.- 7 8 0 0 0 0 1
human platelets human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -- 2 7 0 0 0 0 1
containing phospholipids containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -.() 4 7 0 0 0 0 1
(1):141-8. doi: (1):141-8. ( (1 (1) (1): BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ():-.:./ 8 4 0 0 0 0 1
333. Thomas 333. 3 33 333 333. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,. 8 8 0 0 0 0 1
Phospholipid-esterified eicosanoids phospholipid-esterified P Ph Pho Phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 -- 2 8 0 0 0 0 1
human platelets human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 7 0 0 0 0 1
generation. J generation. g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./ 11 7 0 0 0 0 1
jbc.M109.078428 jbc.M109.078428 jbc.m109.078428 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .. 2 1 0 0 0 0 1
334. Aldrovandi 334. 3 33 334 334. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,, 6 8 0 0 0 0 1
LJ, et lj, L LJ LJ, LJ, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ,.- 3 9 0 0 0 0 1
cyclooxygenase-1 that cyclooxygenase-1 c cy cyc cycl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -. 2 8 0 0 0 0 1
J Lipid j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 6 ()():-.:./. 11 7 0 0 0 0 1
335. Karara 335. 3 33 335 335. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,. 5 7 0 0 0 0 1
epoxyeicosatrienoyl-phospholipids. A epoxyeicosatrienoyl-phospholipids. e ep epo epox BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 -. 2 8 0 0 0 0 1
containing epoxidized containing c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .() 3 8 0 0 0 0 1
(12):7561-9. (12):7561-9. (12):7561-9. ( (1 (12 (12) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ():-. 5 1 0 0 0 0 1
336. O'Donnell 336. 3 33 336 336. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .',,,. 6 8 0 0 0 0 1
oxidized phospholipids oxidized o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 8 0 0 0 0 1
innate immunity innate i in inn inna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():. 7 8 0 0 0 0 1
doi: 10.1126/scisignal.aau2293 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 :./. 4 3 0 0 0 0 1
337. Morgan 337. 3 33 337 337. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,, 7 8 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .-: 3 9 0 0 0 0 1
localization and localization l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 --. 3 8 0 0 0 0 1
Chem (2009) chem C Ch Che Chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ()():-.:./.. 12 7 0 0 0 0 1
338. Liu 338. 3 33 338 338. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,. 7 8 0 0 0 0 1
oxidized phospholipids oxidized o ox oxi oxid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 --- 3 7 0 0 0 0 1
lysophospholipids. J lysophospholipids. l ly lys lyso BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .()():-.:./ 11 8 0 0 0 0 1
jbc.RA119.008766 jbc.RA119.008766 jbc.ra119.008766 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .. 2 2 0 0 0 0 1
339. Jenkins 339. 3 33 339 339. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,. 7 9 0 0 0 0 1
is an is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 0 0 0 0 1
and plasmenylethanolamine and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -. 2 8 0 0 0 0 1
(2018) 293(22):8693-709. (2018) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ()():-.:./.. 12 6 0 0 0 0 1
340. Schroepfer 340. 3 34 340 340. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ..: 3 9 0 0 0 0 1
processes. Physiol processes. p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./.... 15 9 0 0 0 0 1
341. Bjorkhem 341. 3 34 341 341. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,. 8 10 0 0 0 0 1
From brain from F Fr Fro From BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 .- 2 8 0 0 0 0 1
important for important i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -() 3 8 0 0 0 0 1
humans. J humans. h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./ 11 7 0 0 0 0 1
jbc.M103828200 jbc.M103828200 jbc.m103828200 j jb jbc jbc. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 . 1 1 0 0 0 0 1
342. Tuckey 342. 3 34 342 342. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.- 4 8 0 0 0 0 1
purified from purified p pu pur puri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 :- 2 8 0 0 0 0 1
450scc. Biochim 450scc. 4 45 450 450s BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .()():-.:./- 12 8 0 0 0 0 1
4838(93)90180-y 4838(93)90180-y 4838(93)90180-y 4 48 483 4838 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ()- 3 1 0 0 0 0 1
343. Mast 343. 3 34 343 343. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,. 7 9 0 0 0 0 1
Structural basis structural S St Str Stru BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 - 1 9 0 0 0 0 1
chain cleavage chain c ch cha chai BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-. 8 7 0 0 0 0 1
doi: 10.1074/jbc.M110.188433 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 :./.. 5 3 0 0 0 0 1
344. Lund 344. 3 34 344 344. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,. 6 9 0 0 0 0 1
human cholesterol human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -, 2 8 0 0 0 0 1
synthesize a synthesize s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 . 1 8 0 0 0 0 1
(1998) 273(51):34316-27. (1998) ( (1 (19 (199 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ()():-.:./... 13 6 0 0 0 0 1
345. Blanc 345. 3 34 345 345. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,. 8 9 0 0 0 0 1
transcription factor transcription t tr tra tran BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -- 2 7 0 0 0 0 1
hydroxycholesterol to hydroxycholesterol h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 .() 3 8 0 0 0 0 1
38(1):106-18. doi: 38(1):106-18. 3 38 38( 38(1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ():-.:./.... 12 5 0 0 0 0 1
346. Bauman 346. 3 34 346 346. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,, 6 7 0 0 0 0 1
Russell DW. russell R Ru Rus Russ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 6 .- 2 8 0 0 0 0 1
Toll-like receptor toll-like T To Tol Toll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 -. 2 8 0 0 0 0 1
Natl Acad natl N Na Nat Natl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ()():-.:./. 11 8 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 11 11 no 0 8 0 1 0 0 0
31 31 31 3 31 31 31 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 0 0 1 0 0 0
347. McDonald 347. 3 34 347 347. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.:-: 6 9 0 0 0 0 1
immunology. J immunology. i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .()():-.:./. 12 8 0 0 0 0 1
348. Liu 348. 3 34 348 348. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,.- 9 9 0 0 0 0 1
inducible cholesterol-25-hydroxylase inducible i in ind indu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -- 2 8 0 0 0 0 1
production of production p pr pro prod BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 -.()():-. 9 8 0 0 0 0 1
doi: 10.1016/j.immuni.2012.11.005 doi: d do doi doi: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 :./.... 7 4 0 0 0 0 1
349. Hannedouche 349. 3 34 349 349. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,. 8 8 0 0 0 0 1
Oxysterols direct oxysterols O Ox Oxy Oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 .() 3 8 0 0 0 0 1
(7357):524-7. doi: (7357):524-7. ( (7 (73 (735 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ():-.:./ 8 4 0 0 0 0 1
350. Liu 350. 3 35 350 350. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,.- 9 9 0 0 0 0 1
cell migration cell c ce cel cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .()():-.:./ 11 9 0 0 0 0 1
nature10226 nature10226 nature10226 n na nat natu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 no 0 1 0 0 0 0 1
351. Bodin 351. 3 35 351 351. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,. 8 9 0 0 0 0 1
Antiepileptic drugs antiepileptic A An Ant Anti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 - 1 8 0 0 0 0 1
humans: evidence humans: h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 :. 2 8 0 0 0 0 1
(2001) 276(42):38685-9. (2001) ( (2 (20 (200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ()():-.:./. 11 6 0 0 0 0 1
352. Heverin 352. 3 35 352 352. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,. 8 9 0 0 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -:- 3 8 0 0 0 0 1
genes when genes g ge gen gene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 . 1 9 0 0 0 0 1
Biol (2007) biol B Bi Bio Biol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ()():-.:./.. 12 7 0 0 0 0 1
353. Pandak 353. 3 35 353 353. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.: 4 9 0 0 0 0 1
an alternative an a an an an BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 ().()():-.:./ 13 8 0 0 0 0 1
j.livres.2019.05.001 j.livres.2019.05.001 j.livres.2019.05.001 j j. j.l j.li BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 .... 4 2 0 0 0 0 1
354. Griffiths 354. 3 35 354 354. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,-,,,,. 9 9 0 0 0 0 1
Metabolism of metabolism M Me Met Meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 -: 2 8 0 0 0 0 1
metabolic disorders. metabolic m me met meta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .():-.:./ 9 8 0 0 0 0 1
j.freeradbiomed.2019.04.020 j.freeradbiomed.2019.04.020 j.freeradbiomed.2019.04.020 j j. j.f j.fr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 .... 4 3 0 0 0 0 1
355. Abdel-Khalik 355. 3 35 355 355. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .-,,,,,,. 9 9 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ,------- 8 8 0 0 0 0 1
7alpha,25-dihydroxy-3-oxocholest-4-en-26-oic acids 7alpha,25-dihydroxy-3-oxocholest-4-en-26-oic 7 7a 7al 7alp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,------- 8 7 0 0 0 0 1
cerebrospinal fluid cerebrospinal c ce cer cere BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .():-.:./ 9 8 0 0 0 0 1
j.biochi.2018.06.020 j.biochi.2018.06.020 j.biochi.2018.06.020 j j. j.b j.bi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 .... 4 2 0 0 0 0 1
356. Vaz 356. 3 35 356 356. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,. 3 9 0 0 0 0 1
biosynthesis. Mol biosynthesis. b bi bio bios BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 .():-.:./.... 13 9 0 0 0 0 1
357. Mazzacuva 357. 3 35 357 357. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,,,. 8 9 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 0 0 0 0 1
Niemann-Pick C niemann-pick N Ni Nie Niem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 -.()():-.:./ 12 8 0 0 0 0 1
1873-3468.12196 1873-3468.12196 1873-3468.12196 1 18 187 1873 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 -. 2 1 0 0 0 0 1
358. Jiang 358. 3 35 358 358. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,-,,,,. 9 9 0 0 0 0 1
Development of development D De Dev Deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 0 -- 2 8 0 0 0 0 1
type C. type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .()():.:./. 11 8 0 0 0 0 1
aaf2326 aaf2326 aaf2326 a aa aaf aaf2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 no 0 0 0 0 0 0 1
359. Setchell 359. 3 35 359 359. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,',,,,. 9 9 0 0 0 0 1
Identification of identification I Id Ide Iden BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 : 1 9 0 0 0 0 1
oxysterol 7alpha-hydroxylase oxysterol o ox oxy oxys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 -. 2 9 0 0 0 0 1
Invest (1998) invest I In Inv Inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 ()():-.:./ 10 6 0 0 0 0 1
360. Sjövall 360. 3 36 360 360. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,,,,.. 7 10 0 0 0 0 1
In: H in: I In In: In: BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 :,..: 5 8 0 0 0 0 1
(2010). p. (2010). ( (2 (20 (201 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ()..-.:./ 9 5 0 0 0 0 1
361. Axelson 361. 3 36 361 361. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,.- 4 9 0 0 0 0 1
indicators of indicators i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 8 0 0 0 0 1
in man. in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 6 .()():-.:./-() 14 8 0 0 0 0 1
90182-R 90182-R 90182-r 9 90 901 9018 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 - 1 0 0 0 0 0 1
362. Rose 362. 3 36 362 362. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,., 9 9 0 0 0 0 1
novel brain novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 , 1 8 0 0 0 0 1
7alpha-hydroxy dehydroepiandrosterone 7alpha-hydroxy 7 7a 7al 7alp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -- 2 6 0 0 0 0 1
pregnenolone. Proc pregnenolone. p pr pre preg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 ....()():-.: 12 8 0 0 0 0 1
10.1073/pnas.94.10.4925 10.1073/pnas.94.10.4925 10.1073/pnas.94.10.4925 1 10 10. 10.1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ./... 5 2 0 0 0 0 1
363. Schwarz 363. 3 36 363 363. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,.- 5 9 0 0 0 0 1
acid biosynthesis. acid a ac aci acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./ 11 8 0 0 0 0 1
00041433-199804000-00006 00041433-199804000-00006 00041433-199804000-00006 0 00 000 0004 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 -- 2 3 0 0 0 0 1
364. Shackleton 364. 3 36 364 364. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .. 2 9 0 0 0 0 1
of sterol of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./ 11 9 0 0 0 0 1
s11745-011-3605-6 s11745-011-3605-6 s11745-011-3605-6 s s1 s11 s117 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 --- 3 2 0 0 0 0 1
365. Andrew 365. 3 36 365 365. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 ... 3 9 0 0 0 0 1
Endocrinol Metab endocrinol E En End Endo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ()():-.:./.. 12 7 0 0 0 0 1
366. Baulieu 366. 3 36 366 366. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,.:. 6 9 0 0 0 0 1
Int Rev int I In Int Int BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ():-.:./-()- 12 8 0 0 0 0 1
367. Schumacher 367. 3 36 367 367. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,, 6 8 0 0 0 0 1
Nicola AF, nicola N Ni Nic Nico BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 6 ,. 2 9 0 0 0 0 1
stress, neurodegeneration stress, s st str stre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 ,. 2 9 0 0 0 0 1
(2015) 103:42-57. (2015) ( (2 (20 (201 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ():-.:./.... 12 6 0 0 0 0 1
368. Storbeck 368. 3 36 368 368. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,. 8 10 0 0 0 0 1
Steroid Metabolome steroid S St Ste Ster BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 no 0 8 0 0 0 0 1
and Metabolism. and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 .()():-.:./.- 13 8 0 0 0 0 1
00262 00262 00262 0 00 002 0026 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 6 no 0 0 0 0 0 0 1
369. Schiffer 369. 3 36 369 369. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,,. 8 9 0 0 0 0 1
Human steroid human H Hu Hum Huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 6 , 1 8 0 0 0 0 1
reflected by reflected r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 :. 2 8 0 0 0 0 1
J Steroid j J J J J BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 6 ():.:./ 7 7 0 0 0 0 1
j.jsbmb.2019.105439 j.jsbmb.2019.105439 j.jsbmb.2019.105439 j j. j.j j.js BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 6 ... 3 2 0 0 0 0 1
370. Krone 370. 3 37 370 370. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 .,,,,,. 7 9 0 0 0 0 1
chromatography/mass spectrometry chromatography/mass c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 6 /(/)- 5 7 0 0 0 0 1
discovery tool discovery d di dis disc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 no 0 9 0 0 0 0 1
chromatography tandem chromatography c ch chr chro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 (//). 5 8 0 0 0 0 1
Mol Biol mol M Mo Mol Mol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ()(-):-.:./.... 15 8 0 0 0 0 1
Conflict of conflict C Co Con Conf BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 : 1 9 0 0 0 0 1
absence of absence a ab abs abse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 10 0 0 0 0 1
potential conflict potential p po pot pote BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 3 0 0 0 0 1
Copyright © copyright C Co Cop Copy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ,,,'.- 6 9 0 0 0 0 1
access article access a ac acc acce BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 no 0 9 0 0 0 0 1
License (CC license L Li Lic Lice BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 ().,, 5 9 0 0 0 0 1
provided the provided p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ()() 4 9 0 0 0 0 1
original publication original o or ori orig BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 , 1 9 0 0 0 0 1
practice. No practice. p pr pra prac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 ., 2 10 0 0 0 0 1
these terms. these t th the thes BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 10 . 1 1 0 0 0 0 1
Hajeyah et hajeyah H Ha Haj Haje BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 . 1 4 0 1 0 0 0
Biosynthesis of biosynthesis B Bi Bio Bios BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 no 0 10 0 1 0 0 0
Frontiers in frontiers F Fr Fro Fron BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 11 .. 2 10 0 1 1 0 0
November 2020 november N No Nov Nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 1 0 0 11 11 no 0 8 0 1 0 0 0
32 32 32 3 32 32 32 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 11 no 0 0 0 1 0 0 0

